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ABSTRACT 
 
Background:  Black South African women living in urban settings have the highest 
prevalence of obesity in the sub–Saharan African region, and consequently a high prevalence 
of cardiometabolic diseases.  The risk factors for obesity and the metabolic syndrome are not 
well studied in this population group, and the inter–relationship between diseases risk factors 
for metabolic syndrome is poorly understood, in addition to whether one factor predominates.  
 
Aim:  The aim is three–fold: (i) To assess the physical activity patterns of middle–aged, 
urban black South African women, and if these patterns are associated with metabolic 
outcomes; (ii) To examine the association between lifestyle and psycho–social factors and 
changes in body composition over 10 years in this population; and (iii) To identify risk 
factors for the various components of metabolic syndrome. 
 
Methods:  Drawing on the longitudinal Birth to Twenty Plus cohort (a longitudinal study of 
the health and development of children and their families) data collected in 2003 and 2013 
was used to address the respective aims of the thesis. In particular, data on (i) anthropometry; 
(ii) body composition; (iii) blood pressure; (iv) cardiometabolic markers; (v) environmental 
factors (physical activity, smoking and smokeless tobacco consumption, and alcohol 
consumption); (vi) psycho–social factors; (vii) socio–economic status; and (viii) education 
status was used. Analytical methods comprised of descriptive, correlations, comparisons, 
multivariable regression, and logistic regression. Paper 1 described the patterns, levels and 
correlates of physical activity in 977 African women.  Paper 2 was a longitudinal study of the 
role of environmental and psycho–social factors in predicting changes in body composition 
over 10 years (N=430).  Body composition from ultrasound and DXA analyses, blood 
pressure, cardiometabolic and demographic factors were measured in 702 black African 
women from Soweto, Johannesburg for paper 3, which was a descriptive, cross–sectional 
study using data from the 2011/13 wave of data collection. 
 
  
viii 
 
Results:  The prevalence of obesity (48.0% (baseline) to 67.8% (follow–up)) and metabolic 
syndrome (40.0% (baseline) to 49.6% (follow–up)  increased significantly over ten years.  
The majority of the population were classified as “active” according to global physical 
activity questionnaire criteria, and the domain that contributed most to overall weekly 
physical activity was walking for travel. Sitting time (mins/wk) was not different between the 
activity groups, but was positively associated with triglyceride levels and diastolic blood 
pressure.  Total physical activity was inversely associated with fasting insulin, and physical 
activity in the work domain was associated with fat–free, soft–tissue mass. Two distinct 
groups of overweight/obese females were identified using body–size dissatisfaction and 
body–size discrepancy scores: one that was content with their body–size and one that wished 
to be leaner. Vigorous physical activity at baseline was inversely associated with absolute 
changes in all measures of adiposity.  In subjects who underestimated their body–size at 
baseline (74.0 % of the study population) changes in total and peripheral levels of body fat 
were less than in subjects who correctly identified their body–size. In the group that 
underestimated body–size, more women wanted to be leaner than in the group who knew 
their body–size (60.1 % vs 47.5 %, p < 0.05).  Logistic regression analysis demonstrated that 
adiponectin (odds ratio [95% CIs]: 0.84 [0.77, 0.92], p<0.0005) and abdominal subcutaneous 
fat (0.56 [0.39, 0.79], p=0.001) reduced metabolic syndrome risk whilst insulin resistance 
(1.31 [1.16, 1.48], p<0.0005) and trunk fat–free, soft–tissue mass (1.34 [1.10, 1.61], p=0.002) 
increased risk. Within this group of risk factors, the relationship of adiponectin with 
metabolic syndrome risk, when analysed across adiponectin hexiles, was the least affected by 
adjustment for the other risk factors. 
 
Conclusions:  The findings of this thesis show that the majority of urban black South African 
women have a high prevalence of obesity and cardiometabolic disease risk factors despite 
being classified as ‘physically active’.  However, the intensity of the respective domains of 
physical activity is unknown.  As walking as a means of travel/transport is a major 
contributor to physical activity, future research should attempt to determine whether the 
intensity of this activity plays a role in the prevention of cardiometabolic diseases.  It was 
also demonstrated that an underestimation of body–size is common and is associated with a 
lower gain in total body adiposity and a desire to lose weight in most of the participants.   
Finally, this thesis observed that adiponectin has a significant protective role against 
metabolic syndrome that is independent of other risk factors. The protective and augmentive 
ix 
 
effects of abdominal subcutaneous fat and lean trunk mass, respectively, on metabolic 
syndrome risk demonstrate the existence of novel interactions between body composition and 
cardiometabolic disease. 
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PREFACE 
 
The 2010 Wits Faculty of Health Sciences’ Prestigious Research Lecture entitled, “Mandela’s 
Children: Securing the health and well–being of future generations,” was the main motivator 
for this doctoral study (1). The speakers highlighted the main health challenges of children 
and infants in South Africa, and how these were possibly related to the adult manifestation of 
disease, particularly in black South African women living in urban settings.  The researcher 
was intrigued to learn of the increasing obesity epidemic in the country and its influence on 
metabolic syndrome in these women. 
 
The obesity epidemic has become more noticeable in children and adults since 2000, with 
low–and–middle–income countries (LMIC) predicted to continue increasing, yet seems to be 
decelerating in richer countries (2). Obesity is a complex multifaceted disease, which is 
thought to be strongly related to lifestyle behaviours, and is linked to hypercholesterolaemia,  
hypertension, and other chronic diseases (3).  A worrying observation is the increasing 
prevalence of metabolic syndrome in African women (4), an entity that has been shown to 
increase the risk of cardiac events and diabetes. Traditional African culture has demonstrated 
a social preference for larger body–size and general tolerance of obesity in African women 
(5).  These psycho–social factors and the fact that an urban environment is more obesogenic 
than a rural setting, poses a greater risk of obesity and related diseases in urbanised black 
South African women.     
 
An opportunity to investigate this trend further developed when I was granted permission, as 
part of my PhD project, to recruit caregivers from the Birth–to–Twenty (Bt20) study, based in 
Soweto, Johannesburg (6).   The researcher was able to collect advanced body composition 
data using dual energy x–ray absorptiometry and ultrasonography, and to document body 
image perception, and the level of physical activity of the women as a result of the equipment 
and tools available at Bt20. Therefore, the results of this thesis add to the limited evidence 
regarding body fat distribution, biochemical, environmental and psycho–social factors 
associated with obesity and related cardiometabolic disorders in black South African women. 
 
1 
 
STRUCTURE OF THE DOCUMENT 
 
The thesis is with publications and there are three parts to the thesis (Figure 1.1).  
 Part 1 of the thesis comprises the literature review and the consolidated methodology, 
Chapters 1 and 2, respectively. 
 Part 2 of the thesis encompasses the results Chapters 3, 4, and 5 which contain the 
findings of the studies. 
 Part 3 is the final component of the thesis and includes the conclusions and suggestions 
for future research (Chapter 6). 
 
 
Figure 1.1: Graphical representation of the publications in this PhD thesis 
 
 
PhD thesis 
Paper 1 (Chapter 3) 
Patterns, levels and correlates of self–
reported physical activity in urban 
black Soweto women 
 
Paper 2 (Chapter 4) 
The role of lifestyle and psycho–social 
factors in predicting changes in body 
composition in black South African 
women  
 
Paper 3 (Chapter 5) 
Metabolic and body composition risk 
factors associated with metabolic 
syndrome in a cohort of black sub–
Saharan African women 
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PART 1 
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CHAPTER 1 – LITERATURE REVIEW  
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1.1 Introduction 
 
The constellation of components that form the metabolic syndrome are prevalent in black 
African transitioning societies (2, 4, 7-9).  Primary health care in South Africa is currently 
being reformed into one that is more inclusive and multi–disciplinary  (10).  The focus is 
shifting away from community clinics that only specialise on individual non–communicable 
diseases (NCD) such as diabetes or hypertension as discrete components towards a holistic 
approach to disease management whereby one clinic is able to deal with multiple disorders 
(11).  Given the fact that the South African health care system is being re–engineered it is 
important to look at the components of metabolic syndrome not as discrete and individualistic 
but more as a constellation of factors.  Even though there are some that criticise the use of the 
term ‘metabolic syndrome’, most critics have settled on the fact that there are subjects who 
have a higher risk of cardiometabolic diseases compared with others (12-14). Therefore a 
critical part of impacting or intervening on the high prevalence of obesity and metabolic 
syndrome in black South African women is to understand the contributing factors driving 
these diseases. 
 
1.2 Conceptual Framework 
 
The conceptual framework used for this thesis is displayed in Figure 1.2.  It has been adapted 
and modified from Brunzell et al. (15) whose model suggests that the risk factors for 
cardiovascular disease can appear as individual elements, that lead to the emergence of  a 
collection of various cardiometabolic diseases, essentially represented by the metabolic 
syndrome.  Since the clustering of these elements increases the overall risk of morbidity and 
cardiovascular disease (16), it is important to determine the underlying risk factors involved. 
 
Data from other developing African countries undergoing rapid urbanisation demonstrate that 
the prevalence of the separate metabolic syndrome components are higher in urban dwelling 
women compared with those living in the rural setting (17-19).  Obesity has a positive 
association with metabolic syndrome (20), and can result in endocrine abnormalities and 
early mortality as illustrated in Figure 1.2.   There is a lack of data on the physical activity 
5 
 
patterns of African populations (21), and the influence of psycho–social factors on obesity is 
not confirmed in adult African women (22).  Therefore, the framework also depicts the 
possible influence of socio–economic, lifestyle and psycho–social factors on obesity and 
metabolic syndrome.  Identifying the risk factors influencing obesity and metabolic syndrome 
is fundamental to understanding the high prevalence of the individual cardiometabolic 
diseases in black South African women, particularly in those women living in urban areas 
who seem to be more susceptible to this phenomenon. 
 
 
 
Figure 1.2: Potential factors associated with obesity and metabolic syndrome; adapted 
from: Brunzell et al. (2008) (15).  The proposed linkages between the elements are 
represented by dashed lines in this conceptual, hypothetical framework. 
 
The subsequent sections provide an overview of the possible risk factors for obesity and 
metabolic syndrome, followed by a review of the studies examining the contribution of body 
composition, metabolic factors, psycho–social factors, socio–economic status, and 
environmental factors on the development of metabolic syndrome. 
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1.3 Obesity 
1.3.1 Background  
 
In Africa, women notably have higher body mass index (BMI) values than men, and black 
South African women have the greatest obesity prevalence in the sub–Saharan African region 
(2).  Black women in South Africa are more affected by NCDs compared with men (23), a 
development  which is characteristic of other countries on the African continent and LMICs 
(24, 25).  Furthermore, obesity is higher in urban black South African women compared with 
those women living in rural South Africa (26), and the increasing movement of populations 
from rural to urban settings is an important contributing factor to the obesity epidemic in 
sub–Saharan Africa (27-29).  
 
Urbanisation in Africa is known to encompass the adoption of behaviours such as unhealthy 
eating and physical inactivity (30).  Therefore, urban–dwelling black South African women 
are also estimated to expend less energy than rural women (21, 31), and are considerably 
more sedentary (32).  These lifestyle behaviours are thought to influence obesity and its 
related disorders, particularly resulting in higher fat accumulation and insulin resistance in 
black Africans compared with white subjects (33).  Other behavioural factors that increase 
obesity risk are tobacco use and the overconsumption of alcohol and dietary fats (34).  As 
people transition, walking as a means of transport decreases as socio–economic status (SES) 
improves (35), which is concerning for the future risk of metabolic syndrome in African 
populations.  Black South African women are also generally poorer; less educated and have 
lower SES levels than other population groups in the country (36).  These factors have been 
associated with the obesity epidemic in African women (22). Moreover, traditional beliefs 
around body image have been demonstrated to impact on obesity, driven mostly by a general 
acceptance of larger body–size in African populations  (22).  In the following sections I will 
discuss factors specific for obesity and in a later section I will discuss factors common to 
obesity and metabolic syndrome. 
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1.3.2 Definition 
 
Obesity is a disease characterized by both fat deposition of new fat cells and an increase in 
the size of existing cells that endangers health (37).  It was generally thought that excess body 
fat deposition resulted from a discrepancy between energy output (physical activity) and 
energy intake (caloric intake). The result is a positive energy balance and if this pattern 
continues, overweight and obesity will develop over time.  In essence, traditional thinking 
attributed obesity to an excess intake of food, and not enough physical activity. The aetiology 
regarding obesity is however more complex than this simplistic theoretical model.  For 
example, energy output can be in the form of erratic behaviour such as restlessness while 
sitting (38), a percentage of the food consumed is eliminated during the digestive process 
rather than absorbed (39), and most of the available tools for the measurement of energy 
output do not account for these confounding factors. The present lifestyles of South Africans 
have been made easier by the global technological advancement, resulting in vocations that 
require minimal energy expenditure (40, 41).  Although caloric intake has been shown to be 
associated with obesity (42), factors such as hereditary and smoking may also be associated 
with lower risk of weight gain, implying that obesity is not simply a disease of over 
consumption.  Bouchard et al. for example have shown that the variance in weight gain could 
be attributed to heredity factors (43, 44), while a Danish adoption study observed that the 
BMI categories of adoptees and their biological parents were correlated (45). These studies 
suggest that genetics has a major input into determining body fat mass. 
 
Approximately three million deaths globally are caused by cardiometabolic diseases such as 
diabetes annually, for which excessive body weight is one of the main risk factors (46, 47). A 
crude measure used to determine excess body weight is body mass index (BMI), which uses a 
weight for height index to reflect adult total body fat (48).  It is calculated by dividing the 
persons total body weight (kg) by the square of the standing height (in metres). Categories of 
BMI include normal (BMI≥18.5 and <25 kg/m2), overweight (BMI: ≥25, but <30 kg/m2), and 
obesity (BMI: ≥30 kg/m2).  Health problems related to excess body weight increase from a 
BMI >25 (overweight and obesity categories of BMI) (48). The main disadvantage of BMI is 
that it does not distinguish between muscle mass, adipose tissue or bone; however,  increased 
risk of coronary artery disease, hypertension, dyslipidaemia, and mortality have a direct 
relationship with BMI (Table 1.1) (49) 
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Table 1.1: Body mass index (BMI) and waist circumference used to classify risk of disease 
for hypertension, cardiovascular disease, and type 2 diabetes 
Risk of disease 
a
 relative to normal body weight and waist circumference 
BMI 
category 
BMI (kg/m
2
) Men, ≤102 cm 
Women, ≤88 cm 
Men, >102 cm 
Women, >88 cm 
 
Underweight <18.5 – – 
Normal 18.5-24.9 – – 
Overweight 25.0-29.9 Increased High 
 
 
Obesity, 
class 
   
I 30.0-34.9 High Very high 
II 35.0-39.9 Very high Very high 
 
III ≥40 Extremely high Extremely high 
 
a
 Dashes (-) specify that that there was no further risk allocated at these levels of BMI. 
Information from Expert panel: Clinical guidelines on the identification, evaluation, and 
treatment of overweight and obesity in adults: executive summary. The American Journal of 
Clinical Nutrition 1998, 68:899–917 (50) 
 
Waist circumference is a proxy measure of central obesity,  and is a good indicator of disease 
risk (50). The cut off levels for waist circumference in Table 1.1 are currently used in the 
diagnosis of the metabolic syndrome by the National Cholesterol Education Program  
(NCEP) (51), while the European Group for the Study of Insulin Resistance use slightly 
lower levels of ≥80 and ≥94 cm, in women and men respectively (52). The International 
Diabetes Federation (IDF) uses the latter cut points, and when compared with NCEP, most of 
the same individuals are classified with metabolic syndrome,  thus demonstrating their 
similarity (53). In sub–Saharan African countries such as South Africa, the IDF cut–off for 
waist circumference is recognised (16).  Another proxy indicator of visceral obesity is waist–
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to–hip ratio, which although studies have shown an association of this measure with type 2 
diabetes, the wider scientific community debates the clinical usefulness of this ratio as a 
predictor of metabolic diseases (54).  Intrinsic factors such as population group, gender and 
age may determine the worth of using waist–to–hip ratio as these confounding factors have 
been shown to influence body composition outcomes (54).  Nevertheless, the use of ratios can 
be problematic due to the difficulty of biological interpretation, low sensitivity to weight 
change, and the high likelihood of statistical error when conducting analyses (55).  Thus, the 
evidence suggests that BMI and waist circumference seem to be better indicators of obesity 
compared with waist–to–hip ratio. 
 
1.3.3 Epidemiology 
 
Excessive body weight was previously thought to be a problem of mostly developed 
countries as a result of overconsumption and high economic stature (56); however, the burden 
of obesity has become a global phenomenon affecting countries across the economic 
spectrum.   
 
Overweight and obesity prevalence has risen since 1980 as has the prevalence of comorbid 
diseases which have been accompanied by an increased risk of premature mortality and 
morbidity (57). The increase in obesity is described as pandemic (58), affecting millions of 
people worldwide, and is expected to advance more rapidly in the next 16 years (59). In 
1990, nearly two million deaths could be linked to excess body weight (60).  Ten years later, 
the number of deaths attributable to overweight and obesity rose by 1.44 million. The global 
burden of diseases has shifted from a focus on children–related communicable diseases to 
NCDs in the adult population, which includes the key components of metabolic syndrome 
(60). The increasing prevalence of overweight and obesity is also associated with a reduction 
in longevity and life expectancy in developed countries (61).  
 
The international patterns of obesity prevalence vary noticeably across countries (Table 1.2). 
In developing countries, the proportion of those subjects with obesity in the population is 
high and is estimated to further increase (2). In some of the LMICs, the countries have 
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transitioned from a chronic energy deficient state to one of over nutrition, but in other 
developing countries these extremes of nutrition can coexist within the same region or 
country (56). In comparison, developed countries have had a marked increase in the 
incidence of obesity between 1980 and 2006, however from 2006 to 2013 the rate of 
incidence has decreased (2).  The prevalence of obesity likewise differs across regions (62). 
The BMI increase between 1980 and 2008 was highest in the tropical regions of Oceania, 
such as Tonga and Samoa, while some central and eastern European countries displayed near 
zero increases or slight decreases for women (62).  Evidence from Ng et al. (2) highlights that 
men in developing countries have lower prevalence rates of overweight and obesity compared 
with women; while in developed countries the prevalence of obesity is similar across the 
genders. In the African region, women have higher BMI values compared with men (2).   
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Table 1.2 2013 Age–standardised country estimates of obesity for men and women, including 
comprehensive South African data (SANHANES) 
Region/country Men Women 
Angola 12.0 (10.7, 13.4) 18.7 (16.7, 20.9) 
Argentina 21.2 (19.1, 23.3) 20.4 (18.3, 22.6) 
China 3.8 (3.5, 4.3) 5.0 (4.5, 5.5) 
Fiji 14.8 (13.3, 16.5) 35.4 (32.6, 38.8) 
Japan 4.5 (4.0, 5.0) 3.3 (3.0, 3.7) 
Kenya 6.3 (5.6, 7.2) 15.2 (13.7, 16.8) 
Lesotho 6.9 (6.2, 7.6) 31.3 (29.7, 32.8) 
Mozambique 3.5 (3.0, 3.9) 9.2 (8.3, 10.3) 
Russia 15.3 (13.8, 17.0) 28.5 (26.1, 30.9) 
Singapore 12.0 (10.7, 13.4) 10.8 (9.6, 12.0) 
Tonga 52.4 (49.7, 55.2) 67.2 (64.5, 69.9) 
Turkey 20.1 (18.7, 21.3) 34.1 (32.4, 35.8) 
United Kingdom 24.5 (23.4, 25.7) 25.4 (24.2, 26.6) 
United States of America 31.7 (30.0, 33.4) 33.9 (31.8, 35.7) 
Vietnam 1.5 (1.3, 1.7) 1.7 (1.4, 1.9) 
South Africa 10.6 (8.6, 12.6) 39.2 (37.0, 41.5) 
Urban South Africa 13.2 (9.8, 16.7) 42.2 (38.4, 45.9) 
Rural South Africa 6.1 (2.9, 9.3) 31.8 (27.3, 36.3) 
Black South African 9.4 (7.4, 11.4) 39.9 (37.4, 42.4) 
Caucasian South African  * * 
Coloured/mixed ethnicity South African 15.1 (9.3, 21.0) 34.9 (30.6, 39.2) 
Asian/Indian South African 7.6 (1.2, 14.0) 32.4 (17.5, 47.3) 
*Caucasian South African sample too low for reliable reporting (N=65 for men, and N=79 for 
women) 
 
In the sub–Saharan African region, it is South African women who have the highest 
prevalence of  obesity (2). Black South African women are more affected by NCDs than men 
(23), a situation  which is characteristic of other African and developing countries (24, 25).  
This suggests that black South African females have a higher likelihood of metabolic 
syndrome compared with white females living in the country.  Table 1.3 displays that obesity 
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is more prevalent in the urban setting compared with the rural.  The ethnic differences in 
obesity prevalence are also clear, and South Africa has the best data to show these differences 
because of the country’s ethnic assortment.  
 
1.3.4 Psycho–social factors 
 
The misperception of body–size can influence the risk of overweight and obesity (63).  
Another important factor that could determine excess BMI is a dissatisfaction with current 
body image, indicating that some may have a desire to be thinner, others content with body–
size, and still others wanting to have a larger body–size (64).  In certain Western societies, 
BMI is positively associated with body–size dissatisfaction, and males have lower body–size 
dissatisfaction compared with females (65, 66).  
 
Within African populations a number of cultural beliefs exist pertaining to body–size 
preference (22). These include a social desire to have a large body–size and a general 
tendency for men to choose women in the higher BMI categories (67).  Previous studies in 
South Africa using body silhouettes to determine body–size perception  have shown that 
black African females tend not to be satisfied with the way they look (Figure 1.3) (26, 68), 
suggesting a high level of body–weight discrepancy between how they currently look and 
what they envisage their ideal body–size and shape to be.  The use of body silhouettes to 
distinguish the body-size dissatisfaction of black South African women has been validated 
(69, 70). 
 
Traditionally a larger body–size is favoured more by black South African women (5, 67, 71), 
whereas being lean is considered to be weak, and linked with scarcity and chronic infectious 
diseases (72). Black South African women with higher BMI also feel they are able to perform 
physical tasks requiring moderate muscle strength and household chores more easily 
compared with thinner women (73). 
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This cultural preference for obesity has led to behaviours in some populations that encourage 
weight gain in children and adolescents.   For example, some African communities practise 
the tradition of force feeding young women to make them gain weight, making them more 
attractive brides for potential suitors (74, 75).  Rearing plump children is also viewed as an 
indication of good parenting (67).  The acceptance of a culturally appropriate larger body–
size may also play a role on the eating habits of black women (76). 
 
A recent study has shown that black South African adolescent females favoured body image 
silhouettes representing higher BMIs in comparison with white adolescent females (77).  This 
study also demonstrated that when queried about the body–size they perceived their families 
wanted them to be, black female adolescents mostly selected those body silhouettes 
symbolising larger BMIs compared with white female adolescents.  Another study in South 
Africa indicated that acculturation of young black African females may be taking place, and 
that the western principles regarding body–size preference may be clashing with the 
traditional African ideals (78).  In addition, fewer white adolescent girls are dissatisfied with 
their bodies, and have a lower likelihood of controlling what they eat compared with black 
age–matched females (77).  Similarly, black adolescent girls are more likely to develop 
disorders associated with dietary intake (such as anorexia or bulimia nervosa) or become 
preoccupied with the consumption of food as they transition into adulthood (77).  This 
implies that black South African adolescent girls are more influenced by body–size 
perception compared with whites, which could partly explain the increasing prevalence of 
obesity in adult African women. 
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Figure 1.3: Body silhouettes used in the definition of fatness and thinness in black African 
women (source: Stunkard et al. (1983) (79))  
 
However, data from the South African National Health and Nutrition Examination Survey 
(SANHANES) demonstrated that black South African women when compared to women 
from other ethnic groups are generally happier with current body weight and have a higher 
proportion of women whose perceived BMI is equal to actual BMI (Figure 1.4) (23). In 
contrast, other ethnic groups in South Africa have a higher percentage of women who 
attempted to lose weight in the past 12 months. This suggests that despite a high prevalence 
of excess BMI, the majority of black African women are content with their body–size, and 
are not concerned with managing weight gain.   
 
Recent data showed that body–size dissatisfaction is experienced across various SES strata 
and, although the prevalence is highest in the obese category, those who displayed healthy 
dietary intake patterns also have a high prevalence of body–size dissatisfaction (66).   
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Source of data: SANHANES 2013 (23) 
Figure 1.4: Body– size dissatisfaction, body–size discrepancy and weight management in 
black African women compared with other ethnic groups (coloured, white, and Indian ethnic 
groups) in South Africa 
 
1.4 Metabolic syndrome  
1.4.1 Background 
 
People with obesity often exhibit other co–existent NCDs, indicating the possible 
interrelationship of risk factors (80).  Metabolic syndrome is characterised by the clustering 
of numerous atherosclerotic, and cardiovascular disease risk factors, including raised blood 
pressure, hyperglycaemia, central obesity and dyslipidaemia (20).  This constellation of 
cardiometabolic disease risk factors also increases the risk of type 2 diabetes, cardiovascular 
disease and all–cause mortality (16), each with an estimated relative risk of 2.99, 1.65 and 
1.27 respectively (81).  The underlying causes of the syndrome are uncertain, but fat gain 
seems to promote its onset, particularly when it occurs abdominally (80). Reaven suggested 
that insulin resistance was the main driver of metabolic syndrome (82), however more 
recently it has been proposed that large waist circumference, a proxy measure of intra–
abdominal adiposity, and abnormal serum triglyceride concentration  are central to the 
syndrome (83).  I will discuss the factors specific for metabolic syndrome here, while those 
factors shared by obesity and metabolic syndrome will be discussed later. 
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1.4.2 Definition of “metabolic syndrome” 
 
There are several definitions for “metabolic syndrome”, but it is the National Cholesterol 
Education Program Expert Panel, Adult Treatment Panel III (NCEP) and The International 
Diabetes Federation (IDF) definitions that have most commonly been used. A positive 
diagnosis using the NCEP classification is made when 3 or more of the following 
cardiovascular disease risk factors are present: raised blood pressure, low high–density 
lipoprotein cholesterol (HDL) , impaired fasting blood glucose, hypertriglyceridemia, high 
waist circumference (Table 1.3) (84).  In comparison, the IDF definition stresses ethnic–
specific thresholds for central obesity (85). The two definitions have been compared, and 
found to be compatible (53).   A new definition was proposed in 2009 by various 
organisations, which suggested harmonising the definitions of metabolic syndrome (16). 
Thus, rather than emphasising one particular component, 3 or more of the five components 
need to be present for a positive diagnosis, and region–specific cut–offs for central obesity 
were maintained.  In South Africa, the Europid definition for waist circumference is still 
being used for the diagnosis, however a recent study suggested that this threshold should be 
increased in African women (4).  
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Table 1.3: Criteria used to identify metabolic syndrome in a population/cohort by means of 
two widely used guidelines and the new ‘harmonised guidelines’* 
Risk factors National 
Cholesterol 
Education Program 
Expert Panel, Adult 
Treatment Panel III 
(NCEP) 
International 
Diabetes Federation 
(IDF) 
Harmonised 
guidelines 
Abnormal waist 
circumference (cm) 
≥102 (males) 
≥88 (females) 
≥94 (males) 
≥80 (females) 
≥94 (males) 
≥80 (females) 
High serum 
triglycerides (mmol.L
-
1
) 
≥1.7 NCEP or specific 
management 
NCEP or 
specific 
management 
Low high–density 
lipoprotein cholesterol 
(mmol.L
-1
) 
<1.03 (males) 
<1.30 (females) 
NCEP or specific 
management 
<1.0 (males) 
<1.30 (females) 
Elevated blood 
pressure (mm Hg) 
≥130 (systolic) 
and/or  
≥85 (diastolic) 
NCEP or diagnosed 
hypertension 
NCEP or 
diagnosed 
hypertension 
Impaired fasting blood 
glucose (mmol.L
-1
) 
≥6.10 ≥5.6 ≥5.6 
 
*NCEP and Harmonised require 3 or more of 5 for diagnosis whilst IDF requires waist 
circumference plus 2 or more of rest.  
 
1.4.3 Epidemiology of metabolic syndrome in African women 
 
The increasing prevalence of obesity in LMICs correlates with the increasing presence of 
metabolic syndrome in various population groups.  The incidence of the syndrome in black 
South African women is high using the IDF criteria (4), comparable to studies of other 
African women (7-9), and higher than most developing Asian countries and developed 
European countries (86) (Table 1.4).  Table 1.4 also displays that most African countries have 
a higher proportion of women with the presence of the metabolic syndrome compared with 
men. When compared with rural black African populations (7), an estimated 13.6 % more 
women present with metabolic syndrome in the urban setting (4), which can be explained by 
the higher risk of obesity associated with the urban environment.   
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The previous thinking around what was considered the main driving force for the metabolic 
syndrome seemed to centre around insulin resistance (82, 87, 88), but more recent studies 
seem to agree on the fact that it is central obesity that is the key determinant of the syndrome 
(83).  Data from studies performed in various African regions support this theory (4, 18, 89), 
showing that some components of the metabolic syndrome are more prominent than others in 
African populations. Thus, abdominal obesity, low HDL and elevated blood pressure are 
observed to be more noticeable compared with high serum triglycerides and elevated fasting 
glucose levels.  Black South African (and African American) women have significantly less 
visceral adipose tissue compared with their white counterparts, and the association with 
peripheral insulin sensitivity is lower in black compared with white South African women 
(90-92). Moreover, the theory that visceral adiposity is the main driving factor of the 
metabolic syndrome in black sub–Saharan Africans has been shown (87).  
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Table 1.4: Prevalence of metabolic syndrome in selected adult African, South African and 
developed countries 
Reference Criteria 
used 
Study design  n Age 
(years)* 
Country (ethnicity) Male 
(%) 
Female 
(%) 
Studies of developed nations 
Aguilar et al., 
2015 (93) 
NCEP/ AHA National Health 
and Nutrition 
Examination 
Survey 2011–12 – 
Cross–sectional  
1, 931 ≥20 USA (mixed, but no 
Asians)  
32.8 36.6 
Khan and 
Jackson, 2015 
(94) 
Harmonized 
method 
Cross–sectional 1, 403 20–68 USA (South Asian 
Americans) 
47.0 54.0 
Cameron et 
al., 2009 (95) 
IDF Cross–sectional 6, 072 50.5 ± 
11.7 
Australia (White) 39.2 27.9 
Salminen et 
al., 2011 (96) 
IDF Follow–up 1, 260  Finland (White) 37.0 63.0 
        
Studies of developing non–African countries 
Kim, 2015 
(97) 
NCEP Cross–sectional 11, 810 ≥45 South Korea 
(Asians) 
53.2 35.7 
Fan et al., 
2005 (98) 
NCEP–ATP 
III 
Cross–sectional 3, 175 52.4 ± 
15.1 
Shanghai, China 
(Asian) 
22.9 20.8 
Gupta et al., 
2004 (99) 
NCEP Cross–sectional 1, 091 >20 North Indian (Asian) 22.9 39.9 
Bhowmik et 
al., 2015 
(100) 
IDF Cross–sectional 2, 293 ≥20 Bangladesh (Asian) 19.2 27.5 
Ozsahin et al., 
2004 (101) 
ATP III Cross–sectional 1, 637 20–79 Adana, Turkey 
(Middle Eastern) 
23.7 39.1 
Al–Lawati et 
al., 2003 
(102) 
NCEP–ATP 
III 
Cross–sectional 1, 419 >20 Oman (Middle 
Eastern) 
19.5 23.0 
Chu and Moy, 
2013 (103) 
NCEP–ATP 
III 
Cross–sectional 219 45.9 ± 
6.5 
Kuala Lumpur, 
Malaysia (Asian) 
37.1 24.2 
Studies of African populations 
Akintunde et 
al., 2011 
(104) 
IDF Cross–sectional 140 55.1 ± 
10.8 
Osogbo, Nigeria 
(black African 
23 37 
Tran et al., 
2012 (105) 
IDF Cross–sectional 1, 935 ≥24 Addis Ababa, 
Ethiopia (black 
African) 
14.0 24.0 
Assah et al., NCEP–ATP Cross–sectional 552 25–55 Cameroon (black 7.0 25.0 
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2011 (106) III African) 
Balti et al., 
2013 (107) 
Harmonized Cross–sectional 33 61.9 ± 
29.9 
Cameroon (black 
African) 
50.0 71.0 
Kenge et al., 
2012 (108) 
IDF Cross–sectional 308 55.8 ± 
10.5 
Cameroon (black 
African) 
58.0 86.1 
Garrido et al., 
2009 (109) 
ATP III Cross–sectional 51 39.2 ± 
11.1 
Botswana (black 
African) 
15.9 24.5 
Adeoye et al., 
2015 (110) 
IDF Cross–sectional 256 42.0 ± 
9.4 
Nigeria (black 
African) 
17.0 14.0 
Ipadeola and 
Adeleye, 2015 
(111) 
IDF Cross–sectional 340 >40 Nigeria (black 
African) 
2.4 34.9 
Labhardt et 
al., 2014 
(112) 
IDF Cross–sectional 1, 026 ≥25 Lesotho (black 
African) 
9.8 22.9 
Mogre et al., 
2014 (113) 
IDF Cross–sectional 200 ≥30 Ghana (black 
African 
13.0 27.3 
South African studies 
Crowther and 
Norris, 2012 
(4) 
Harmonized Cross–sectional 1, 251 40.0 ± 
10.6 
Soweto, 
Johannesburg (black 
South African) 
– 42.1 
Schutte and 
Olckers, 2007 
(114) 
IDF Cross–sectional 102 31.3 ± 8.6 Potchestroom, 
North–west province 
(black South 
African) 
– 24.8 
Jennings et 
al., 2008 (87) 
IDF Cross–sectional 225 27.0 ± 
7.0 
Cape Town (black 
South African) 
– 9.9 
Ntyintyane et 
al., 2007 (8) 
IDF Cross–sectional 23 51.1 ± 
8.8 
Johannesburg (black 
South African) 
51.5 85.7 
Motala et al., 
2011 (7) 
IDF Cross–sectional 947 >15 Kwa–Zulu Natal 
(black South 
African) 
11.2 21.2 
Kalk and 
Joffe, 2008 
(115) 
IDF Cross–sectional 500 >30 Black South African 46.5 52.9 
Peer et al., 
2015 (116) 
Harmonized Cross–sectional 1, 099 25–74 Cape Town (black 
South African) 
16.5 43.0 
George et al., 
2013 (117) 
Harmonized Cross–sectional 373 41.6 ± 
13.1 
Soweto, 
Johannesburg (black 
South African) 
– 29.2 
Erasmus et 
al., 2012(118) 
IDF Cross–sectional 563 50.9 ±
9.1 
Bellville, Cape 
Town (mixed ethnic 
background) 
30.6 67.8 
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* Age range or mean age of participants as provided by the respective journal articles, 
National Cholesterol Education Program (NCEP); Adult Treatment Panel III (ATP); World 
Health Organisation (WHO); American Heart Association (AHA); International Diabetes 
Federation (IDF) 
 
1.4.4 Anthropometric and metabolic risk factors for metabolic syndrome 
 
Metabolic syndrome is composed of a collection of interconnected cardiometabolic diseases, 
which together increase the risk of type 2 diabetes and cardiovascular disease (16, 20).   The 
presence of multiple metabolic disease states in individuals could indicate the possibility of 
an interrelationship between components of the syndrome and that there may be a shared 
predisposing factor for the various individual elements of the syndrome (80, 119).   
 
1.4.4.1 Anthropometric risk factors for metabolic syndrome 
 
The major areas of fat deposition are visceral and subcutaneous compartments of the body 
(120). Visceral adipose tissue seems to be more closely linked with cardiometabolic diseases 
compared with subcutaneous (121).  The visceral fat deposit (indicated by central 
obesity/waist circumference) and ectopic sites are the preferred region of lipid uptake in 
higher BMIs (120, 122). This is confirmed by the evidence that obese women have 
significantly higher levels of visceral fat and insulin resistance compared with lean women 
(90).  In a study of black South African women visceral obesity was shown to be the main 
driver of the high prevalence of metabolic syndrome (4). Other studies have shown that black 
South African (and African American) women have lower visceral adipose tissue and greater 
peripheral subcutaneous adipose tissue compared with white counterparts (90-92). The link 
between metabolic syndrome and visceral adiposity is confirmed in other African populations 
(18, 111), and in Australian and Mauritian cohorts (123).  The mechanism through which 
visceral adiposity increases the risk of metabolic syndrome is through the sustained 
consumption of excess dietary lipids and the resultant reduced performance of insulin 
receptors.  The uptake of lipids in the visceral compartment is enhanced by high serum 
insulin concentrations (124).  Visceral adipose tissue increases in size and amount by 
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hypertrophy and hyperplasia respectively.  This releases TNF–α and IL–6, insulin 
antagonistic adipokines, resulting in impaired insulin sensitivity (124). Over time the visceral 
adipose tissue loses its ability to function optimally, progressively leading to the metabolic 
syndrome (121). Moreover, visceral adipose tissue is associated with development of 
elevated systolic blood pressure (125), while a decrease in visceral fat was associated with 
improved fasting glucose and lipid profiles in a longitudinal study (126).  These data confirm 
the importance of visceral adipose tissue in the aetiology of the metabolic syndrome. 
 
In contrast, the subcutaneous adipose tissue compartment is relatively larger than the visceral 
depot and is composed of the truncal and gluteofemoral regions. The former region is heavier 
than the gluteofemoral region, and is associated with type 2 diabetes (127, 128), thus may 
provide a greater risk of metabolic syndrome in comparison.  In fact, adipose tissue in the 
gluteofemoral region functions as a chronic metabolic bank of free fatty acid (FFA) storage, 
thus lowering ectopic adiposity (122, 129). In addition, studies have shown that 
gluteofemoral adipose tissue has been shown to increase HDL and lower total and low–
density lipoprotein (LDL) cholesterol (130-132). Finally, although studies emphasise the 
contribution of upper body adiposity in the aetiology of the metabolic syndrome, the 
importance of gluteofemoral fat as a protective mechanism should not be ignored.  Grundy et 
al. observed that lower truncal:body fat ratio is associated with lower risk of metabolic 
syndrome, particularly with regards to improving HDL levels, lowering serum triglycerides, 
and systolic blood pressure and reducing insulin resistance (133).  Similarly, Goodpaster et 
al. observed a negative association between subcutaneous fat in the thigh region and 
metabolic syndrome (134).   
 
1.4.4.1.1 Lean mass and metabolic syndrome 
 
A number of age–related changes contribute to sarcopenia, a phenomenon which is 
associated with the decline of muscle mass and an increase in muscle weakness (135, 136).  
Studies of African and American women have also shown evidence of sarcopenia during the 
menopausal transition and its link to components of the metabolic syndrome (137, 138).  
These studies suggest that women experiencing menopause may have a higher level of fat 
deposition in relation to fat–free muscle mass.  The increase in sarcopenia is also linked to 
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lower resting metabolic rate as people age, indicating the importance of maintaining strength 
type physical activity throughout the lifespan (139).  Sustaining regular resistance training is 
particularly important as the effects of sarcopenia are gradually increased after the age of 30, 
but the decline in muscle mass accelerates rapidly after 50 years of age by approximately 10 
to 15 % (140).     
 
Studies have shown that premature progression of sarcopenia can be delayed by participation 
in a regimen of habitual physical activity (141, 142) during the ageing process by increasing 
the muscular force of the musculature (143). Therefore, the pattern of physical dysfunction 
and increased obesity can be reversed with exercise, especially when focussed on increasing 
the site–specific strength of the large musculature involved with functionality. The inclusion 
of habitual moderate–vigorous physical activity can also lead to a reduced risk of 
cardiometabolic diseases in older subjects (144).                                                                                                                                                                                                                                                                                                                                                                                                              
 
A study of older individuals has shown that those with sarcopenia and excess adiposity have 
a higher risk of insulin resistance and associated co–morbid diseases compared with those in 
the non–sarcopenic lean, non–sarcopenic non–obese, or sarcopenic non–obese groups (145).  
A Japanese study of healthy women, showed similar associations between sarcopenia and 
cardiovascular diseases (146).  Both cross–sectional and longitudinal studies show that 
women who have transitioned into menopause have lower levels of fat–free, soft–tissue mass 
and higher fat mass values compared with pre–menopausal women (137, 138, 147).  This 
evidence suggests that women in the post–menopausal category are at more risk of metabolic 
syndrome compared with those who are pre–menopausal.  In support of these facts, other 
studies have shown that decreased lean muscle mass increases the risk of metabolic syndrome 
in adults (148-151).  
 
Sarcopenia also seems to be associated with increased risk of hypertension (152), low HDL 
levels (153), high cholesterol levels (154), type 2 diabetes (155), and the accumulation of 
fatty deposits in the visceral region (156).  Therefore, the increasing prevalence of obesity 
and metabolic syndrome in African women could be linked to the progressive changes in 
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muscle architecture imposed by the complex ageing process, suggesting a potential role for 
lower lean muscle mass in the development of metabolic syndrome. 
 
1.4.4.2 Metabolic risk factors for metabolic syndrome 
1.4.4.2.1 Insulin resistance 
 
Postprandial normoglycaemia is maintained in insulin–sensitive subjects by the release of 
insulin.  In contrast, in those individuals with insulin resistance, pancreatic islet β–cells 
produce excess amounts of insulin for glucose uptake, while hepatic production of glucose 
fails to be suppressed (157).  Chronic dysfunction of the pancreatic islet β–cells results in 
depletion of insulin in this reserve because of higher metabolic demand in insulin resistance 
(158).   
 
The aetiology of insulin resistance is multifaceted, but a fundamental feature of this condition 
is the inability of plasma insulin to suppress hyperglycaemia (159).   Insulin resistance has 
been linked with the onset of metabolic syndrome (15), however, the components of 
metabolic syndrome can develop independent of insulin resistance (12).  The main feature of 
insulin resistance is a disruption in the normal glucose homeostasis  (80), resulting in a high 
concentration blood glucose and ineffective plasma insulin.  Sustained hyperglycaemia 
stimulates an increased risk for diabetes–associated disorders such as neuropathies (48).  
Conversely,  approximately 30 % of people diagnosed with metabolic syndrome have normal 
insulin functionality (80). The involvement of insulin resistance in the progression towards 
metabolic syndrome is debatable, but evidence has shown that obesity precedes the 
development of other components of metabolic syndrome (160).  In contrast, a study of type 
2 diabetics observed no association between insulin resistance and the components of 
metabolic syndrome (161), which could possibly be explained by the existence of diabetes 
(162). 
 
Obesity has a positive association with insulin resistance and directly influences metabolic 
syndrome risk (20), and can subsequently result in biochemical and endocrine abnormalities.  
Whole body adiposity is the main contributor of insulin resistance at lower BMIs as this 
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region is more insulin sensitive compared with the visceral depot and therefore will 
accumulate more lipid (163).  However, as BMI increases, the accumulation of lipids in the 
subcutaneous fat region reduces as the factors controlling insulin sensitivity suppress 
triglyceride accumulation (164).  The visceral fat deposit (indicated by waist circumference) 
and ectopic sites subsequently become the preferred region of lipid uptake at higher BMIs 
(120, 122). This is confirmed by the evidence that obese women have significantly higher 
levels of visceral fat and insulin resistance compared with lean women (90).  With increasing 
waist circumference, black South African women also accumulate less visceral adipose tissue 
compared with white women (92). 
 
Ectopic fat deposition in skeletal muscle, liver and other organs is associated with insulin 
resistance (165) and the metabolic syndrome (166).  The underlying reason is thought to be 
related to an excess consumption of energy–rich foods in the diet, which results in a ‘spill–
over’ lipid storage effect, from the various adipose tissue compartments to the organs and 
skeletal musculature. A meta–analysis and systematic review found that the fat in the 
epicardial region was much thicker in those with metabolic syndrome compared with those 
subjects without metabolic syndrome (167).  Epicardial fat was also associated with the 
individual components of the syndrome, but showed a greater association with BMI, waist 
circumference and visceral adiposity.  Similarly, ectopic fat in the liver is also associated with 
metabolic syndrome and its components (168). 
 
Insulin resistance can also be influenced by adiponectin (164), mainly by the action of this 
adipokine on insulin function (169).   The level of adiponectin is modulated by visceral 
adipose tissue. Thus as the visceral compartment reduces, the concentration of adiponectin 
increases, and subsequently improves insulin sensitivity in subjects (170).  Conversely, lower 
levels of adiponectin are associated with insulin resistance (171). Administration of 
endogenous adiponectin in those subjects diagnosed with insulin resistance has been shown 
to improve insulin sensitivity (172). These data show that adiponectin may have an important 
influence on key metabolic diseases associated with metabolic syndrome.   
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1.4.4.2.2 Adipokines and inflammatory factors 
 
Adipose tissue is not simply a passive reservoir for lipids as previously thought (164).  In 
response to afferent signals, this endocrine organ secretes adipokines which function at the 
local and endocrine level.  In conditions of excess adiposity, these adipokines are associated 
with an increased risk of cardiometabolic diseases such as insulin resistance and hypertension  
(170, 173). Some of these adipokines are linked to metabolic syndrome and will be discussed 
below.    
 
1.4.4.2.2.1 Adiponectin 
 
Adiponectin is one such protein implicated in metabolic diseases (164), and seems to be one 
of the main factors in the relationship between fat accumulation and insulin resistance (174).  
The concentration of plasma adiponectin is significantly lower in obese subjects and those 
who present with type 2 diabetes (175).  Evidence has also confirmed that adiponectin 
modulates insulin sensitivity (169).  A lower concentration is therefore linked with insulin 
resistance, particularly as visceral fat increases (170).  The secretion of adiponectin from the 
visceral compartment seems to be higher compared with subcutaneous fat in non–obese 
subjects, however as BMI increases the secretion of adiponectin from this region decreases 
(176).  The in–vitro treatment of isolated human adipocytes with insulin resulted in increased 
adiponectin secretion from adipocytes isolated from the visceral deport but not from those 
taken from the subcutaneous region (176).  This suggests that improved insulin sensitivity is 
enhanced by increased secretion of adiponectin from the visceral region rather than the 
subcutaneous region. 
 
In a longitudinal study of the Pima Indians of Arizona, USA, findings showed that 
hypoadiponectemia was associated with obesity and insulin resistance (171), while 
hyperadiponectemia showed a protective, independent effect against the onset of type 2 
diabetes (177).    Higher concentrations of adiponectin correlate with lower BMI and higher 
insulin sensitivity in a combined sample of different South African population groups, 
however Caucasian subjects had higher levels of adiponectin compared with the other ethnic 
groups (33).  Few data are available on the role of adiponectin in the aetiology of metabolic 
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syndrome in developing countries (178), but studies of African populations suggest a 
protective role of adiponectin against metabolic syndrome (33, 179).  Finally, evidence 
suggests an association of low adiponectin concentration with individual components of 
metabolic syndrome and the syndrome itself (180-182). 
 
1.4.4.2.2.2 Leptin 
 
Leptin is another adipokine which is positively associated with fat accumulation.  As adipose 
tissue increases in mass, leptin concentration increases to suppress satiety via the 
hypothalamus (157).  In animal studies, the administration of leptin to lean and leptin–
deficient obese mice resulted in a reduction in food intake (183). This indicates that leptin is 
able to suppress hunger rapidly during normal biological conditions.  Fat accumulation is 
associated with increased concentrations of plasma leptin in humans, whilst a decrease in 
body weight following the control of dietary intake is associated with lower levels of plasma 
leptin in humans and mice (184).   
 
The majority of obese subjects are not deficient in leptin and demonstrate higher levels of 
leptin compared with leaner individuals (185), implying the decreased appetite–suppressing 
effects of leptin or increased leptin resistance in obese individuals.  Leptin resistance may be 
due to impairment of the leptin transporter system in the brain rather than mere saturation due 
to higher levels of circulating leptin (186). 
 
In a South African cross–sectional study, leptin concentrations were higher in black African 
women with known coronary artery disease compared with matched males, and an 
association with metabolic syndrome was demonstrated (173).  In other South African 
studies, leptin correlates with insulin resistance and central adiposity, variables which seem to 
be fundamental to the metabolic syndrome (187, 188).  There also seems to be ethnic 
differences in leptin concentration of South African women.  For example, white South 
African women have lower leptin levels compared with BMI–matched black women (189).  
Leptin concentrations were shown to be higher in obese black South African women 
compared with obese white women at fasting and glucose loading periods, indicating an 
28 
 
ethnic variation in the metabolism of adipocytokines  (190).  A relationship between high 
leptin concentration and the other components of metabolic syndrome has been observed in 
South African studies.  The positive association between leptin and blood pressure in black 
South African women was shown in various South African studies (191-193), while leptin 
does not seem to correlate with total or LDL cholesterol in patients with diagnosed familial 
hypercholesterolemia (FH) and CAD (194) . The latter needs to be confirmed in African 
women without FH.   
 
1.4.4.2.2.3 Inflammatory factors 
 
Metabolic syndrome seems to be associated with certain inflammatory markers (85).  C–
reactive protein (CRP) and interleukins have been found to have an association with 
metabolic syndrome in Chinese subjects (195),  however some studies have only confirmed 
the relationship between CRP and metabolic syndrome in women (196), while others show 
no association between interleukins, tissue necrosis factor–α and the metabolic syndrome 
(197).  Similarly, studies have observed the relationships of resistin (198), vaspin gene 
expression (199), retinol–binding protein 4 (200) with the metabolic syndrome.  However the 
role of inflammatory markers in the pathogenesis of obesity–related disorders and metabolic 
syndrome is controversial (201).  Nevertheless, the secretion of CRP by the liver is stimulated 
by adipokines during the expansion of adipose compartments in the visceral region, 
suggesting that this inflammatory marker may be an important predictor of the development 
of type 2 diabetes and metabolic syndrome in subjects at risk (80).  Thus, further research is 
required to confirm the association of inflammatory markers with metabolic syndrome and its 
components. 
 
1.5 Shared risk factors for obesity and metabolic syndrome 
 
Obesity and metabolic syndrome are complex and multi–faceted diseases.  A number of the 
underlying risk factors are shared. This section explores whether these common risk factors 
lead to metabolic disease because of obesity or whether they act directly to cause disease, or 
whether it is a combination of both. 
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1.5.1 Physical inactivity and sedentary behaviour in developing countries 
 
Physical inactivity is an important environmental risk associated with chronic diseases.  
Recent WHO estimates show that insufficient activity is responsible for 3.2 million deaths 
globally (202).  Data on the physical activity patterns of people living in developing countries 
are sparse (21), however, data from South America imply that physical inactivity in the lower 
SES strata has increased over time (203).  This suggests that there may be a regional shift in 
the pattern of physical activity in certain developing countries.  A recent cross–sectional 
study showed that physical activity levels did not vary significantly in different regional 
settings, and there was an inverse correlation between moderate–vigorous physical activity 
(MVPA) and SES characteristics in higher income countries and LMICs (204).  The 
relationship between SES and physical activity was largely due to increased vehicle 
ownership across different SES groups, indicating that increasing global access to motor 
vehicles and other labour-saving devices might partly be the reason for the decline in activity 
and the subsequent increased onset of chronic diseases and disabilities.   
 
South Africa is the third most physically inactive country in Africa, and only 1.6 % less 
active than Namibia in second place (205). The consequence of such a high prevalence of 
physical inactivity is that black South African women rank in the top proportion of obesity 
prevalence in the African continent (2).  In Cameroon, a sub–Saharan African country also 
experiencing epidemiological transition, rural dwelling people have demonstrated higher 
amounts of energy expenditure compared with urban dwellers (106).  Those who presented 
with lower levels of physical activity were shown to have higher levels of metabolic 
syndrome, indicating the link between energy expenditure and cardiometabolic diseases.  The 
economic cost related to insufficient physical activity ranges from 1 to 3 % of the total budget 
spent on healthcare in South Africa (206), however, reversing the situation remains 
challenging, especially in developing countries with limited resources (207).   
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1.5.1.1 The definition of physical activity 
 
Physical activity is broadly defined as the voluntary movement of the body by the contraction 
of skeletal musculature, resulting in the expenditure of energy (48). The WHO formulated the 
global physical activity questionnaire (GPAQ) for the investigation of physical activity 
patterns of populations around the world (208). The recommendations for physical activity 
from GPAQ include: moderate physical activity for a total of 150 minutes per week (≥5 days 
per week); or vigorous physical activity for 60 minutes per week (≥3 days per week); or 600 
metabolic minutes per week [≥5 days moderate-vigorous physical activity (MVPA)] (209). 
The tool was formulated as part of the World Health Organisation STEPwise approach to 
Surveillance initiative to help LMICs collect data on chronic diseases and physical activity, 
but is now commonly used around the world and has produced a substantial amount of 
research on the worldwide patterns of physical activity (21).  Accomplishing the 
recommendations for energy expenditure ensures that health is improved or maintained, and 
lowers the risk of mortality related with metabolic syndrome (205).  However, citizens of 
most countries around the world are insufficiently active, and only a small percentage are 
actively involved in regular, moderate–vigorous physical activity (210).  
 
1.5.1.2 Different domains of physical activity in developing countries 
 
It was previously thought that physical activity was higher in high income countries (210), 
but emerging evidence suggests that the pattern of physical activity is improving in LMICs 
(202).  This seems to be mostly as a result of greater time spent walking as a means of 
transport and high amounts of physical activity during work time.  In comparison, people in 
higher income countries typically accumulate total weekly physical activity from recreation 
or leisure time activities (211).  This indicates that as people’s wealth increases, there seems 
to be a shift towards participating in more leisure time physical activity (212).  The available 
data on African populations shows evidence of regional variation in the pattern of physical 
activity (213).  For instance, in some African countries such as Eritrea and Mali total energy 
expenditure is mostly driven by active commuting, while in other countries in the African 
region most of the daily physical  activity is performed in the work domain (213).  Black 
South African women seem to accumulate most of their weekly physical activity in the 
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walking for transport domain (214, 215). The Transition and Health during Urbanisation of 
South Africans (THUSA) study showed that most of the participants were insufficiently 
physically active (28).  A third of the sample who were sufficiently active accumulated 
physical activity in walking for travel and work domains.  The THUSA study also showed 
that physical inactivity posed a higher risk of fat accumulation compared with nutritional 
status or SES. 
 
1.5.1.3 Walking as a means of transport  
 
Active commuting by walking is associated with better health outcomes, and walking for 
longer durations has been inversely associated with blood pressure and type 2 diabetes (216), 
indicating that walking for transport may lower the risk of metabolic diseases if sustained.  
However, data suggest that this form of activity should be performed at a brisk pace in order 
to gain optimal cardiometabolic health benefits (217-219).   
 
In rural South Africa, most women walk more than the recommended 10,000 accumulated 
daily steps, resulting in a low risk of excess fat accumulation (220).  Women in urban South 
Africa demonstrate lower accumulated time spent walking and a higher prevalence of obesity 
compared with women in rural settings (2, 220).   Studies have shown that less than thirty 
minutes of accumulated moderate intensity physical activity or brisk walking do not result in 
any significant decrease in the future risk of stroke or hyperglycaemia (221, 222), whilst 
other studies widely support the benefit of higher amounts of accumulated energy 
expenditure for the prevention of cardiovascular diseases (28, 32, 41, 106, 223, 224).  These 
data suggest that more than 30 minutes per day of moderate intensity physical activity are 
needed for optimal prevention of cardiometabolic diseases.  Recent pooled data (2015) from 
various middle income countries indicated that those who performed ≥150 minutes per week 
of active walking for transport had better outcomes in terms of waist circumference; BMI and 
systolic blood pressure (225).   This implies that even though people in LMICs 
predominantly engage in non–recreation related physical activity, the same potential for 
disease prevention observed in higher income countries from increased recreation physical 
activity can still be achieved by increasing time performed in walking for transport. 
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1.5.1.4 Sedentary behaviour 
 
Time engaged in sedentary activity is strongly related to the onset of cardiovascular diseases 
(226), with data showing that, as sedentary time increases, so the risk of all–cause mortality 
increases,  even after adjustment for time spent expending energy (227).  This indicates that, 
the risk of cardiovascular diseases may still be a threat because of extended sedentary time, 
despite a relatively high duration of moderate–vigorous activity.  Sedentary behaviour can be 
defined roughly as the failure to significantly increase energy expenditure above resting 
metabolic levels (228). On the other hand, the Sedentary Behaviour Research Network’s 
definition for sedentary time describes that sedentary time is time spent sitting during waking 
hours, particularly a metabolic equivalent (MET) level of “energy expenditure ≤1.5 METs 
whilst in the sitting or reclining position” (229).  Extended time in sedentary activities can 
increase the risk of obesity because these activities do not allow for a negative energy balance 
threshold to be reached (230, 231).   Most of these sedentary activities are certainly everyday 
activities, but these data imply that additional, more intense physical activity (>1.5 METs) is 
necessary for the maintenance of disease prevention.  
 
Available data of sedentary behaviour shows that there are differences in the amount of 
sitting time in developing versus higher income countries.  In LMICs such as Brazil, China, 
and India, sitting time is reported at an average of  210 sitting minutes per day (232).  In 
comparison, developed countries such as Norway and Sweden display higher amounts of 
sitting time (an estimated average of 330 sitting minutes per day) (232),  despite relatively 
lower levels of obese women compared with African countries (233).  Nevertheless, 
longitudinal evidence does confirm there has been an increase in the prevalence of excess 
adiposity in Nordic women over the past few years and is projected to increase further (234). 
The higher level of sitting time in richer countries is related to better economic factors and a 
greater propensity for people owning sedentary–promoting assets such as motor vehicles and 
satellite television and increased television viewing time (235, 236).  Vehicle ownership is 
associated with decreased physical activity time and increased risk of acute  myocardial 
infarction (235, 236). 
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South Africans on average have a high level of sedentary time in the midst of increasing 
obesity and related diseases (23, 237), and the economic growth of the country has made the 
purchasing of sedentary–promoting assets more affordable for the large majority.  The 
modern lifestyles of South African people are comparatively less energy–demanding than in 
the past when technology was not as advanced (40, 41).  As a result of this lack of activity, 
sedentary behaviour is maintained without adequate expenditure of the ingested calories.  
Data from different South African population groups show that women living in urban 
settings have higher sitting times than urban men and women living in rural areas (32, 220, 
224, 238-240).   Data have shown that postmenopausal women who are involved in higher–
intensity physical activity have a lower accumulation of adipose tissue in the visceral 
compartment compared with those who are sedentary or engage only in light physical activity 
(241).  Recent South African data showed that black African women who met these physical 
activity guidelines at baseline presented with a lower risk of insulin resistance and high HDL 
levels at follow–up compared with less active women, despite total body weight having 
increased in both groups over a 5.5 year study period (214). In summary, these studies 
highlight that, while physical activity is associated with positive health outcomes and the 
reverse for sitting time, scientists are still investigating and trying to understand the physical 
activity patterns of those living in emerging nations (21), especially in black women from 
South Africa who have a high level of obesity and related diseases. 
 
1.5.2 Diet 
 
The higher prevalence of excess adiposity in black South African women compared with 
whites confirms that South Africa is in the advanced stages of the nutritional transition (242).  
The emergence of metabolic diseases associated with metabolic syndrome in South Africans 
could be attributable to the adoption of lifestyle behaviour associated with nutritional 
transition (237),  with those in the lower SES stratum consuming cheaper, energy–dense 
foods, predominantly purchased from informal street food vendors (243).   Such excessive 
caloric intake could be associated with the high prevalence of obesity in black African 
women (122).  Preference for higher caloric intake might also be explained by a general 
acceptance of larger body–size in African populations  (76).    
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Studies have shown that black children and adolescents in South Africa are not reaching the 
recommended daily allowance for energy intake (244-247).  In comparison, urban black adult 
African women are receiving enough dietary energy intake, but mostly from refined 
carbohydrates (248).  A diet high in carbohydrates is associated with atherogenic 
dyslipidaemia (249), particularly a lowered HDL concentration and increasing serum 
triglyceride concentration (250).  Moreover, African populations do not consume sufficient 
fruits and vegetables (251), and compared with rural black African women, urban–dwelling 
women consume more total fat, saturated fat and sugar (23, 252).   
 
It was recently shown that even though the wealth of developing and developed countries 
differs vastly, the economic differences between the socio–economic classes in these 
countries is wide and has an influence on the outcome of cardiometabolic disease risk (253).  
The availability of healthy food is sparser in the poorer communities while the rich have a 
much broader selection of quality foods.  This indicates that the problem of unhealthy eating 
associated with obesity can be alleviated by reducing the food inequality imposed by 
economic circumstances.  
 
1.5.3 Age 
 
Ageing is associated with the natural, progressive loss of physiological function of 
approximately 2 % per annum in healthy adults (254).  The prevalence of metabolic 
syndrome seems to be positively associated with ageing in most communities around the 
world (53, 99, 255, 256).  The reason for the relatively linear relationship of age with 
metabolic syndrome and its components is linked to the age–related increases in resting 
systolic blood pressures and glucose levels (257).  Individuals who are older seem to have 
lower end–diastolic volumes compared with younger people (258), whilst diastolic function 
declines with increasing age (259).  Nevertheless, the influence of systolic dysfunction has a 
greater impact on metabolic syndrome in ageing subjects compared with diastolic blood 
pressure.  This is confirmed by the linear relationship between systolic blood pressure and 
metabolic syndrome, while diastolic blood pressure does not correlate with the syndrome 
(257).  
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The presence of type 2 diabetes and high fasting glucose levels seems to increase with age, 
independent of BMI (257). Interestingly, Gabriely observed that as visceral fat accumulates 
with ageing, the regulation of blood glucose progressively deteriorates, indicating that the 
visceral compartment is a better indicator of diabetes risk in older subjects compared with 
BMI (260). Moreover,  even though fat mass accumulates in both visceral and subcutaneous 
compartments with age, the quality and functionality of adipose tissue only in the visceral 
region declines with age (261).   
 
1.5.4 Socio–economic status and education 
 
People in the lower socio–economic stratum are universally faced with health inequality and 
multiple deprivations (262).   Socio–economic status (SES) is a complex and multifaceted 
notion, having being defined by Bollen et al. (1999) as signifying 
the position of individuals, families, households, or other aggregates on one or more 
dimensions of stratification.  These dimensions include income, education, prestige, wealth, 
or other aspects of standing that the members of society deem salient (263).   
 
Evidence from studies shows that lower SES is associated with a higher number of negative 
health outcomes (264, 265), however, between–country analyses show that the relationship 
between SES and BMI is not consistent (266). For instance, in the richer, developed regions 
of the world, SES has an inverse relationship with BMI (267); however, in LMICs, the 
relationship between SES and BMI is uncertain.  For example, national surveys performed in 
low–income Latin American countries showed that higher SES correlated with higher levels 
of BMI (268-270).   In contrast, in the comparatively higher income Latin American country 
of Mexico, the relationship between obesity and SES appears to be negative (271).  In South 
Africa (26, 76, 272) and other countries in sub–Saharan Africa (273, 274), the relationship 
between obesity and SES has constantly been shown to be positive.  During the apartheid era 
the black majority were predominantly in the lower SES groups and have historically been 
marginalised by limited access to education, healthcare, and the ability to earn a sustainable 
income (28, 275, 276).  They were generally living in poverty in segregated regions. The 
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impact of SES as a potential contributor of metabolic disease outcomes in the South African 
context is therefore important to consider. 
 
Even in the post–apartheid era, the majority of black people are still living in relatively 
poorer conditions compared with other population groups, with most not having completed 
high school (2). Recently published data on poverty trends in South Africa demonstrated that 
the income of black African groups increased by 35.4 % from 2006 to 2011 compared with 
0.4 % in white–headed households; however, 40.3 % of black–headed households were living 
in poverty in 2011 and there are still disparities in the social assistance system of South 
Africa (277). Lower SES groups bear the greatest burden of diseases of disability and ill 
health in South Africa, and the prevalence of the individual metabolic syndrome components 
is now also increasing in the poor and not just among the more affluent white population 
(278).  
 
Over two–thirds of black Africans (66.8 %) were in the upper portion of poverty in 2006, 
unchanging in 2009 (66.9 %), and then decreasing to just over half of the group (54 %) in 
2011 (277).  In terms of access to quality healthcare, only 10.8 % of black Africans were on 
medical aid schemes in 2013 (279).  Likewise, only 3.2 % of adult black Africans (between 
18 and 29 years old) were studying in higher education institutions in the same year (279).  
 
The variation in overweight and obesity prevalence between white and black African groups 
could in part be the result of the disparities between ethnic groups emanating from the pre–
1994 era (280), however, these disparities still exist in 2015.  In addition, education has been 
found to have a positive association with BMI, independent of SES in the sub–Saharan 
African region (26, 76, 272-274), however previous studies in LMICs have observed that 
education is negatively correlated with BMI in urban settings, whereas, in rural regions, the 
relationship with obesity is direct or non–linear (270, 281). Data from the South African 
demographic and health survey of 2003 shows that men and women with some form of 
schooling have higher BMI values than those who have not attended school or tertiary 
education (282).   
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1.5.5 Smoking, and smokeless tobacco  
 
Cardiovascular diseases are significantly increased with smoking, independent of age, gender 
or body composition; however, in active smokers with metabolic syndrome, the 
cardiovascular disease  risk is two times higher than that of those without metabolic 
syndrome who smoke, and nearly six times higher than those non–smokers with metabolic 
syndrome (283).  There also seems to be a dose–dependent relationship between tobacco 
consumption and risk of cardiometabolic diseases (284), suggesting that as the frequency of 
cigarette smoking increases so does the potential for metabolic syndrome.  Tobacco 
consumption in South Africans is relatively high in black males, and in comparison with 
other population groups, black South African women have a significantly lower prevalence of 
active smoking (23). 
 
Active smoking provides comparatively higher risks for cardiovascular diseases compared 
with other risk factors. This can be explained by a number of potential pathways.  The 
hypothalamic–pituitary–adrenal axis production of plasma cortisol is associated with active 
smoking (285).  Cortisol is insulin antagonistic and increased levels disrupt normal glucose 
metabolism, resulting in increased lipolysis and elevated plasma glucose concentration (286).  
In active smokers, the basal concentration of plasma insulin is high, independent of other 
factors contributing to lower insulin sensitivity (287).  Therefore, prolonged hypersecretion 
of cortisol in chronic active smokers increases the risk of type 2 diabetes (288), but seems to 
diminish substantially after cessation (289).  The concentration of plasma cortisol is also 
higher during the day in habitual smokers compared with non–smokers (290).   
 
Smoking is also associated with an increased visceral fat accumulation, evident by a higher 
waist circumference in active smokers compared with non–smokers (291). This is influenced 
by a higher plasma concentration of cortisol as a result of increased sympathetic nervous 
system activation (292).  In addition to tobacco consumption resulting in high basal plasma 
cortisol concentrations, female smokers were previously observed to have an increased 
androgen:estrogen ratio (293), while in male active smokers, visceral fat accumulation is 
increased due to lower testosterone levels (294).  This clarifies the strong association of 
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tobacco consumption with lower insulin sensitivity (295-297), and the risk of type 2 diabetes 
(288).  However, the appetite suppressing qualities of nicotine are well known.  People who 
actively smoke gain less total body fat over time and have a lower total body fat mass in 
comparison with non–smokers, and cessation of smoking is strongly linked to acute fat 
accumulation (298). 
 
Active smoking also increases endothelial dysfunction by decreasing the production of 
endothelial nitrous oxide, which is responsible for vessel integrity (299).  Chronic exposure 
to tobacco smoke also reduces contractility of the arterial wall (300), increases the risk of 
non–calcified plaques (301), and thrombotic platelet formation in the lumen of vessels (302).  
Thus, smoking cessation not only reduces the risk of chronic elevated blood pressure, but also 
lowers the risk of atherosclerosis. 
 
The consumption of smokeless tobacco (snuff) is comparatively more popular than cigarette 
smoking among black South African women (303). Oral snuff is addictive and the 
concentrations of carcinogenic tobacco–specific N–nitrosamines (TSNAs) and nicotine in 
snuff products from countries around the world are high (304). South African snuff has a 
lower concentration of TSNAs compared with the majority of products from other countries, 
but the amount of unionised nicotine in the products is high  (304).  Unionising nicotine 
allows for faster absorption rates of nicotine, independent of the preferred method of 
consumption.   The relative risk of cardiovascular disease  mortality for users of smokeless 
tobacco is not as high as cigarette smoking (305, 306), while studies have shown that snuff 
use is not associated with an increased risk of myocardial infarction (307) or stroke (308). 
 
The relationship between the use of snuff and type 2 diabetes is unclear.   For example, in one 
study, smokeless tobacco was shown to be associated with type 2 diabetes in a dose–
dependent manner (309), while in another study no relationship between these variables was 
observed, even after taking into account environmental factors (physical inactivity and 
excessive alcohol consumption) (310).  The relationship between snuff and dyslipidaemia is 
similarly unclear.  Higher total cholesterol levels were noted in users of smokeless tobacco 
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compared with non–users (311) while in another study, no significant differences were 
demonstrated (312).  
 
In summary, these studies show that the association of smokeless tobacco with 
cardiometabolic factors seems to be unclear even though the consumption of smokeless 
tobacco has previously been associated with increased fat deposition in the visceral region 
(137).  A study has also shown a relationship between smokeless tobacco and metabolic 
syndrome (313), but this needs to be tested in the African context. 
 
1.5.6 Alcohol consumption  
 
Various gastrointestinal diseases and cancers have been associated with the abuse of alcohol 
(314, 315).  Alcohol abuse is also associated with the onset of cardiometabolic diseases, and 
nearly 6 % of all global deaths in 2012 were related to alcohol (202).  In contrast, it seems 
that a low–to–moderate consumption of alcohol reduces the risk of coronary artery disease by 
approximately 20 %, while the risk increases significantly if alcohol consumption exceeds 90 
grams per day (316).  Moderate consumption of alcohol also seems to protect against the 
development of diabetes and sudden cardiac arrest in diabetic patients (317).   
 
The acute consumption of alcohol increases insulin resistance in the skeletal musculature, 
possibly mediated by decreasing hepatic glutathione or  hepatic–insulin sensitising substance  
(318). Studies demonstrate that the frequency of alcohol consumption is inversely associated 
with BMI  (319, 320), while intermittent bouts of excessive alcohol consumption such as 
binge drinking are associated with higher waist circumference (321).  Epidemiological 
studies have shown that alcohol seems to be particularly more protective against weight gain 
in women compared with men (322). In support of these findings, a longitudinal study 
demonstrated that the frequency of alcohol consumption is inversely associated with central 
adiposity, independent of gender, age, physical activity level, tobacco use, baseline waist 
circumference, type or amount of alcoholic beverage consumed, or socioeconomic status 
(323).  The protective effect of alcohol against increasing waist circumference in non–binge 
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or frequent drinkers can be explained by increased thermogenesis, modulated by alcohol 
dehydrogenase and the microsomal ethanol–oxidising system functionality, effectively 
metabolising alcohol in the body (324). 
 
South Africans have a moderate consumption of alcohol in relation to other countries, and 
evidence shows that alcohol consumption increases linearly as wealth improves (202).  This 
indicates that there may be a relationship between SES and the consumption of alcohol.  
More South African men consume alcohol than women,  and there are more urban–dwelling 
people indulging in health debilitating drinking activities compared with rural dwelling 
people (23).  In comparison with other ethnic groups, black male Africans are more likely to 
participate in binge drinking activity (325). 
 
1.6 Metabolic syndrome and its link with increased risk of future chronic diseases 
 
The significance of the metabolic syndrome as a predictor of future chronic diseases or as a 
risk factor for cardiovascular disease is controversial (326).  Apart from the deleterious 
effects of the components that make up the clustered syndrome on the circulatory system, a 
number of studies have observed that type 2 diabetes and cardiovascular disease are 
associated with metabolic syndrome (327-331).  However, the finding that metabolic 
syndrome is associated with future risk of type 2 diabetes is not surprising as many of the 
definitions of metabolic syndrome have impaired fasting glucose included as a criteria (20).  
Similarly, the finding that metabolic syndrome increased the risk for CVD in some studies 
could be anticipated as the syndrome contains factors which increase the risk for CVD (328, 
331).  Established methods of modelling for type 2 diabetes (Diabetes Predicting Model) and 
CVD (Framingham Risk Score) were shown to be better predictors than metabolic syndrome 
in the San Antonio Heart longitudinal study (332).  In contrast, a recent study of 
hypertensives showed that the metabolic syndrome, independent of its individual 
components, is a better predictor of future cardiovascular events compared with the 
Heartscore model, which is an established model of cardiovascular risk (333).  In support of 
this, the findings from Gupta et al. show that metabolic syndrome has no effect on coronary 
outcomes, but increases the risk of future cerebrovascular events and all–cause mortality, 
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independent of its various components (334).  It has also been observed that the risk of all–
cause mortality and CVD morbidity are increased in hypertensive patients with the syndrome 
(335).  Thus, even though it seems that metabolic syndrome can be a good predictor of future 
disease, some limitations are still evident.  For example, the criteria used for diagnosis can be 
problematic: subjects may be diagnosed with metabolic syndrome that already have 
established diabetes or other co–morbid diseases,  the usefulness of metabolic syndrome as a 
therapeutic/management tool is restricted, categorising of risk factors into a binary state 
rather using the original continuous variable, metabolic syndrome ascribes relative risk of 
disease rather than absolute risk (336).   
 
1.7 Research gaps 
 
The prevalence of obesity in developing countries is increasing, and is particularly high in 
urban, black South African women (2). Consequently, the incidence of metabolic syndrome 
is common in these women (4); however, few data are available on the risk factors associated 
with these diseases. 
 
Urbanisation has been linked with the adoption of behavioural patterns associated with the 
development of excess adiposity (30).  The rapid technological advances of the modern era 
and the on-going urbanisation taking place in developing countries have resulted in people 
expending less energy and sitting more compared with those in rural–settings (21, 337).  
However, few data are available on the physical activity patterns of people living in urban 
centres in LMICs.   
 
Tobacco consumption is associated with visceral adiposity (291), and an inverse association 
between alcohol and fat accumulation has been demonstrated (323).   Both of these 
behaviours are not common in South African women, nevertheless, few data are available on 
the association of smoking, alcohol consumption with cardiometabolic diseases in African 
populations.  Evidence from the recent SANHANES shows that the consumption of 
smokeless tobacco is high in black South African women (23).  Data on the relationship of 
smokeless tobacco and metabolic syndrome is conflicting, with some studies showing a 
relationship (313) and others not (338).  The smokeless tobacco sold in South Africa has a 
higher nicotine absorption rate compared with products in other countries (304).   
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Traditional African cultural ideals regarding body–size preference favour women who are in 
the overweight/obese categories of body mass index (5).  The propensity to follow these 
beliefs could also influence dietary habits and levels of physical activity.  However, recent 
evidence suggests that traditional beliefs around body image are changing in young, black 
adolescent South African females (77, 78).  This implies that adult black African women may 
also be experiencing acculturation of belief patterns, but there is a lack of data on the psycho-
social factors associated with obesity in African populations. 
 
Certain adipokines may have a potential role in the pathogenesis of metabolic syndrome (170, 
173). Few studies have demonstrated a link between these compounds and cardiometabolic 
diseases in African populations.  
 
Age is associated with the natural decline in lean muscle mass, and data suggests an 
association between lean mass and cardiometabolic diseases (339). The premature 
development of sarcopenia influenced by lack of physical activity and increased sitting time 
can increase the risk of developing cardiometabolic diseases (142), however this has not been 
studied in African populations. 
 
There have not been any studies showing the interrelationship of risk factors in their 
association with metabolic syndrome in African populations. The principal risk factors for 
metabolic syndrome are not known in this population, especially so in urban African women 
where the prevalence of both obesity and metabolic syndrome are high (4).  
 
 
1.8 Research question 
 
My research question is: 
What are the risk factors for obesity and metabolic syndrome in African women? 
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1.9 Objectives and hypotheses  
Objectives 
The specific objectives of this thesis were as follows: 
1. To describe patterns of physical activity in a middle–aged cohort of urban black South 
African women living in Soweto, Johannesburg 
2. To examine the association between socio–economic status and physical activity patterns  
3. To determine if physical activity is associated with anthropometry and metabolic 
variables 
4. To describe the change in body composition over a10–year study period in a cohort of 
urban black South African women. 
5. To determine whether baseline measurements of body–size dissatisfaction and body–size 
discrepancy are associated with baseline body composition measures, and correlate with 
changes in body composition over 10–years of follow–up. 
6. To determine whether baseline lifestyle factors including diet and physical activity are 
associated with changes in body composition 
7. To identify the main contributing factors to the cardiometabolic features of the metabolic 
syndrome in a cohort of urban African women known to have a high prevalence of 
obesity and metabolic syndrome 
8. To determine how disease risk varied across the range of levels of each risk factor 
9. To examine whether each risk factor modulated the contribution of the other factors to 
disease risk across their range 
10. To determine which individual components of the metabolic syndrome were influenced 
by each of the risk factors 
  
Hypotheses 
1. Urban, black South African women have a high prevalence of obesity and metabolic 
disease both of which are associated with physical inactivity. 
2. Body–size perception and physical activity are associated with changes in body 
composition in black South African women.  In an under-studied population with a high 
prevalence of cardiometabolic diseases novel risk factors for metabolic syndrome would 
be identified and that disease risk would vary across the range of these variables.  
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3. Physical activity in black South African women is high, but mostly as a result of the 
walking for transport domain of physical activity. 
4. The majority of black South African women have a high amount of weekly sitting time, 
and this is related to high risk of metabolic syndrome. 
5. In an under-studied population with a high prevalence of cardiometabolic diseases novel 
risk factors for metabolic syndrome would be identified and disease risk would vary 
across the range of these variables. 
6. We also hypothesised that each risk factor for metabolic syndrome for metabolic 
syndrome would modify the contribution of the other factors to disease risk by varying 
degrees across their range.  
7. We further hypothesised that each of these factors will influence metabolic syndrome risk 
by effects on individual components of the syndrome. 
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CHAPTER 2 – METHODOLOGY 
2.1 Introduction 
 
The methodology used for the collection of data for this PhD thesis will be outlined in this 
chapter. There were similarities in methodology in all of the studies, which are described in 
more detail in this chapter; however, any variation in the research methods for the respective 
studies will be discussed in the appropriate results chapters.  English was used for 
administering the questionnaires, however, whenever specific questions were not understood, 
and the research assistants were available to assist with comprehension in the participants’ 
home languages.  Statistical methodologies for the different studies are described in detail in 
the respective results chapters. 
 
2.2 Study setting – Soweto, Johannesburg 
 
The Soweto metropolitan region is 15 kilometres southwest of Johannesburg’s former 
business centre (Figure 2.1).  The area was initially created as a separate district to 
accommodate the black African miners who worked in the surrounding gold mines (340). 
The region is now mostly populated by black South Africans, most of which are female, 
originate from the isiZulu ethnic group, and speak a native home language as well as 
conversational English (341).  Approximately 40% of Johannesburg’s total population reside 
in Soweto, and the 2011 census estimates the population size around 1.27 million.  The total 
area of Soweto is 200 km
2
 and includes 34 sub–districts with most houses having being built 
with bricks (340). 
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Figure 2.1: Map displaying Soweto, Johannesburg in the Gauteng province; source of 
data: Cohort Profile: Mandela’s children: The 1990 birth to twenty study in South Africa 
(342) 
 
2.3 Overview of the Birth–to–Twenty study cohort 
 
The Birth–to–Twenty (Bt20) cohort study started in 1990 with a sample of 3,273 participants 
to examine the health and development of children born in the Soweto, Johannesburg region 
(Figure 2.1) (343).  Women were enrolled in their second and third trimester of pregnancy 
through public health facilities and interviewed regarding their health and social history and 
current circumstances. Attrition over two decades has been comparatively low (30 %), mostly 
occurring during the children’s infancy and early childhood (344).  The Bt20 sample is 
representative of families that have remained residents of Soweto for over 20 years, with 
equal numbers of male and female participants. Bt20 also monitors the health of the 
biological mothers or caregivers of the children and it is from these subjects that the study 
cohort was drawn.  A total of  2 200 caregivers/mothers remain in contact with the 
administrators of the study, resulting in the Bt20 study being the leading longitudinal study of 
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African health and development on the continent (344).  The Bt20 data collection facilities 
are located at Bt20, Baragwanath Hospital, Soweto, and at the University of the 
Witwatersrand Medical School, Johannesburg. The Human Research Ethics Committee at the 
University of the Witwatersrand (Medical) granted ethical clearance to perform this study 
(M110627 – see Appendix 1).  Participants gave consent to participate in the study (see 
Appendix 3)  
 
Methods used in all of the publications 
 
2.4 Height, weight, waist and hip circumference measurements 
 
Total body weight (kg) was measured to the nearest 0.1 kg using a digital weighing scale 
(Dismedinc., Anjou, Canada) and standing height was measured to the nearest mm using a 
wall stadiometer (Holtain Ltd., Crosswell, UK). The participants wore minimal clothing and 
did not have shoes on during the measurements. Trained research assistants conducted the 
measurements, and the coefficients of variation for body weight and standing height 
measurements were both <1 %.  Body mass index (BMI, kg.m
-2
) was calculated and 
classified as normal-weight (≥18.5 and < 25 kg.m-2), overweight (≥25 and < 30 kg.m-2) or 
obese (≥30 kg.m-2) (48). Using a flexible, but inelastic measuring tape, a measurement of the 
waist circumference was taken at the narrowest part of the trunk, horizontally, while the 
participants were standing with arms at the side, relaxed abdomen, and feet together (48). 
Similarly, the hip circumference measurement was taken at the widest circumference of the 
proximal thigh, just under the fold of the gluteus, with feet separated slightly (48).  The 
coefficients of variation (CV) were <1 % for body weight and standing height measurements, 
and <2 % for waist and hip circumference measurements (Appendix 4).   
 
2.5 Dual–energy X–ray absorptiometry measurements  
 
Dual–energy X–ray absorptiometry (DXA) (Hologic QDR 4500A, software version 11.2, 
Hologic Inc., Bedford, Massachusetts, USA) was used to measure total body fat mass, central 
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(trunk) and peripheral (arms and legs) adiposity, and total body, central (trunk) and peripheral 
(appendicular) fat–free soft–tissue mass. Anatomical sites were used as markers in DXA to 
determine cut-off lines for central and peripheral fat (345). The region for central fat mass 
included the area between the iliac crest and anterior surface of the mandible, with the spine, 
upper arm and truncal regions at the glenoid fossa, excluded by means of vertical (for spine) 
and lateral (for the latter region) boundary lines (346). The legs were separated by the central 
vertical line at the region where the oblique lines meet (from the underside of the foot to the 
iliac crest cut-off, along the femur and lower leg) (346).  The glenoid fossa to the hand 
formed the anatomical markers for the arm. Coefficient of variances for DXA parameters 
were <2 % for total fat mass, and 1 % for fat–free soft tissue mass. 
 
The arms included the region below the line through the glenoid fossa.  
Vertical lines extending downward from the waist cut-off were positioned to separate thigh 
from hands, and oblique lines were positioned to pass through the femoral neck and join the 
central vertical line between the legs, in order to isolate the legs 
 
2.6 Methods specific to the respective publications 
 
Further detail specific to the publications can be found in the individual results chapters.  
 
2.7 Statistical Analysis  
 
The statistical methodology is described in the methodology sections of the individual results 
chapters. 
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PART 2 
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CHAPTER 3: PATTERNS, LEVELS AND CORRELATES OF SELF–REPORTED 
PHYSICAL ACTIVITY IN URBAN BLACK SOWETO WOMEN 
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3.1 Background  
 
South Africa is a middle income country experiencing epidemiological transition due to rapid 
urbanisation. Nearly two thirds of the population live in urban areas, with the urban poor 
carrying the greatest risk of mortality from modifiable NCDs (27, 28, 347). Physical 
inactivity is accepted as one of the key chronic disease risk factors with 2008 estimations 
showing that physical inactivity was responsible for approximately 9.0 % of deaths globally 
(205), however data on its prevalence within developing countries are sparse (21).  
 
South Africa is estimated to be the third most physically inactive country in Africa, with 
more than half of the population being physically inactive (51.1 %) (205). Studies have 
shown that South African women are more inactive than men (21, 337), suggesting that they 
may be at a higher risk for chronic diseases resulting from physical inactivity (348). A study 
from the South African Comparative Risk Assessment Collaborating Group has shown that in 
adult South African women, an estimated 27.7 % of colon cancer, 22.7 % of ischaemic 
strokes, 20.1 % of type 2 diabetes mellitus, 30.5 % of ischaemic heart disease, and 16.5 % of 
female breast cancer are attributed to inactivity (41). Black South African women have the 
highest prevalence of obesity (26), which may partly be influenced by socioeconomic status 
(22), but may also be related to physical activity since it has been observed that black females 
in South Africa have significantly less total energy expenditure than white women (349). 
Urban–dwelling black South African females have recently been confirmed to be less 
physically active than rural women who usually accumulate higher levels of physical activity 
by participating in subsistence related activity and walking (32). Data from the Transition and 
Health during Urbanisation of South Africans (THUSA) study has shown that physical 
inactivity is associated with obesity outcomes in black South African women (28).  Sitting 
time, a proxy measurement for sedentary behaviour, increases the risk for all–cause mortality 
independent of physical activity time (350). Only a few studies have reported the estimated 
prevalence of sedentary behaviour in black South African females (32, 220, 351). These 
studies showed that rural women were significantly more sedentary than rural men (220), and 
that urban women were significantly more sedentary than rural women (32).  
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We hypothesise that urban, black African females have a high prevalence of obesity and 
metabolic disease both of which are associated with physical inactivity. Therefore, the aim of 
this study was three–fold: (i) to describe patterns of physical activity in a middle–aged cohort 
of urban black South African women who have recently been shown to have a high 
prevalence of metabolic syndrome and related disorders (4); (ii) to examine the association 
between socio–economic status and physical activity patterns in this cohort; and (iii) to 
determine if physical activity is associated with anthropometry and metabolic variables. 
 
3.2 Methods 
 
The methods used in this chapter that are common to the other results chapters have been 
described in Chapter 2. These methods are: the measurement of height (n=977), weight 
(n=977), waist and hip circumferences (both n=964), DXA derived whole body fat and fat–
free, soft–tissue mass (FFSTM) (both n=655). The methods specific to this chapter, and 
which are described below are: the measurement of lipid profiles (HDL (n=462), LDL 
(n=462), serum triglycerides (n=463), and total cholesterol (n=463)), fasting glucose (n=551) 
and insulin (n=352), insulin resistance using the homeostasis model assessment (HOMA) 
technique, blood pressure (n=925), physical activity and sitting time minutes per week, and 
socioeconomic status.   
 
3.2.1 Study population 
 
The study design was cross–sectional, retrospective (data drawn from 2002/3) and included 
black African women living in an urban setting, who had previously been shown to have a 
high prevalence of metabolic syndrome (4). Participants for this study were included if they 
answered the Global Physical Activity Questionnaire (GPAQ) and excluded if they were 
from other ethnic groups, or younger than 18 years of age. The final sample size was 977 
individuals which represented 78 % of the black South African caregivers from the original 
population of Bt20 caregivers (n= 1,251), and of whom 71. 8 % were biological mothers of 
the Bt20 index children. 
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3.2.2 Blood pressure 
 
The Omron M6 (version HEM–7001–E, Omron, Kyoto, Japan) was used to record brachial 
blood pressure (BP). Three measurements were taken after the participant had rested (≥5 
minutes) in the seated position with the cuff around the right upper arm, supported at the 
level of the heart (48). The average of the last two BP measurements was recorded (Appendix 
4).  
 
3.2.3 Blood collection and biochemical analysis 
 
Participants were asked to fast overnight (minimum of 8 hours). The fasting period was 
confirmed on arrival to the data collection facility. Fasting blood samples were collected and 
centrifuged to obtain plasma and serum samples. Aliquoted samples were placed into 
cryovials and stored at –80 °C until assayed.  The ADVIA Centaur XP Immunoassay System 
(Siemens Diagnostics, Tarrytown, USA) was used to perform immunoassays for fasting 
insulin, and the coefficient of variation (CV) range for the fasting insulin immunoassay was 
5.9 to 4.8 %, while the reference range was 0.5 to 300 µU.L
-1
. Insulin resistance was 
calculated using the homeostasis model assessment (HOMA) method (352). The ADVIA 
1800 Chemistry System (Siemens Diagnostics, Tarrytown, USA) was used to determine lipid 
profile (total cholesterol [assay range; CV: 0.26 to 17.5 mmol.L
-1
; 0.30 %]; high–density 
lipoprotein cholesterol (HDL): [0.10 to 3.00 mmol.L
-1
; 1.00 to 2.30 %]; and serum 
triglycerides: [0.00 to 6.22 mmol.L
-1
; 0.50 to 1.60 %]) and indicators of diabetes mellitus 
(fasting glucose [assay range; CV: 0.20 to 38.9 mmol.L
-1
; 0.40 to 0.50 %]. The Friedwald 
formula was used to calculate low–density lipoprotein cholesterol (LDL) (353).  
 
3.2.4 Diagnosis of cardiometabolic disease risk factors 
 
Cardiometabolic disease risk factors were defined as systolic BP ≥130 mmHg, diastolic BP ≥ 
85 mm Hg, fasting blood glucose ≥5.6 mmol.L-1 (type 2 diabetes), triglycerides (TG) ≥ 1.7 
mmol.L
-1
, high–density lipoprotein cholesterol (HDL) <1.3 mmol.L-1, low–density 
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lipoprotein cholesterol (LDL) ≥ 3 mmol.L-1, and total cholesterol (TC) ≥ 5 mmol.L-1 (16).  
Central obesity was defined as a waist circumference ≥ 80 cm (16).  Metabolic syndrome was 
defined using the harmonised guidelines (16).  
 
3.2.5 Questionnaires 
3.2.5.1 Physical activity and sitting time questionnaire 
 
The Global Physical Activity Questionnaire (GPAQ) was completed via interview to obtain 
self–reported physical activity.  This instrument is useful for large studies of physical activity 
patterns, and has been validated for use in both developed and developing settings (208).  It 
has been utilised in South Africa and throughout other African countries (213). Data collected 
using this instrument allow for global physical activity surveillance and comparison of 
regional data, especially in Africa where there is limited physical activity and sedentary 
behaviour data. The GPAQ is also reliable for use in the South African setting, with 
satisfactory Kappa statistics ranging from 0.66 (93.9 % agreement) to 0.78 (89.3 % 
agreement) across various domains of physical activity (208). Total moderate–vigorous 
physical activity (MVPA) in minutes per week (mins/wk) were calculated from the 
accumulative occupation, travel–related (walking for travel) and leisure time physical 
activity.  Examples of moderate (for example, mopping the floor at home) and vigorous (for 
example, carrying a load on the head while walking uphill) intensity activities in these 
various domains were explained to each of the participants.  Walking for travel was analysed 
individually as it was the most common form of physical activity noted in the study 
population. Minutes per week of work and leisure time physical activity were combined. The 
reason for combining the constructs of work and leisure time physical activity was to isolate 
walking for transport as a unique construct. We could therefore analyse ‘walking’ 
independent of the former two constructs. Thus, we had a proxy measure of moderate-
vigorous physical activity (in the form of work-leisure physical activity) which could be 
compared with light physical activity (in the form of walking for transport). Sitting time 
(measured in mins/wk) was obtained and used as a proxy measure of sedentary behaviour.  
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The participants were also grouped according to the GPAQ criteria, into GPAQ active or 
GPAQ inactive categories (209). The hours of physical activity and metabolic–equivalent 
(MET) values per activity were multiplied together to give MET minutes per week in order to 
determine GPAQ activity categories.  Moderate activity was allocated a MET value of four 
and vigorous physical activity a value of eight as outlined in the World Health Organisation 
guidelines (209).  GPAQ active was defined as taking part in: moderate physical activity for a 
total of 150 minutes per week (≥5 days per week); or vigorous physical activity for 60 
minutes per week (≥3 days per week); or 600 MET minutes per week (≥5 days moderate–
vigorous physical activity (MVPA)) (209). Participants who did not meet these criteria were 
classified as inactive (Appendix 5). 
 
3.2.5.2 Socio–economic status  
 
Socio–economic status was determined using a standardised household SES questionnaire, 
previously validated for use in this study population (354). The questionnaire was based on 
the ownership of twelve household commodities: electricity, television, radio, motor vehicle, 
refrigerator, washing machine, telephone, video machine, microwave, electronic media 
network television channel decoder for subscription television, digital satellite television, and 
mobile phone. The twelve household commodities were ranked in order of value and an 
overall SES score was then calculated using the ranks. The overall SES score ranged from 0 
to 78.  Television and motor vehicle ownership were stratified and analysed separately from 
the other household possessions as they are recognised as stimulators of sedentary behaviour 
(235, 355) (Appendix 8).    
 
3.3 Statistical methods 
 
Statistica version 12 (StatSoft, Tulsa, OK, USA) was used to carry out the statistical analyses 
(356). Prevalence levels for metabolic syndrome were determined using the harmonised 
guidelines (16) whilst diabetes was defined using the American Diabetes Association criteria 
(fasting glucose: ≥7 mmol.L-1).  Multiple imputation was used in dealing with missing body 
composition (fat mass, and fat–free, soft–tissue mass) and metabolic outcome variables 
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(fasting blood glucose, fasting insulin, HOMA, HDL, LDL, triglycerides, and total 
cholesterol). Multiple imputation was used to deal with the problem of missing data. Due to 
having multiple outcomes and the strong correlation amongst the outcome themselves, we 
used multiple imputation with chained equations. Examination of the patterns in missing data, 
showed a good proportion of participants having missing information in some outcomes but 
observed information in other outcomes. Thus, the chained equations used the available 
information in the outcomes, the relationship between the outcomes, and the relationship with 
other covariates in the imputations. As a consequence, different numbers for the variables are 
shown.  Due to the amount of missing information in some variables, we checked how well 
the multiple imputation estimated the relationships. A comparison of results (model 
parameter estimates) showed no difference between analysis done using observed data and 
analysis done after multiple imputation. However, some factors that were initially not 
significantly correlated with the outcome variables were found to be correlated after 
imputation 
Dependent variables that were not normally distributed (systolic BP, fasting blood glucose, 
fasting insulin, HOMA, LDL, HDL, triglycerides) were log transformed to normality.  Model 
assumptions of normality and constant variance were tested using Q–Q plots, and plots of 
residuals versus predicted values, respectively. Data are presented as mean ± SD if normally 
distributed; otherwise median [interquartile range (IQR)] is presented. 
  
T–tests were used to compare body composition and metabolic outcomes between Global 
Physical Activity Questionnaire (GPAQ) active and inactive subjects, individuals who 
presented with the extremes of moderate–vigorous physical activity (MVPA) (above 90th and 
below 10
th
 percentile) and physical activity between subjects who owned or did not own a 
motor vehicle or TV. A cluster variable was created using sitting time with total MVPA and 
then using ANOVA to compare metabolic and body composition measures between subjects 
in: highest tertiles for MVPA and sitting time (n = 129), lowest tertile for MVPA and sitting 
time (n = 111), highest tertile for MVPA and lowest tertile for sitting time (n = 77) and 
lowest tertile for MVPA and highest tertile for sitting time (n = 90). The cluster variable was 
created to determine if a combination of two extremes of behaviour that are known to 
modulate fat mass affects both adiposity and metabolic function. Differences between tertiles 
of walking for travel MVPA were explored using an ANOVA for body composition 
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measures and metabolic outcomes, and Tukeys test, which takes into account multiple 
comparisons, was used for the post–hoc analysis.  
 
Multiple linear regression analyses were performed to determine if any of the physical 
activity variables were associated with the body composition and metabolic variables. The 
dependent variables were: total body fat mass, fat–free soft tissue mass, waist circumference, 
HOMA, fasting blood glucose, fasting insulin, total cholesterol, LDL, HDL and triglyceride, 
and systolic and diastolic blood pressures. The independent variables to include in the initial 
models were chosen based on scientific plausibility and for the models with anthropometric 
measures as the dependent variable these were: age, SES, fat mass (for the waist model only), 
sitting time, total MVPA, work MVPA, leisure MVPA and walking for travel. The multiple 
linear regression models that used metabolic measures as the dependent variables included 
the following independent variables: age, SES, total body fat mass, fat–free soft tissue mass, 
waist circumference, sitting time, total MVPA, work MVPA, leisure MVPA and walking for 
travel MVPA. Before performing multiple linear regression, simple univariate regressions 
were used to determine which of the independent variables listed above were associated with 
the various dependent variables and those with p<0.05 were included in the regression 
models and all such variables were kept in the final model. The final models were also 
checked for multicollinearity using the Variance Inflation factor (VIF), but no 
multicollinearity was noted (all VIFs< 3.0). The results of the regression models are reported 
as standardised β values to facilitate direct comparisons of the strengths of the associations. 
Significance was accepted at a level of p< 0.05.  
 
3.4 Results 
3.4.1 Subject characteristics, anthropometric measures and metabolic outcomes 
 
The mean age of this cohort was 41.0 ± 7.84 years, with a high mean BMI (30.3 ± 6.73 kg.m
-
2
) and waist circumference (86.9 ± 13.2 cm) (Table 3.1). The percentage fat mass was also 
high (40.8 ± 7.38 %). Fasting blood glucose levels were slightly raised, whilst insulin and 
HOMA levels were normal, and HDL levels were low (0.99 (IQR 0.78–2.00)), as were total 
cholesterol, LDL and triglyceride levels. Blood pressure values were within normal limits.  
58 
 
Table 3.1: Subject characteristics, body composition and metabolic outcomes of middle aged 
black African women from the Birth to Twenty caregiver cohort 
Characteristics n  
Mean ± SD or 
Median (IQR)  
Age (years) 964 41.0 ± 7.84 
Body mass index (kg.m
-2
) 977 30.3 ± 6.73 
Waist circumference (cm) 964 86.9 ± 13.2 
Hip circumference (cm) 964 112 ± 13.6 
Waist–to–hip ratio 964 0.78 ± 0.08 
Fat mass (kg) 
 
655  28.9 ± 10.7  
Fat–free, soft–tissue mass (kg) 
 
655  38.1 ± 5.96  
Fat percentage (%) 
 
655  40.8 ± 7.38  
Fasting blood glucose (mmol.L
-1
) 551  5.09 (4.59–5.80)  
Fasting insulin (mU.L
-1
) 352  6.74 (4.46–9.14) 
Homeostasis model insulin resistance  330  1.48 (0.96–2.11)  
High–density lipoprotein cholesterol (mmol.L-1) 462  0.99 (0.78–2.04)  
Low–density lipoprotein cholesterol (mmol.L-1) 462  1.31 (0.88–1.77)  
Triglycerides (mmol.L
-1
) 463  0.95 (0.71–1.67)  
Total cholesterol (mmol.L
-1
) 463  3.44 ± 1.77  
Systolic  blood pressure (mm Hg) 925 112 (103–126)  
Diastolic blood pressure (mm Hg) 925 76.4 ± 12.5 
Data presented as mean ± SD or median (interquartile range (IQR)) 
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3.4.2 Physical activity 
 
Physical activity data was obtained for 977 participants, 67 % of whom were classified as 
physically active according to the Global Physical Activity Questionnaire (GPAQ) criteria. 
When using the WHO criteria, 75 % of the participants met the minimum recommended 
guidelines for attainment of 150 minutes of moderate activity or 75 minutes of vigorous 
weekly activity (209). Age was not significantly different between the physical activity 
groups. All domains of physical activity, except vigorous PA (p = 0.64), were significantly 
higher (all p< 0.001) in the GPAQ active group compared with the GPAQ inactive group 
(Fig. 3.1 A and B). The median sitting time for the whole group was 3 hours a day, and was 
not significantly different between the activity groups (GPAQ active: 3 (IQR: 2–5) vs. GPAQ 
inactive: 3 (IQR: 1.5–4 hours per day).  
 
Fig. 3.1A 
 
Fig. 3.1B 
 
 
Figure 3.1: Comparative diagram of cumulative weekly physical activity for total MVPA, 
total vigorous and moderate physical activity (Fig. 3.1A), and physical activity in the 
occupation–, transport– and recreational–time (Fig. 3.1B) between GPAQ active and 
GPAQ inactive groups; 
*
P< 0.05 when compared with matching physical activity domain 
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3.4.3 Association between physical activity and socio–economic status (SES) 
 
Household SES score was inversely associated with time spent walking for travel (r = -0.10; 
p< 0.01), but was not associated with any other activity variable. Walking for travel was 
divided into tertiles for analysis, lowest tertile: n = 322, 0–90 minutes per week; middle 
tertile: n = 316, 90–210 minutes per week; and highest tertile: n = 339, ≥ 210 minutes per 
week. Participants in the lowest tertile for walking for travel had a significantly higher 
household SES score (6.48 ± 2.29) compared with women in the middle (6.08 ± 2.28, 
p< 0.05) and highest (5.81 ± 2.37, p< 0.001) tertiles.  
 
3.4.4 Sedentary promoting assets and physical activity 
 
Time spent walking for travel was significantly higher in the women who did not own a 
motor vehicle compared with those who did (p< 0.01), and significantly higher in the women 
who did not own a television compared with those who did (p= 0.001) (Table 3.2). Leisure 
time physical activity was significantly higher in the women who owned a motor vehicle 
compared with those who did not (p< 0.01). Women who owned a television reported less 
MVPA minutes/wk (p<0.01) and total moderate PA (p<0.01), than women who did not own a 
television (Table 3.2). Sitting time in the GPAQ active group, 1260 (IQR: 840–2100) minutes 
per week, did not differ significantly from the inactive group, 1260 (IQR: 630–1680) minutes 
per week. 
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Table 3.2: Physical activity domains of participants who do and do not own a motor vehicle 
or television (TV) ownership 
Physical activity domains
*
 Motor vehicle and TV ownership 
No motor 
vehicle 
(n=601) 
Motor 
vehicle 
(n=211) 
p–
value 
No TV 
(n=738) 
TV 
(n=74) 
p–
value 
Total moderate–vigorous 
physical activity  
 
400 (150–
1320) 
315 (150–
1260) 
0.53 615 
(240–
2160) 
360 
(150–
1260) 
0.004 
Total moderate physical 
activity 
 
360 (140–
1260) 
300 (120–
1200) 
0.46 615 
(210–
2100) 
315 
(120–
1230) 
0.002 
Total vigorous physical 
activity 
 
0 (0–0) 0 (0–0) 0.16 0 (0–0) 0 (0–
0) 
0.41 
Total work (moderate–
vigorous physical activity)  
 
0 (0–330) 0 (0–0) 0.39 0 (0–
720) 
0 (0–
0) 
0.06 
Total walking for travel  
 
150 (60–300) 120 (40–
240) 
0.003 210 
(120–
420) 
140 
(60–
280) 
0.001 
Total leisure (moderate– 
vigorous physical activity)  
 
0 (0–120) 30 (0–120) 0.004 0 (0–
180) 
0 (0–
120) 
0.39 
Work–leisure (moderate–
vigorous physical activity) 
60 (0–960) 90 (0–760) 0.38 120 (0–
1680) 
60 (0–
60) 
0.16 
Sitting time 1260 (840–
2100) 
1260 (840–
1680) 
0.26 1260 
(840–
1680) 
1260 
(840–
2100) 
0.94 
*
Units are minutes/week expressed as median (interquartile range) 
 
3.4.5 Association between physical activity, and anthropometric measures and 
metabolic outcomes 
 
The prevalence of overweight was 29.2 % (95 % CIs 26.3, 32.0), obesity 48.0 % (95 % CIs 
44.9, 51.1), 66.2 % of the women had a waist circumference ≥80 cm (95 % CIs 63.2, 69.1), 
diabetes was observed in 29.0 % (95 % CIs 25.2, 32.8) of the cohort and the prevalence of 
metabolic syndrome in this cohort was 40.0 % (95 % CIs 35.5, 44.6). Table 3.3 shows that 
the absolute levels of the anthropometric and metabolic variables did not differ between the 
GPAQ active and inactive groups. In addition, there were no significant differences between 
any of the anthropometric or metabolic variables when comparing women in the 90
th
 (n=99) 
and 10
th
 (n=101) percentiles for MVPA (data not shown). Sitting time was not different 
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between those with metabolic syndrome and those without (data not shown). The exploratory 
cluster variable also failed to show any significant differences between cluster groups for 
BMI, waist circumference, body fat, systolic blood pressure, diastolic blood pressure, fasting 
blood glucose, HDL, LDL, total cholesterol, and triglycerides (data not shown).  
 
The results of the multiple regression analyses using observed data can be viewed in 
Appendix 11. Due to the amount of missing information in some variables, we checked how 
well the multiple imputation estimated the relationships. A comparison of results (model 
parameter estimates) showed no difference between analysis done using observed data and 
analysis done after multiple imputation. Using imputed data, multiple linear regression 
analysis demonstrated that sitting time was positively associated with HDL, triglycerides, and 
diastolic blood pressure (Table 3.4). The relationship between sitting time and HDL was 
confounded by the interaction between triglycerides and HDL. Thus, when triglycerides were 
added to the HDL model, sitting time showed an inverse, non–significant relationship with 
HDL (β coefficient: –2.13, p= 0.67). However, when triglycerides were removed from the 
HDL model, sitting time showed a positive association with HDL (β: 0.000002, p= 0.02). 
Inverse associations were observed between total MVPA and insulin, and between walking 
for travel and total cholesterol, whilst work MPVA was positively associated with fat–free, 
soft–tissue mass. Age was found to be positively associated with body fat, waist 
circumference, fasting blood glucose, total cholesterol, LDL, triglycerides, systolic and 
diastolic blood pressure, whilst SES was positively associated with body fat mass and fat–
free, soft–tissue mass. Waist circumference was associated with fasting glucose, fasting 
insulin, LDL, total cholesterol, systolic and diastolic blood pressure (Table 3.4). No 
independent variables were found to correlate with HOMA levels following the regression 
analysis.  
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Table 3.3: Comparison of metabolic risk outcomes and body composition between active and 
inactive black South African women based on multiple imputation 
Dependent variables GPAQ inactive GPAQ active 
N Mean (95% CI) N Mean (95% CI) 
Fasting blood glucose (mmol.L
-1
) 309 5.13 (4.92, 5.33) 630 5.32 (5.10, 5.53) 
Fasting insulin (pmol.L
-1
) 306 7.14 (6.31, 8.09) 625 6.78 (5.96, 7.71) 
High–density lipoprotein cholesterol (mmol.L-1) 306 1.27 (1.15, 1.40) 618 1.38 (1.23, 1.55) 
Low–density lipoprotein cholesterol (mmol.L-1) 306 1.26 (1.18, 1.35) 618 1.18 (1.12, 1.24) 
Total cholesterol (mmol.L
-1
) 306 3.52 (3.3, 3.75) 618 3.30 (3.10, 3.50) 
Triglycerides (mmol.L
-1
) 306 1.06 (0.98, 1.14) 618 1.10 (1.03,1.17)  
Systolic blood pressure (mm Hg) 305 115 (112, 117) 620 114 (112, 117) 
Diastolic blood pressure (mm Hg) 305 76.0 (74.0, 77.0) 620 77.0 (76.0, 78.0) 
Fat mass (kg) 309 29.4 (28.2, 30.6) 635 29.0 (28.1, 29.9) 
Fat–free, soft–tissue mass (kg) 309 38.1 (37.5, 38.8) 635 38.3 (37.8, 38.8) 
Waist circumference (cm) 316 86.1 (84.6, 87.5) 650 87.2 (86.2, 88.3) 
Body mass index (kg.m
-2
) 321 30.2 (29.5, 31.0) 656 30.3 (29.8, 30.8) 
Data expressed as mean (95% CIs); GPAQ: Global physical activity questionnaire 
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Table 3.4:  Multiple linear regression models for anthropometric and metabolic variables 
using imputed data  
Dependent 
variable 
N Independent 
variables 
Coefficients ( 95% CI)‡ Beta Coefficient† 
(p–value) 
Adjusted R
2
 
(p–value) 
Fasting glucose 918 Age 
Waist 
0.001 (0.0004, 0.002) 
0.0007 (0.0003, 0.001) 
 
0.10 (0.003) 
0.11 (0.001) 
0.02 
(<0.001) 
Fasting insulin 916 Age 
Waist 
Total MVPA 
–0.002 (–0.005, 0.002) 
0.006 (0.004, 0.007) 
–0.00002 (–0.00004, –
0.000004) 
 
–0.07 (0.04) 
0.35 (<0.001) 
–0.11(<0.001) 
0.13 
(<0.001) 
High–density 
lipoprotein 
cholesterol 
914 Age 
Waist 
Sitting time 
–0.001 (–0.003, 0.001) 
–0.003 (–0.004, –0.002) 
0.00002 (0.000003, 
0.00003) 
 
–0.05 (0.16) 
–0.16 (<0.001) 
0.08 (0.02) 
0.04 
(<0.001) 
Low–density 
lipoprotein 
cholesterol 
917 Age 
Waist 
0.006 (0.002, 0.009) 
0.002 (0.0005, 0.004) 
 
0.28 (<0.001) 
0.18 (<0.001) 
0.13 
(<0.001) 
Total 
cholesterol 
917 Age 
Waist 
Walking for 
travel 
0.04 (0.02, 0.07) 
0.009 (–0.009, 0.03) 
–0.0003 (–0.0009, 
0.0002) 
 
0.25 (<0.001) 
0.09 (0.007) 
–0.08 (0.01) 
0.09 
(<0.001) 
Triglycerides 921 Age 
Sitting time 
0.002 (–0.0002, 0.004) 
0.00002 (0.000001, 
0.00004) 
 
0.08 (0.01) 
0.12 (<0.001) 
0.02 
(<0.001) 
Systolic blood 
pressure 
925 Age 
Waist 
0.002 (0.002, 0.003) 
0.0009 (0.0006, 0.001) 
 
0.24 (<0.001) 
0.17 (<0.001) 
0.10 
(<0.001) 
Diastolic blood 
pressure 
912 Age 
Waist 
Sitting time 
0.21 (0.10, 0.30) 
0.20 (0.14, 0.26) 
0.001 (0.0002, 0.002) 
 
0.13 (<0.001) 
0.21 (<0.001) 
0.08 (0.01) 
0.08 
(<0.001) 
Body fat 925 Age 
SES score 
201.03 (112, 291) 
46.4 (9.82, 82.9) 
 
0.15 (<0.001) 
0.08 (0.009) 
0.03 
(<0.001) 
Fat–free, soft–
tissue mass 
925 Age 
SES score 
Work MVPA 
1.11 (–46.4, 48.6) 
15.31 (–4.00, 34.62) 
0.46 (–0.001, 0.92) 
 
0.002 (0.96) 
0.05 (0.12) 
0.06 (0.05) 
0.01 (0.098) 
Waist 
circumference 
925 Age 0.35 (0.25, 0.45) 0.21 (<0.001) 0.04 
(<0.001) 
‡: Unstandardised model coefficients; †: Standardised model coefficients; MVPA: moderate–
vigorous physical activity 
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3.5 Discussion 
 
The aim of this cross–sectional study was to determine the physical activity patterns of a 
cohort of middle–aged black women from Soweto, Johannesburg, who have previously been 
shown to be at high risk for metabolic disease. In this cohort of women in whom 67.0 % were 
classified as physically active, the prevalence of obesity was 48.0 %. This study is one of 
only a few to measure sedentary time in black South African women, and shows that despite 
a high level of physical activity and relatively low sitting time (214), metabolic disease risk is 
still high. Walking for travel significantly contributed to weekly physical activity, and was 
inversely associated with sedentary promoting assets including motor vehicle and television 
ownership. 
 
The WHO defines being sufficiently active as accumulating a minimum of 150 minutes of 
moderate activity or 75 minutes of vigorous activity per week, however, this method does not 
take into account the various domains of physical activity (209). Physical activity in 
developed countries typically encompasses a greater contribution from leisure time activity, 
whereas in developing countries work– and travel–related physical activity are the major 
contributors to daily energy expenditure  (211, 351). In addition, physical inactivity is  higher 
in more affluent countries than lower income countries (210). However, longitudinal data 
from Brazil shows that physical activity has improved over a five year period in the lower 
socioeconomic stratum, suggesting a shift in physical activity patterns in low and middle 
income countries (203). Using the GPAQ criteria which also takes into account the number of 
days per week of PA, the majority (67.0 %) of women in this study were classified as 
physically active.  This is comparable to the global level of physical activity in women 
(66.1 %), in a study which also highlighted the lack of physical activity data from low and 
middle income African and Asian countries  (210). However, the physical activity range in 
our study  falls into the higher end of the range reported in other studies of black South 
African women (45.2–70.8 %) (224, 238).  In the study by Alberts et al. (2005) 45.2 % (age–
standardized) of rural women were classified as physically active at home using a lifestyle 
questionnaire (238), while the THUSA study found that 70.8 % of rural women were 
physically active using a physical activity index which stratified the groups of physical 
activity in tertiles (224). In comparison to these two South African studies, most of the 
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women in the current study performed walking for travel (89.0 %) whereas the percentage of 
subjects commuting by walking was lower in the THUSA study (27.4 %) and the study by 
Alberts et al. (2005) (16 %). However, it should be noted that the methods used in these 
studies for assessing physical activity were different to those used in the current study, 
making comparisons difficult. 
 
This is one of the first studies to quantify daily sitting time (excluding sleep time), a proxy for 
sedentary time (357), in a large female African population.  Evidence from studies suggest 
that sitting time is associated with both obesity and other metabolic diseases (230, 231). In 
our study sitting time was positively associated with triglycerides and diastolic blood 
pressure, which has also been observed in other studies (230, 358). In the current study 50.0 
% of the women reported sitting for 3 or more hours a day which is comparable to studies 
from India, China, and Brazil who report 3.5, 4, and 4.5 hours of sitting per day, respectively 
(232, 359). In our study, sitting time was not different between the active and inactive groups, 
suggesting that in this population, the amount of time spent sitting is independent of physical 
activity, and should be investigated as a distinct entity. This opinion is also shared by 
Bankoski et al. (226) and Chau et al. (360) who found that sedentary time was strongly 
related to the risk of metabolic disease independent of the time spent being physically active. 
Recent findings also show that patterns of sedentary behaviour varies by life domains such as 
television watching, personal computer use, and travel time (359). 
 
Previous studies have identified motor vehicle ownership as a sedentary promoting asset 
(235, 236). Held et al. (2102) found that participants who owned a motor vehicle had an 
increased risk of myocardial infarction (236). Similarly the review by Douglas et al. (2011) 
emphasises the integral role of car ownership in the increasing prevalence of physical 
inactivity and obesity in countries with low levels of active transport (235). The current 
growth of the South African economy has resulted in motor vehicles becoming more 
affordable to a larger proportion of the population, as a result of which, vehicle ownership is 
increasing in urban settings such as Soweto (361). In our study, sitting time was not different 
between the women who owned motor vehicles and those that did not; however the women 
who did not own a motor vehicle walked significantly more and performed significantly less 
leisure time physical activity than the women who did own a motor vehicle. This data 
67 
 
suggests that the negative effect of car ownership on walking may be counteracted by an 
increased amount of leisure time physical activity. Leisure time physical activity has 
previously been shown to be associated with SES (212), so the role of SES and time spent in 
different sedentary life domains in determining physical activity patterns must also be 
considered (360). 
 
The domains of physical activity in developing countries favour travel– and occupation–
related physical activity, which was confirmed in our findings (211). Importantly, our study 
has provided data on the different domains of physical activity, which has only been 
investigated in a small number of African countries (213, 214, 351). Our findings show that 
the majority of the women (89.5 %) did not perform vigorous activity and that walking and 
occupational physical activities were the domains with the highest contribution (34 % from 
walking and 56 % from occupation related physical activity) to overall physical activity. A 
similar pattern of physical activity is evident in African countries such as Eritrea, Cameroon, 
Mali, and Mauritania, where active commuting contributes more than 50 % to total daily 
physical activity (213).  Our study showed a positive association between activity in the work 
domain and fat–free, soft–tissue mass, suggesting that physical activity may have a role in 
improving the overall health profile of this ageing population of women, despite them having 
a high body fat percentage. It should be noted here that together with age and SES, this model 
only explained a small (1%) and non-significant % of the variance in fat–free, soft–tissue 
mass. A recent study however concurred with this finding, showing that exercise improved 
physical fitness and lean mass, but did not result in significant body fat or lipid profile 
changes following a 24 week intervention of strength and endurance training (362). Studies 
have also shown that participation in regular physical activity is the best means of preventing 
the effects of sarcopenia on the physical functioning of ageing individuals (141, 142). Leisure 
time activity contributes the most to overall physical activity in developed countries (21). A 
recent systematic review of the health benefits of walking as a means of transport confirms 
that there may be positive effects on hypertension and type 2 diabetes mellitus with longer 
duration walking (216).   
 
A very high prevalence of type 2 diabetes was found in our study population with a mean age 
of only 41, and this is probably a result of the high level of obesity in this group. Our findings 
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showed that total MVPA was inversely associated with fasting insulin, indicating that being 
physically active has a role in enhancing insulin sensitivity. These results correspond with 
South African studies which showed that physically active urbanised black women had lower 
serum insulin levels than inactive women (28), subsequently resulting in higher levels of 
insulin sensitivity (214). These studies imply that meeting the recommended guidelines for 
physical activity may have long–lasting effects on insulin sensitivity. 
 
This study used the GPAQ to measure physical activity. The GPAQ is cost–effective and has 
been validated for use in developing countries (211, 363). The reliability of the GPAQ has 
been tested in South Africa, with the results showed acceptable Kappa statistics, ranging from 
0.66 (93.9 % agreement) to 0.78 (89.3 % agreement) across the domains of physical activity 
(208). However, the major challenge of using this instrument is that it assesses self–reported 
physical activity which may lead to an overestimation of weekly activity (364). Secondly, the 
GPAQ is not as sensitive as objective measurements of physical activity; however the GPAQ 
is still a useful tool for physical activity surveillance. Our South African data compares well 
with data from other African countries (213), such as Mozambique, Niger and Malawi who 
attain the majority of their activity from the work domain, ranging from 60 to 75% of total 
MVPA (213).  
 
Another key drawback of this study is that it was cross sectional and therefore causality 
cannot be determined. We did not find an association between any of the physical activity 
domains and anthropometric measures or metabolic outcomes using a variety of statistical 
analyses. In an urban dwelling Cameroon population of women, lower amounts of MVPA 
was performed compared with ours (94 vs. 119 MVPA mins/per day) and a negative 
association was observed between physical activity and prevalence of metabolic syndrome 
(106). Cook et al. (2010) found that more than half of the women (55.2 %) in rural South 
Africa performed more than the recommended 10000 steps per day, and that ambulation 
reduced obesity risk in rural South Africans (220). A reasonable assumption for the 
differences between these studies and the current study could be in the use of self–reported 
questionnaires in our study compared with objective measurement of physical activity used in 
the other studies. However another reason for the difference could be that the prevalence of 
obesity was also lower in the Cook study (27.1 %) and similarly, the mean BMI of the 
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women in the Cameroon study ranged from 23.7 in the highest quartile of physical activity to 
28.3 in the lowest.  The employment status of this study population was not measured, thus 
we could not determine whether physical activity varied across occupation. 
 
3.6 Conclusions 
 
We have shown that despite the majority of urban dwelling black South African women 
being classified as physically active, there is still a high prevalence of obesity and metabolic 
disease in this population. As in other developing countries, the majority of time spent in 
physical activity is in the form of walking for travel, however the intensity of this activity is 
not known. Thus, we recommend that future research aims to determine whether the intensity 
of this walking modifies the level of cardiometabolic risk factors in this population. This 
study showed that sitting time was positively associated with serum triglyceride levels and 
diastolic blood pressure, whilst total MVPA was inversely associated with serum insulin 
levels. This data implies that future intervention studies for cardiometabolic disease 
prevention in urban African populations must aim to reduce daily sitting time and increase 
total MVPA.   
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CHAPTER 4: THE ROLE OF LIFESTYLE AND PSYCHO–SOCIAL FACTORS IN 
PREDICTING CHANGES IN BODY COMPOSITION IN BLACK SOUTH AFRICAN 
WOMEN  
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4.1 Background 
 
Recent research has predicted that the proportion of overweight and obese women in 
developing countries such as South Africa will continue to rise, whereas the reverse applies 
to developed countries (2).  The increasing prevalence of excess body fat deposition 
(observed in BMI values ≥25 kg.m-2) in the South African population is associated with an 
excessive burden of several NCDs such as type 2 diabetes and hypertension (280, 365).  
Black South African women are more affected by obesity than men (23), a pattern that is 
common across the African continent and other developing countries (2).  Furthermore, the 
recent South African National Health and Nutrition Examination Survey observed that a 
lower proportion of rural compared with urban black South African women have obesity 
(31.8% compared with 42.2 %) (23),  as urbanised women live in an environment that 
favours unhealthy dietary patterns (30), reduced physical activity (PA) (21, 224), and greater 
sedentary time (32). However no studies have investigated whether these factors predict 
changes in body composition in an African population over time.  
 
Psycho–social factors associated with obesity and body–size preference specific to black 
South African women have been reported in cross sectional studies (69, 70).  These factors 
include social desirability to be fatter and a general tolerance of obesity (67).  Black South 
African women and adolescent girls have been shown to underestimate actual body–size, 
indicating a high level of body–size discrepancy, and have a low level of body–size 
dissatisfaction (26, 68).  Culturally a larger body–size is preferred as it is perceived to signify 
beauty, wealth, happiness, higher socioeconomic status, and ability to produce children (69), 
while thinness is associated with weakness, poverty and illness such as tuberculosis and 
human immunodeficiency virus (72). Furthermore, a recent study has shown that the body 
image silhouette chosen by urbanised black female adolescents for their ideal body silhouette 
represents a higher BMI than that chosen by white female adolescents.  Within the same 
study, when asked what body silhouette they perceive their families would prefer them to 
have, black participants chose a silhouette with a BMI that was higher than that chosen by the 
white participants (77). This study also showed that a higher percentage of black girls had an 
EAT–26 (Eating Attitudes Test) score > 20 (indicating the possibility of developing eating 
disorders such as anorexia nervosa, bulimia nervosa, or preoccupation with food), and that a 
higher proportion of black adolescents girls, compared with white girls, had greater body–
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size dissatisfaction, and were more likely to control what they ate. Another South African 
study similarly suggested that acculturation may be occurring in young black females, and 
that there could be a conflict between traditional beliefs and Western ideals around body–size 
(78). Most of the recent data relating to changes in perceptions about body size come from 
studies in adolescents, with little data available for middle-aged women. Therefore, the aim 
of this study was three–fold: (i) to describe the change in body composition over a 10 year 
period in a cohort of urban black South African women; (ii) to determine whether baseline 
measurements of body–size dissatisfaction and body–size discrepancy are associated with 
baseline body composition measures, and correlate with changes in body composition 
variables over 10–years of follow–up, and (iii) to determine whether baseline lifestyle factors 
including diet and physical activity are associated with changes in body composition. 
 
4.2 Methods 
 
The methods used in this chapter that are common to the other results chapters have been 
described in Chapter 2. These methods are: measurement of height, weight, waist and hip 
circumferences, DXA derived trunk fat, whole body fat and fat–free, soft–tissue mass 
(FFSTM). The methods specific to this chapter, and which are described below are: the 
measurement of body–size perception and body–size discrepancy, sitting time, physical 
activity, highest level of education, and asset ownership (proxy measure of socioeconomic 
status).   
 
4.2.1 Study population 
 
This longitudinal study included black SA urban–dwelling women from Soweto, 
Johannesburg.  These women were caregivers of participants from the Birth to Twenty (Bt20) 
cohort, as described in Chapter 3. The majority (78.8%) of the sample were biological 
mothers of the Bt20 cohort, with the remainder being related to the child in some way.  
Baseline data were collected on all caregivers who were black African and > 18 years of age 
in 2002/3 (n=1,251).  Follow–up data collection was completed 10 years later (2012/13) on 
702 women, 428 of whom had anthropometric (weight and height) data at both time points. 
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4.2.2 Questionnaires 
4.2.2.1 Physical activity and sitting time questionnaire 
 
Baseline physical activity and sitting time were determined using the GPAQ (described in 
Section 3.2.5.1); however, participants were not stratified into physical activity groups for 
this study. 
 
4.2.2.2 Socio–economic status  
 
Ownership of household assets, a proxy measure of SES, was determined using a validated 
questionnaire (described in Section 3.2.5.2) (354).  Level of education was also used as a 
proxy measure of SES for the longitudinal study, and was categorised as “no education” 
(coded as “0”), “completed primary school but did not attend high school” (coded as “1”), 
“attended high school but did not graduate” (coded as “2”), and “completed high school” 
(coded as “3”) (Appendix 8).   
 
4.2.2.3 Body–size dissatisfaction and body–size discrepancy  
 
At baseline, drawings of nine female body silhouettes (adapted from Stunkard et al. (79)) 
ranging from “very thin” (numbered as 1) to “very heavy” (numbered as 9) were shown to 
participants and used to evaluate body–size dissatisfaction and body–size discrepancy.  Body–
size discrepancy was assessed by calculating a discrepancy score between perceived and 
actual weight status (PAD) using a method adapted from a South African (69) and an Italian 
(366) study. The participant chose a silhouette that they considered best represented their 
current weight. These were coded as follows: 1 = silhouettes 1 and 2 [underweight]; 2 = 
silhouettes 3 to 5 [normal weight]; 3 = silhouettes 6 and 7 [overweight]; 4 = silhouettes 8 and 
9 [obese]).  The PAD score was then calculated by subtracting the actual BMI status (coded 
using measured BMI as: 1 = underweight [<18.5 kg.m
-2
], 2 = normal weight [18.5 
74 
 
to 24.9 kg.m
-2
], 3 = overweight [25.0 to 29.9 kg.m
-2], 4 = obese [≥30.0 kg.m-2]) from the code 
for the perceived weight status silhouettes. Negative PAD scores represent underestimation 
of weight status, positive scores represent overestimation of weight status, and zero scores 
represent participants who had an accurate perception of their weight status.   
 
Body–size dissatisfaction was measured by asking the participant to choose the silhouette that 
best portrayed how they wanted to look (known as the ‘ideal’ body shape).  This was then 
subtracted from the ‘feel’ score (the silhouette that portrays what they perceive themselves to 
look like) to calculate the feel minus ideal (FID) score. Positive scores represent a desire to 
be leaner, a zero score represents contentment with body–size, and negative scores indicate a 
desire to be fatter (69, 367). The body–size dissatisfaction and body–size discrepancy scores 
were used to categorise the participants into negative, zero and positive groups of PAD and 
FID (Appendix 6). 
 
4.2.2.4 Dietary intake, alcohol consumption, and smoking status  
 
High fat consumption was measured at baseline using an adapted food frequency 
questionnaire from a previous South African study investigating factors associated with 
overweight and obesity (368).  The questionnaire determined consumption frequency of 
high–fat foods in the past week including fatty cuts of red meat, chicken with skin, full cream 
milk, processed meats, crisps, and fried food items, for example fried eggs, fish and French 
fries, consumed on a regular basis (≥1 day per week). Alcohol intake was categorised as low 
(1 drink per day), moderate (2–3 drinks per day), or high (>3 drinks per day). Smoking status 
(never smoked, current smoker, or former smoker) was also determined using this 
questionnaire. All participants were asked if they had attempted to lose weight in the last 24 
months by reducing their food intake, taking diet shakes/drinks, and/or joining organisations 
which focus on structured weight reduction programmes (Appendix 7). 
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4.3 Statistical methods 
 
Analyses were performed on the women for whom we had body composition and weight and 
height data at baseline and 10–year follow–up (N=428). The Statistica software package was 
used for all statistical analyses (version 12, StatSoft, Tulsa, USA) (356).  Data that were not 
normally distributed (total MVPA, total walking for travel, vigorous physical activity, 
moderate physical activity, and total sitting time per week) were log transformed to 
normality.  Continuous, normally distributed variables are presented as mean ± SD whilst 
data that was not normally distributed is presented as median (interquartile range [IQR]).  
Differences between baseline and 10 year data were assessed by Student’s paired t–test or 
McNemer test.  Variables were compared between the 3 FID, and between the 3 PAD groups, 
using ANOVA and followed by the Tukey post hoc test only in cases when the ANOVA was 
significant (p< 0.05). A cluster variable was created using physical activity and consumption 
of fatty foods with ANOVA used to compare body composition across the following groups: 
physically inactive and consume high fat foods (n = 100), physically inactive and consume 
low fat foods (n = 19), physically active and consume high fat foods (n = 240), physically 
active and consume low fat foods (n = 33).  The cluster variable was created to determine if a 
combination of two extremes of behaviour that are known to modulate fat mass affects 
adiposity. 
 
Multiple linear regression analyses were conducted to determine if baseline (predictor) 
variables were associated with absolute changes in the body composition (outcome) variables 
(FFSTM, waist circumference, BMI, central adiposity, peripheral adiposity, and total body fat 
mass) 10 years later after adjusting for potential confounding variables, i.e. age, SES score, 
education, and the respective baseline body composition variables. Results of the multiple 
linear regression models are presented as standardised β values to enable direct comparison 
of the strengths of the associations.  Prior to performing multiple regression analysis, simple 
bivariate analyses were performed to determine which of the following baseline (predictor) 
measures [total vigorous physical activity, total walking for travel, alcohol use, cluster 
variable for physical activity status and consumption of fatty foods, smoking status, weight 
loss practices, FID score and PAD score] were associated with the various dependent 
variables, and those with p< 0.05 were included in the multivariate regression models along 
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with the four possible confounding variables described above. Only the independent variables 
that had significant (p< 0.05) β values are reported in the results section. Collinearity between 
independent variables was assessed using the Variance Inflation Factor (VIF), and no 
collinearity was observed (all VIFs< 2.0).  Dummy variables were generated for the 
following variables: FID and PAD scores, the cluster variable for physical activity and 
consumption of fatty foods, education, smoking status, and alcohol consumption. The 
reference groups for each of these variables were as follows: zero FID, zero PAD, physically 
active and low fat consumption, no education, non–smokers, and people who do not consume 
alcohol. Significance was accepted at an alpha level of p≤ 0.05. 
 
4.4 Results 
4.4.1 Characteristics of the study cohort  
 
Mean age at baseline was 41.1 ± 5.35 years and at follow–up age was 49.3 ± 5.33 years. 
Within the study cohort 49.5 % of participants had completed high school. Complete DXA 
data was not available at both time points for all subjects due to the fact that not all study 
subjects were able to perform DXA scans at the baseline visit on weekdays due to work 
commitments and we could only accommodate a small number of subjects for data collection 
on weekends. Women for whom DXA data was available at both time points (n=264) were 
slightly older, but showed no differences for any of the other measured variables when 
compared with women without (n=164) DXA data (Appendix 13).  There was a significant 
increase in all body composition measures between baseline and follow up (all p<0.001), 
with a mean weight gain for the whole sample of 5.17 ± 8.86 kg (Table 4.1).  The prevalence 
of a high waist circumference (≥80 cm) and obesity (BMI≥30 kg.m-2) increased significantly 
between baseline and follow–up (both p < 0.001).   
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Table 4.1: Body composition characteristics at baseline and at 10–year follow–up 
Variable N
a 
Baseline Follow–up  
Percentage 
change 
Weight (kg) 428 77.4  ± 17.3 82.6 ± 18.9
*
 7.13  ± 12.1 
Body mass index (kg.m
-2
) 428 30.8 ± 6.70 33.1 ± 7.36
*
 7.98  ± 11.9 
Waist circumference (cm) 415 87.7 ± 13.2 98.5 ± 14.7
*
 12.8  ± 11.4 
Hip circumference (cm) 413 114 ± 13.7 119 ± 15.2
*
 4.09  ± 7.44 
Waist–to–hip ratio 413 0.77 ± 0.08 0.83 ± 0.08* 8.65  ± 9.96 
Fat mass (kg) 264 29.8 ± 10.2 32.9 ± 10.6
*
 13.6  ± 23.75 
Fat–free, soft–tissue mass (kg) 264 38.5 ± 5.86 45.0 ± 7.29* 17.2  ± 7.99 
Central adiposity (kg) 261 13.4 ± 5.28  14.4 ± 5.33
*
 11.6  ± 28.7 
Peripheral adiposity (kg) 261 16.4 ± 5.49 17.7 ± 5.84
*
 9.8  ± 20.5 
Obesity (BMI≥30 kg.m-2) 428 50.9 (46.2, 55.7) 65.8 (61.4, 70.4)* 29.3† 
Waist (≥80 cm) 415 70.6 (66.2, 75.0) 89.9 (87.0, 92.8)* 27.3† 
 
Data presented as mean ± SD for continuous data and % (95 % CIs) for categorical data; 
a
N 
at baseline and at 10–year follow–up; *p< 0.001 versus baseline values; †Formula for percent 
change in prevalence: (follow–up prevalence – baseline prevalence)/baseline prevalence 
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4.4.2 Body–size perception and body–size discrepancy 
 
At baseline, 10.5 % of subjects wanted to be fatter (negative FID score), 57.4 % wanted to be 
leaner (positive FID score), and 32.1 % were content with their body image (zero FID score; 
Table 4.2). The proportion of women in each of these groups did not change significantly at 
follow–up, i.e. 9.1 % subjects wanted to be fatter, 53.7 % wanted to be leaner, and 37.2 % 
were content with their body–size. At baseline, women who wanted to be leaner had a 
significantly higher BMI, waist and hip circumferences, central and peripheral adiposity, and 
total fat and fat–free, soft–tissue mass, than those with a negative or zero FID score 
(p<0.0005 for all comparisons). Similar differences were observed at follow up (Appendix 14 
and 14).  There were no differences between the FID groups for absolute change in  any of 
the body composition measures even when this data was expressed as percentage change 
from the baseline, and when FID negative and zero groups were combined and compared 
with the FID positive group. 
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Table 4.2: Comparison across baseline FID groups of baseline body composition measures 
and absolute change in body composition variables over 10–year follow–up   
Variable 
Subjects who 
wanted to be 
fatter  
Subjects who were 
content with their 
body–size 
Subjects who wanted 
to be leaner 
Proportion in each FID 
group (%)
b
 
10.5% (45) 32.1% (138) 57.4% (247) 
Proportion of obesity in 
each FID group (mean % 
(95% CIs) )
b
 
13.6 (3.08-24.2) 36.5 (28.3-44.7) 65.6 (59.6-71.6) 
Age (years) 42.2 ± 5.84 (45) 42.1 ± 5.49 (138) 40.3 ± 5.05 (247) 
BMI (kg.m
-2
)
b
 25.1 ± 4.16 (44) 28.4 ± 4.91 (137)
†
  33.2 ± 6.85 (247)
††† ***
  
Absolute change in BMI 
(kg.m
-2
) 
1.46 ± 2.99 (44) 2.60 ± 3.54 (137) 2.31 ± 3.54 (247) 
Waist circumference (cm)
b
 77.2 ± 8.21 (45) 83.4 ± 10.4 (136) 91.8 ± 13.6 (243)
††† ***
   
Absolute change in waist 
circumference (cm) 
10.5 ± 8.11 (43) 11.1 ± 8.91 (134) 10.7 ± 10.0 (238) 
Hip circumference (cm)
b
 102 ± 9.28 (45) 110 ± 10.8 (136)
†
  119 ± 13.8 (242)
††† ***
   
Absolute change in hip 
circumference (cm) 
2.98 ± 6.08 (43) 4.58 ± 7.42 (133) 4.69 ± 9.86 (237) 
Fat mass (kg)
b
 20.2 ± 6.35 (33) 28.0 ± 9.29 (87)
†
  33.4 ± 10.4 (157)
††† *
  
Absolute change in fat mass 
(kg) 
4.02 ± 6.04 (32) 3.53 ± 6.10 (84) 2.72 ± 5.89 (148) 
Fat–free, soft–tissue mass 
(kg)
b
 
35.9 ± 5.10 (33) 37.1 ± 5.18 (87) 40.3 ± 6.38 (157)
††† ***
    
Absolute change fat–free, 
soft–tissue mass (kg) 
5.78 ± 2.99 (32) 6.49 ± 2.88 (84) 6.80 ± 3.26 (148) 
Central adiposity (kg)
b
 8.68 ± 3.34 (32) 12.3 ± 4.68 (86) 15.2 ± 5.29 (155)
††† *
 
Absolute change in central 
adiposity (kg) 
1.56 ± 2.88 (30) 1.15 ± 3.20 (84) 0.79 ± 3.10 (147) 
Peripheral adiposity (kg)
b
 11.5 ± 3.56 (32) 15.6 ± 5.05 (86) 18.1 ± 5.82 (156)
††† *
 
Absolute change in 
peripheral adiposity (kg) 
1.64 ± 2.67 (30) 1.48 ± 3.06 (84) 1.29 ± 3.46 (148) 
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Data presented as mean ± SD (n); 
†
P< 0.05, 
†††
P< 0.0005 versus subjects who wanted to be 
fatter; 
*
P< 0.05, 
***
P< 0.0005 versus subjects who were content with body shape; 
b 
baseline 
values 
 
With regard to body–size discrepancy at baseline, 74.0 % of the subjects underestimated their 
actual body–size (negative PAD score), 2.00 % overestimated actual body weight (positive 
PAD score), and 24.0 % correctly perceived their actual body weight (zero PAD score; Table 
4.3).  At follow up, the proportion of women in each of the PAD groups were similar to 
baseline, i.e. 73.5 %, 0.70 %, and 25.8 % respectively. Women who underestimated actual 
body weight status had a significantly higher BMI, waist and hip circumferences, and total fat 
and fat–free, soft–tissue mass, than those who overestimated or correctly perceived their 
actual body weight (p<0.0005 for all comparisons).  Women who correctly perceived actual 
body weight had a significantly greater increase in fat mass than the women who 
underestimated body weight.  
 
There were 316 participants who underestimated their body–size. These subjects had a high 
BMI (32.6 ± 5.74; see Table 4.3) and 60.1 % of them wished to be leaner i.e. had a positive 
FID score, 8.20% wanted to be fatter, and 31.7 % were content with their body–size. The 
women who underestimated but were content with their body–size were older (42.7 ± 5.28 vs 
40.4 ± 5.16 years; p< 0.05) and less obese (30.3 ± 4.01 vs 34.5 ± 5.78; p< 0.0005) than those 
women who wanted to be thinner, and less of them completed high school compared with the 
latter group (46.0% vs 56.3%; p= 0.06). There were 103 participants who accurately 
perceived their body–size, of whom 17.5% wanted to be fatter, 35 % were content with their 
body–size and 47.5 % wanted to be leaner (for the latter value (47.5 %), p< 0.05 vs those 
subjects who underestimated body–size and wanted to be lean (60.1 %)). 
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Table 4.3: Comparison across baseline PAD groups of baseline body composition measures 
and absolute change in body composition variables over 10–year follow–up   
Variable 
Subjects who 
underestimated 
actual body–size 
Subjects who 
accurately perceived 
actual body–size 
Subjects who 
overestimated 
actual body–size 
Proportion in each PAD 
group (%)
b
 
74.0% (316) 24.0% (103) 2.00% (9) 
Proportion of obesity in 
each PAD group (mean % 
(95% CIs) )
b
 
65.8 (60.5-71.1) 9.70 (3.89-15.5) 0 (0-0) 
Age (years) 41.3 ± 5.41 (316) 40.3 ± 5.18 (103) 42.4 ± 4.64 (9) 
BMI (kg.m
-2
)
b
 32.6 ± 5.74 (316) 26.2 ± 6.89 (103) 21.5 ± 2.39 (9)
††† ***
  
Absolute change in BMI 
(kg.m
-2
) 
2.17 ± 3.60 (316) 2.80 ± 3.66 (103) 1.81 ± 2.47 (9) 
Waist circumference (cm)
b
 91.0 ± 11.9 (312) 78.6 ± 12.3 (101) 72.0 ± 6.93 (9)
††† * 
 
Absolute change in waist 
circumference (cm) 
10.4 ± 9.73 (307) 12.3 ± 8.79 (97) 10.6 ± 6.97 (9) 
Hip circumference (cm)
b
 117 ± 12.2 (312) 106 ± 13.8 (100) 94.4 ± 7.81 (9)
††† ***
  
Absolute change in hip 
circumference (cm) 
4.17 ± 9.14 (306) 5.54 ± 7.88 (96) 4.73 ± 5.98 (9) 
Fat mass (kg)
b
 33.3 ± 9.38 (209) 21.2 ± 7.98 (60) 15.2 ± 5.03 (7)
††† ***
  
Absolute change in fat mass 
(kg) 
2.57 ± 6.92 (198) 5.04 ± 5.99 (59)
†††
 3.24 ± 3.88 (6) 
Fat–free, soft–tissue mass 
(kg)
b
 
40.3 ± 5.66 (209) 34.8 ± 4.99 (60) 28.4 ± 2.59 (7)
††† ***
  
Absolute change in fat–free, 
soft–tissue mass (kg) 
6.89 ± 3.13 (198) 5.88 ± 2.87 (59) 3.86 ± 2.44 (6) 
Central adiposity (kg)
b
 15.6 ± 4.67 (206) 8.79 ± 4.02 (59) 6.33 ± 2.35 (7)
††† ***
 
Absolute change in central 
adiposity (kg) 
0.73 ± 3.10 (196) 1.85 ± 3.11 (58) 1.20 ± 2.28 (6)
†††
 
Peripheral adiposity (kg)
b
 18.1 ± 5.26 (206) 12.3 ± 4.60 (60) 8.86 ± 3.21 (7) 
Absolute change in 
peripheral adiposity (kg) 
0.99 ± 2.98 (196)
*
  2.74 ± 3.93 (59) 1.25 ± 1.71 (6) 
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Data presented as mean ± SD (n); 
†
P< 0.05, 
†††
P< 0.0005 versus subjects who underestimated 
actual body–size; *P< 0.05, ***P< 0.0005 versus subjects who accurately perceived actual 
body–size; bbaseline values 
 
4.4.3 Lifestyle factors 
 
The median (IQR) sitting time for all participants at baseline was 1260 (840–1890) minutes 
per week, and was significantly different (p< 0.05) between the subjects who wanted to be 
fatter (1680 (840–2940) minutes per week) compared with the subjects who were content 
with their body–size (1260 (840–1680) minutes per week) and the subjects who expressed a 
desire to be thinner (1260 (840–1680) minutes per week). For all participants the median time 
spent in walking for travel was 150 (60–300) minutes per week, for work MVPA was 0 (0–0) 
minutes per week, and for leisure MVPA was 0 (0–120) minutes per week. Total median 
MVPA was 350 (150–1240) minutes per week, total vigorous physical activity and total 
moderate physical activity were 0 (0–0) and 315 (150–1240) minutes per week, respectively. 
None of these physical activity variables measured at baseline were associated with body–
size discrepancy or body–size dissatisfaction, and were also not significantly different 
between the PAD or FID groups.  
 
The majority of participants (88.2 %) reported consuming butter or margarine on bread, 55.9 
% reported eating chicken with skin, 48.6 % ate processed meat, 33.7 % ate red fatty meats, 
and 49.8% drank  full cream milk on a regular basis (>1 time per week).  A significantly 
higher amount of women who wanted to be leaner consumed fatty red meat compared with 
those women who wanted to be fatter (44.4 % vs. 13.5 %, p<0.05).  The majority (97.0 %) of 
the participants did not smoke, and 16.7 % consumed alcohol on a regular basis (≥1 time per 
day), whilst 25.7 % had participated in some form of weight loss strategy in the past 24 
months. A significantly higher number of women who wanted to be leaner participated in 
some form of weight programme compared with those women who indicated a desire to be 
fatter (84.0 % vs. 13.0 %, p<0.0001).  No significant differences were noted between the 
groups defined using the cluster variable (physical activity and fatty food intake) for changes 
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in body composition (as determined by ANOVA). This cluster variable also did not 
contribute significantly to the multiple regression models shown in Table 4.4. 
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Table 4.4:  Multiple linear regression analyses displaying the major predictors of change in 
body composition in black African women from Soweto  
Model 
number 
Dependent 
variables 
N Independent variables Significant 
beta 
coefficients 
(P–value) 
R
2 
(P-
value) 
1 Absolute 
change in 
waist 
circumference 
380 Alcohol intake at baseline (>3 
drinks/day)  
–0.15 (0.003) 0.07 
(<0.0001) 
Total vigorous PA (baseline)  –0.15 (0.002) 
Waist circumference 
(baseline)  
–0.17 (0.001) 
Active smoker at baseline -0.02 (0.66) 
Subjects who wanted to be 
fatter (baseline) 
-0.05 (0.37) 
Subjects who wanted to be 
leaner (baseline) 
0.06 (0.35) 
Subjects who underestimated 
actual body–size (baseline) 
-0.001 (0.99) 
Subjects who overestimated 
actual body–size (baseline) 
-0.03 (0.38) 
Attended high school but did 
not graduate 
0.06 (0.45) 
Completed high school 0.02 (0.98) 
2 Absolute 
change in 
body mass 
index 
430 Total vigorous PA (baseline)  –0.11 (0.02) 0.02 
(<0.01) 
3 Absolute 
change in fat–
free, soft–
tissue mass 
241 Active smoker at baseline  –0.14 (0.02) 0.12 
(<0.0001) Age (baseline)  –0.14 (0.03) 
Fat–free, soft–tissue mass 
(baseline)  
0.21 (0.003) 
4 Absolute 
change in 
total body fat 
264 Subjects who underestimated 
actual body–size (baseline)  
–0.16 (0.01) 0.08 
(<0.0001) 
Total body fat (baseline)  –0.22 (0.002) 
Total vigorous PA (baseline)  –0.12 (0.04) 
5 Absolute 
change in 
central 
adiposity 
260 Central adiposity (baseline)  –0.24 (0.001) 0.09 
(<0.0001) Total vigorous PA (baseline) –0.15 (0.01) 
6 Absolute 
change in 
peripheral 
adiposity 
261 Subjects who underestimated 
actual body–size (baseline)  
–0.15 (0.03) 0.06 
(<0.001) 
Total vigorous PA (baseline)  –0.13 (0.04) 
Data presented as standardised beta coefficient (p–value) 
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4.4.4 Multivariate regression 
 
The multivariate regression models showing the contribution of various baseline factors to 
change in body composition are presented in Table 4.4, with age, SES, education and the 
respective baseline body composition variables included in each of the 6 models. Total 
vigorous physical activity and high alcohol consumption (≥3 drinks/day) were each inversely 
associated with absolute change in waist circumference (model 1). In the model for absolute 
change in BMI (model 2), total vigorous physical activity was the only significant 
independent variable. Smoking and age were inversely associated with change in FFSTM, 
while baseline FFSTM was positively associated (model 3).  Although the prevalence of 
smoking was low (3 %) an effect was seen on change in FFSTM and this is due to a strong 
effect of smoking as shown by the difference in change in FFSTM between smokers (n=13) 
and non–smokers (n=382) (3.03 ± 2.81 vs 6.69 ± 3.13, p= 0.003). Model 4 showed that total 
vigorous physical activity and baseline total body fat were both inversely associated with an 
absolute change in total body fat, which was lower in those who underestimated body–size 
when compared with those who accurately assessed body–size. Total vigorous physical 
activity and baseline central adiposity were both inversely associated with change in central 
adiposity (model 5). Total vigorous physical activity and an underestimation of body–size 
were both negatively associated with absolute change in peripheral adiposity (model 6). 
 
4.5 Discussion 
 
In this cohort of ageing black South African women we observed significant weight gain over 
a 10 year period, with an obesity prevalence of 65.8 % at follow up, and with nearly 90 % of 
the participants having a waist circumference ≥80cm.  The most significant contributors to 
less change in the various body composition measures were the underestimation of body–size 
at baseline, time spent doing vigorous physical activity, and alcohol consumption. 
 
This study is the first to determine the contribution of body image to long–term body 
composition change in black South African women. Our study demonstrates that the majority 
(57.4 %) of the women wished to be leaner, and that these women had higher baseline BMI, 
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total body fat and fat–free mass, central and peripheral adiposity, waist and hip circumference 
values, than the women who wanted to be fatter and those who were happy with their body–
size.  In contrast, previous cross–sectional studies have shown that African women have a 
general acceptance of overweight and obesity (67), with a larger body–size traditionally 
being viewed as a symbol of beauty, wealth, happiness, and optimal fertility in African 
cultures (67, 69, 71), whereas leanness was associated with sickness and lower 
socioeconomic status (72).  Our data therefore suggests that within our cohort of adults the 
acceptance of female obesity within African traditions exists side–by–side with a more 
western ideal of a lower body weight. Within adolescent black females the situation is 
similar, with the study of Gitau et al. (77) showing that although black adolescent females are 
more comfortable with a body–size that is higher than that selected by white adolescents 
females, the black females were more likely to have a predisposition toward eating disorders 
than their white counterparts. This again suggests a clash between the traditional African 
view of overweight/obesity as being the ideal female body state and the modern Western 
tradition of leanness as the ideal female body state (78).   
 
This is the first study to have measured whether the discrepancy between actual and 
perceived weight status in South African women predicts future weight gain. The majority 
(74%) of women at baseline underestimated their weight and had significantly higher 
measures of all body composition parameters at baseline, when compared with the other 
groups. However these women had less absolute change in central and peripheral adiposity at 
follow up when compared with those subjects who had accurately estimated their body–size. 
This may be related to the fact that a higher proportion of this group wanted to be leaner 
when compared with the subjects who accurately identified their body–size. This may be 
advantageous for future obesity intervention programs. Other South African studies have also 
shown that black African females tend to underestimate their actual body–size (26, 68). 
However, 31.7 % of the women who underestimated their body–size were content with their 
weight status, even though their mean BMI was high at 30.3 ± 4.01. Fewer of these women 
had completed high school and were older than those women who wished to be leaner. These 
data suggest that within our study population there are two distinct groups of 
overweight/obese women who differ in terms of age, education and the desire to lose weight. 
These findings may be important when introducing obesity intervention programs into this 
population, with different approaches required for each group of women. 
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This is the first longitudinal study on the effect of physical activity on weight change in black 
African females. Our results showed that baseline total vigorous physical activity was 
inversely associated with change in BMI, waist circumference, total body fat, and central and 
peripheral adiposity. These results are comparable to those from a study conducted in 
middle–aged obese and sedentary American women which showed that higher intensity 
physical activity was more effective in reducing both intra–abdominal and subcutaneous fat 
than lower intensity physical activity (369). Further, it has been observed that exchanging 1 
hour of sitting time with light physical activity can significantly decrease both visceral and 
subcutaneous adipose tissue (370). In our study, sitting time was significantly lower in those 
women who wanted to be leaner compared with those women who wanted to be fatter, but 
body–size dissatisfaction and body–size discrepancy were not associated with differences in 
the level of physical activity. This data suggests that body–size dissatisfaction or discrepancy 
may not have an impact on physical activity behaviour in this population, which is contrary to 
one previous study which has shown that physical activity is perceived to be associated with 
thinness (68), and that body–size dissatisfaction may modulate sedentary behaviour.  
Moreover, participating in vigorous physical activity provides additional advantages to health 
such as improved skeletal health and reduced risk of cardiovascular diseases (371). However, 
only 10% of the women in our study participated in vigorous intensity physical activity, 
which is similar to the data for women from other developing countries (21, 213). These data 
suggest that efforts to combat obesity in this population should include higher intensity 
physical activity programmes, however the programmes should emphasise the gradual and 
safe progression from light to higher intensity, particularly in those women who are obese.  
 
Findings in other studies of alcohol consumption and body weight have shown that more 
frequent drinking is associated with leanness (372, 373), while binge drinking is associated 
with central obesity (321).  In comparison, our findings show that higher alcohol 
consumption was inversely associated with change in waist circumference. This finding is 
consistent with a large Danish longitudinal study which showed that the level of alcohol 
intake was inversely associated with change in waist circumference in women (374).  The 
authors attribute this result to a thermogenic effect, i.e. the action of alcohol dehydrogenase 
and the microsomal ethanol–oxidising system increasing thermogenesis in frequent alcohol 
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drinkers. Our analysis also shows that smoking has an inverse association with change in 
FFSTM, implying that women in our cohort who smoke gain less muscle mass over time. 
Our findings also show that age was negatively associated with change in FFSTM, 
reinforcing the well documented loss of muscle mass with ageing (375). The main result of 
premature sarcopenia would be a loss of functional capacity, particularly for activities of 
daily life that require muscle strength.  Nicotine acts as an appetite suppressant and increases 
energy expenditure, which may explain the reason for smokers tending to have lower body 
weight than non–smokers, and why smoking cessation is followed by an increase in fat mass 
(297).  As active smoking was only observed in 3 % of the cohort in our study, and because 
tobacco consumption was only captured at baseline is causality should be inferred with 
caution. With regards to dietary behaviour, we showed that many of the women in our study 
ate foods high in fat. In spite of this, the consumption of these foods did not influence long 
term weight gain. This is consistent with a large American study, which showed a weak non–
significant correlation between weight change and whole fat dairy foods, but a strong 
negative correlation with nuts, vegetables and fruits (376).  
 
In South Africa (26, 76, 272) and other sub–Saharan African countries (273, 274), SES has 
been shown to be positively associated with obesity in cross sectional studies, as has level of 
education (26, 76, 272-274). However, the findings from our study show that baseline 
measures of education or SES did not affect change in body composition. The reason for this 
finding is not known however one possible explanation may be the low variation in education 
and SES levels within this cohort. Socioeconomic status and alcohol intake were only 
measured at baseline in our study and therefore the effect of changes in these variables could 
not be assessed. However it is unlikely that SES would change sufficiently over the study 
period to modulate any of the outcome variables. It is possible that alterations in alcohol 
consumption over the 10 year period may have effects on body composition changes, but it 
must be noted that the prevalence of alcohol usage in this cohort was low. 
 
This longitudinal study has a number of limitations including the use of self–reported 
physical activity and sedentary behaviour, derived from the GPAQ instrument. This 
questionnaire has the potential to overestimate both physical activity and sitting time.  
However, GPAQ has been shown to be reliable for use in African populations (208), and  our 
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findings are comparable with physical activity data from other African countries (213), and 
adds to a small body of evidence from low–and–middle–income countries. Secondly, the 
self–reported dietary questionnaire only considered high fat foods which have previously 
been associated with obesity in South Africa (368). We observed that consumption of these 
foods were common amongst the participants in this study. Future studies in this population 
should also consider the impact of other foods which were not considered in the present 
investigation e.g. high carbohydrate foods and sugar sweetened drinks. Thirdly, it would have 
been ideal to have more regular follow–up visits of this cohort, but due to infrastructural 
constraints this was not possible. The 10–year period allowed for greater changes of the 
anthropometric variables than would be observed over a shorter time period thus allowing us 
to more easily isolate predictor variables. It is nevertheless important to emphasise that it is 
not known if the changes in body composition over the 10–year period are linear, as assumed 
in the multivariable linear regression analyses. A further limitation was that DXA data was 
not available for the full cohort. However, when comparing the women for who complete 
DXA data was available to those for who it was not, there were no differences in any of the 
measured variables with the exception of age, which was slightly lower in the latter group. 
This suggests minimal selection bias for the group with DXA data available at both time 
points. Lastly, an assumption has been made that the desire for, or the acceptance of, a higher 
body–size is the consequence of a traditional African belief in the positive aspects of obesity. 
Questions were not asked of the study participants to validate this assumption, although 
previous reports have described such beliefs (67, 69). Comparison with a European 
population would have allowed us to determine whether this acceptance of a high body–size 
was more prevalent in an African population, although other studies have shown this to be the 
case (70, 77).   
 
4.6 Conclusions 
 
The findings of this longitudinal study demonstrate that in our cohort of black urbanised 
South African women time spent in vigorous physical activity was associated with smaller 
increases in body weight and adiposity. However, only a small percentage of subjects 
participated in vigorous PA. In addition, the majority of participants who were overweight or 
obese underestimated their body–size and this was related to a smaller gain in body adiposity 
and a more prevalent desire to lose weight than in subjects who accurately identified their 
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body–size. Additionally, in agreement with previous studies that have reported that black 
South African women are more accepting of being obese (67, 69, 71), our study highlighted 
the existence of a further group of overweight/obese women who were content with their 
body–size. Thus, the presence of two distinct groups of overweight/obese women within our 
study population, one wishing to be thinner (57.4%) and the other content with their body–
size (32.1%), may reflect a clash of traditions with the former group appearing to be more 
closely aligned with Western values focussing on leanness and the latter group more aligned 
with the African ideal of overweight/obesity as the preferred body–size. It is recommended 
that more in–depth studies of these groups are necessary to determine whether these 
assumptions are correct and to investigate whether obesity intervention programs would 
require different approaches in each of these populations. 
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CHAPTER 5: METABOLIC AND BODY COMPOSITION RISK FACTORS 
ASSOCIATED WITH METABOLIC SYNDROME IN A COHORT OF WOMEN 
WITH A HIGH PREVALENCE OF CARDIOMETABOLIC DISEASES 
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5.1 Background  
 
Metabolic syndrome, which is one of the major pandemics affecting health across the globe 
(86), is characterised by a clustering of cardiometabolic factors which increase the risk of 
cardiovascular disease and type 2 diabetes (16). A complete understanding of the aetiology of 
the metabolic syndrome is difficult to achieve due to the presence of multiple components, 
each of which have their own individual pathophysiological origins. Furthermore, the 
metabolic syndrome includes metabolic (lipids and glucose), cardiovascular (blood pressure) 
and visceral adiposity (waist circumference) factors with the latter of these, itself having an 
aetiological input into each of the other components (377). Thus, when investigating the 
aetiology of the syndrome, risk factors may be revealed simply because of their correlation 
with waist circumference. 
 
A number of risk factors for metabolic syndrome have been demonstrated (20) however; 
there is little data on how disease risk varies across the range of levels of these variables or 
whether individual factors modulate the disease risk contributed by other identified risk 
markers. Such information would be important to our understanding of the aetiology of the 
metabolic syndrome and may improve our ability to identify true markers of disease risk. The 
identification of risk factors for metabolic syndrome and a greater understanding of their 
inter-relationships may be accomplished by the investigation of populations with high levels 
of cardiometabolic disease prevalence. This is true for urban South African females in whom 
the prevalence of both obesity and metabolic syndrome are high [11] and little is known 
about the disease aetiology.       
 
Therefore, the aims of the current study were as follows to: (i) identify the main contributing 
factors to the cardiometabolic features of the metabolic syndrome in a cohort of urban 
African women known to have a high prevalence of metabolic syndrome; to determine how 
disease risk varied across the range of levels of each risk factor; and (ii) examine whether 
each risk factor modulated the contribution of the other factors to disease risk across their 
range and to determine which individual components of the metabolic syndrome were 
influenced by each of the risk factors. We hypothesised that each risk factor would modify 
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the contribution of the other factors to disease risk by varying degrees across their range. We 
further hypothesised that each of these factors will influence metabolic syndrome risk by 
effects on individual components of the syndrome. It was hoped that this investigation would 
identify the principal risk factors for metabolic syndrome and reveal novel information on the 
interplay between these factors in modulating disease risk. 
 
5.2 Methods 
 
The methods used in this chapter that are common to all the other results chapters have been 
described in Chapter 2. These methods are: measurement of height, weight, waist and hip 
circumferences, DXA derived trunk fat, whole body fat and fat–free, soft–tissue mass 
(FFSTM). Measurement of lipid levels, insulin, insulin resistance and glucose were also 
undertaken in this chapter and are described in detail in Chapter 3 (see section 3.2.3), whilst 
measurement of blood pressure is also described in Chapter 3, section 3.2.2. Methods specific 
to this chapter are described below and are: measurement of adiponectin, leptin, HbA1c, HIV 
status, visceral and subcutaneous abdominal fat, employment status, education level, 
menopausal stage, smoking and use of smokeless tobacco (snuff).     
 
5.2.1 Study population 
 
This cross–sectional study of African women comprised 867  eligible women for recruitment 
into the current study based on the following criteria: age between 40–60 years, not being 
pregnant and being black South African.  However, 165 of this group could not participate in 
the study, for the following reasons: refusal (n = 79), uncontactable (n = 46), died (n = 37), 
and terminally ill (n = 3).  Thus 702 women volunteered to participate, and underwent an 
informed consent process. Ethical clearance was granted by the Human Research Ethics 
Committee (Medical), University of the Witwatersrand. 
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5.2.2 Body composition 
5.2.2.1 Ultrasound analysis 
 
The GE LOGIQ ultrasound system (USS) (GE Healthcare, Piscataway, NJ) was used to 
determine the thickness of visceral (VAT) and subcutaneous adipose tissue (SCAT) with a 2 
to 5 MHz 3C–RS curved array transducer located one centimetre above the umbilicus. The 
ultrasonographic measurements were defined as the distances (depth set at fifteen 
centimetres) from the peritoneum to vertebrae (for VAT), and the depth (distance set at nine 
centimetres) from the surface of the skin to the linea alba (for SCAT). A trained sonographer 
administered all the measurements (CV <2 %, calculated on repeated duplicate measurements 
on fifteen subjects). The methods used for SCAT and VAT measurement by ultrasonography 
have been previously validated (378). 
 
5.2.3 Blood pressure 
 
The method used for the measurement of blood pressure has been described in Section 3.2.2. 
 
5.2.4 Blood collection and biochemical analysis 
 
In addition to the protocol used for the collection of fasting blood and biochemical analysis, 
the methods used to determine HbA1c, adiponectin, and leptin concentration are outlined. 
The ADVIA 1800 Chemistry System (Siemens Diagnostics, Tarrytown, USA) was used to 
measure glycated haemoglobin (HbA1c) [ CV, 0.8 to 1.3 %]).  The low–density lipoprotein 
cholesterol (LDL) was estimated using the Friedewald formula (379). Leptin was measured 
using an ELISA kit (Biovendor Research and Diagnostic Products, Candler, NC) with a CV 
range of 4.2 to 7.6 %.  Total adiponectin was quantified using an ELISA assay kit (R&D 
Systems Inc., Boston Biochem, Cambridge, MA) with a CV range of 2.5 to 4.7 %. 
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5.2.5 Diagnosis of disease and assessment of menopausal status 
 
The cut–points used for diagnosis of each of the individual components of the metabolic 
syndrome were those from the harmonized guidelines (16). Metabolic syndrome was 
diagnosed using 2 different methods: (1) waist circumference was excluded from the 
assessment and the syndrome was diagnosed when 3 or more of the remaining 4 criteria were 
met; (2) waist circumference was included and diagnosis was based on the presence of 3 or 
more of the 5 criteria as prescribed by the harmonized guidelines (16).  
 
A trained HIV counsellor performed HIV testing and recorded the HIV status of the 
participants.  The Alere Determine 
TM
 HIV–1/2 (Alere Medical Co., San Diego, CA) assay kit 
for the rapid detection of HIV antigens/antibodies was offered to all study participants.  It is 
considered to have a high level of acceptance, sensitivity and specificity in African 
populations (380).  Referral to the nearest public hospital or community clinic of was made to 
validate HIV positive findings with more in–depth analyses to ensure appropriate treatment.  
Management of HIV using antiretroviral pharmacotherapy was also noted. 
 
Menopausal status (pre– or post–menopause) was determined by a trained clinician using the 
STRAW +10 criteria (381).   
 
5.2.6 Questionnaires 
5.2.6.1 Socio–economic status   
Education (completed high school or did not complete high school) and employment status 
(employed or unemployed) were determined (see questionnaire in Appendix 8). 
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5.2.6.2 Tobacco and smokeless tobacco consumption  
 
Cigarette smoking (“never” as reference versus “current” and “former”) and smokeless 
tobacco (snuff) status (“yes” or “no”) were determined from questions taken from a 
standardised, validated general health questionnaire (368) (Appendix 7). 
 
5.3 Statistical analysis 
 
All analyses were performed using Statistica (version 12, StatSoft, Tulsa, USA). Continuous, 
normally distributed variables are presented in tables and text as mean ± SD whilst 
continuous variables with a skewed distribution are shown as median (interquartile range). 
The latter variables were log transformed to normality before being analysed. Metabolic and 
anthropometric differences were compared between women with and without metabolic 
syndrome using either a Student’s unpaired t–test for continuous data or a χ2 test for 
categorical data.  
 
Logistic regression analysis was carried out to identify if any of a list of scientifically 
plausible variables were associated with metabolic syndrome. Each of these variables were 
included in a separate univariate logistic regression model with metabolic syndrome as the 
outcome variable. These variables were:  education (completed or did not complete high 
school), age, employment status (employed or unemployed), snuff use (“yes” or “no”), 
smoking (“never” as reference versus “current” and “former”), menopausal status (pre- or 
postmenopausal), HIV status (HIV–negative as reference versus HIV-positive, antiretroviral 
therapy (ART)–naïve and  HIV–positive, receiving ART), adiponectin, leptin, HOMA, 
subcutaneous and visceral adipose thickness, total body fat, total FFSTM, hip and waist 
circumferences.  The variables that were associated with metabolic syndrome risk in the 
univariate logistic regression models with p<0.10 (see section 5.4.2 for a list of these 
variables) were all included in a single multivariable logistic regression model with metabolic 
syndrome again as the outcome variable. Backward, stepwise removal of non–significant 
variables was performed manually until only variables with a significant odds ratio (OR) 
remained in the final model.  Collinearity within both the initial and the final model was 
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quantified via variance inflation factor (VIF) analysis, but none was observed with all VIFs < 
5.00. Each of the independent continuous variables that remained in the multivariable logistic 
regression model were then analysed as hexiles, with the lowest hexile used as the reference, 
in the presence and absence of each of the other independent variables that significantly 
associated with metabolic syndrome.  This allowed us to determine how risk for metabolic 
syndrome varied across the range of each independent variable and whether this was affected 
by the other significant modifiers of metabolic syndrome risk. In addition, the risk factors for 
each component of the metabolic syndrome (except waist) were determined using 
multivariable, backward step–wise logistic regression analysis as described above. 
 
A post hoc power analysis was performed based on the multivariable logistic regression 
models and using the model that would require the largest sample size. This model had 10 
independent variables (k) and the frequency of the categorical variable was 0.142 (p). Using 
the equation, N=(10k)/p this model required a sample size of 704 subjects, which was very 
close to the actual N for this study (702).  
 
5.4 Results 
5.4.1 Subject characteristics 
 
Body composition and metabolic features of the participants with or without metabolic 
syndrome are presented in Table 5.1. Metabolic syndrome was diagnosed using only HDL, 
triglyceride, glucose and blood pressure measurements, and 3 or more of these 4 
measurements had to exceed the cut points defined by the harmonised guidelines (16). The 
prevalence of metabolic syndrome using these criteria was 14.0 % whilst the prevalence 
using the normal criteria that includes waist circumference (16), was 49.6 %.  The prevalence 
of the individual components of the metabolic syndrome were as follows: waist 
circumference ≥80 cm, 90.5 %; hypertension, 64.7 %;  fasting glucose ≥5.6 mmol.L-1, 16.3 
%; triglyceride ≥1.7 mmol.L-1, 15.4 %; HDL <1.3 mmol.L-1, 66.2 %. The prevalence of 
obesity was 67.8 %, of extreme obesity (BMI ≥ 40) was 16.8 %, of LDL ≥3 mmol.L-1 was 
36.4 % and of total cholesterol ≥5 mmol.L-1 was 29.9 %. The data in Table 5.1 demonstrates 
that nearly all the anthropometric and cardiometabolic variables were higher in the women 
with metabolic syndrome than those without, whereas socioeconomic and education status 
were similar between the two groups. When comparing the data in Table 5.1 with data from 
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women diagnosed with or without metabolic syndrome using the full set of 5 criteria from the 
harmonised guidelines (16) (see Appendix 16), it was observed that in these women both leg 
fat (14.8 ± 4.31 vs. 13.5 ± 4.72 kg; p<0.0005) and leptin (31.1 [18.6, 45.9] vs. 22.7 [13.1, 
40.5]; p<0.0005) were significantly higher in subjects with metabolic syndrome but no such 
differences were observed for the women depicted in Table 5.1. In addition, subcutaneous fat 
thickness was not different (p=0.083) between women with (3.49 ± 1.01 cm) or without (3.35 
± 1.03 cm) the metabolic syndrome when diagnosed using the full criteria, but when using 
the criteria without waist, subcutaneous fat thickness was lower in women with metabolic 
syndrome (p<0.05; see Table 5.1).     
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Table 5.1: Anthropometric and metabolic variables in women with and without metabolic 
syndrome
†
  
Variables Women with 
metabolic syndrome
†
 
(n=90) 
Women without 
metabolic syndrome 
(n=552) 
Proportion (mean (95%CIs)) 14.0 (11.3-16.7) 86.0 (83.3-88.7) 
Age (years) 51.0 ± 5.21 49.0 ± 5.19
**
 
Weight (kg) 86.0 ± 14.2 79.1 ± 16.0
**
 
Height (m) 1.58 ± 0.07 1.57 ± 0.06 
BMI (kg.m
-2
) 35.4 ± 6.75 32.8 ± 7.26
*
 
Waist (cm) 106 ± 11.2 97.5 ± 14.4
***
 
Hip (cm) 121 ± 13.3 117 ± 14.8
*
 
Arm fat (kg) 4.13 ± 1.08 3.63 ± 1.26
**
 
Arm FFSTM (kg) 4.86 ± 0.89 4.36 ± 0.80
***
 
Leg fat (kg) 14.0 ± 4.22 14.1 ± 4.64 
Leg FFSTM (kg) 16.5 ± 2.81 15.4 ± 2.82
**
 
Trunk fat (kg) 16.5 ± 4.15 14.0 ± 5.13
***
 
Trunk FFSTM (kg) 23.7 ± 3.26 21.4 ± 3.18
***
 
Total body fat (kg) 34.6 ± 8.47 31.8 ± 10.2
*
 
Total FFSTM (kg) 45.0 ± 6.57 41.2 ± 6.55
***
 
Subcutaneous fat thickness (cm) 3.21 ± 0.74 3.45 ± 1.06
*
 
Visceral fat thickness (cm) 5.07 ± 1.56 4.29 ± 1.72
***
 
Systolic blood pressure (mmHg) 143 [130, 159] 128 [117, 143]
***
 
Diastolic blood pressure (mmHg) 93.0 [87.5, 101] 86.0 [77.5, 94.5]
***
 
HbA1c (%) 6.30  [5.90, 7.70]  5.80 [5.50, 6.20]
***
 
Fasting glucose (mmol.L
-1
) 5.70 [5.00, 7.20] 4.70 [4.40, 5.10]
***
 
Insulin (pmol.L
-1
) 13.5 [8.60, 20.0] 9.80 [6.40, 14.1]
***
 
HOMA 3.93 [2.22, 5.69] 2.01 [1.31, 3.10]
***
 
Adiponectin (μg.mL-1) 4.54 [3.33, 6.77] 7.52 [4.94, 11.2]*** 
Leptin (ng.mL
-1
) 28.0 [18.7, 45.3] 27.3 [14.8, 43.6] 
Total cholesterol (mmol.L
-1
) 4.48 ± 1.12 4.49 ± 1.05 
LDL (mmol.L
-1
) 2.66 ± 0.99 2.73 ± 0.88 
HDL (mmol.L
-1
) 1.00 [0.90, 1.10] 1.20 [1.00, 1.50]
***
 
Triglycerides (mmol.L
-1
) 1.80 [1.20, 2.10] 1.00 [0.80, 1.30]
***
 
Employed (%) 53.3 (42.8, 63.8) 57.5 (53.4, 61.7) 
Completed high school (%) 33.3 (23.2, 43.4) 29.6 (25.7, 33.4) 
Smokers (%) 13.3 (6.17, 20.5) 7.43 (5.23, 9.62) 
Consume snuff (%) 13.5 (6.25, 20.7) 21.8 (18.4, 25.3) 
†
Metabolic syndrome diagnosis was made in subjects in whom 3 or more of the following 4 
variables exceeded the cut points set out by the harmonised guidelines (16): blood pressure, 
glucose, triglyceride and HDL levels; data expressed as mean ± SD, median [interquartile 
range] or % (95% CIs); BMI = body mass index; HOMA= homeostasis model assessment; 
*
p<0.05, 
**
p<0.005, 
***
p<0.0005 vs women with metabolic syndrome 
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5.4.2 Univariate and multivariate logistic regression analyses of metabolic syndrome 
risk 
 
In separate, unadjusted, logistic regression models the following variables were associated 
with metabolic syndrome (diagnosed using only HDL, triglyceride, glucose and blood 
pressure measurements) risk at p<0.10: HOMA, adiponectin, waist and hip circumference, 
total body fat mass, total body FFSTM, subcutaneous and visceral fat thickness, age, 
menopausal status, receiving ART and smoking. These variables were then included in the 
same multivariable logistic regression model with metabolic syndrome as the outcome 
variable. Following backward, stepwise removal of variables with no significant (p>0.05) 
association with metabolic syndrome, the following variables remained in the final model: 
HOMA, adiponectin, total body FFSTM, subcutaneous fat thickness, age and smoking. Total 
body FFSTM is a composite variable of leg, arm and trunk FFSTM and therefore these 
variables were included in the initial multivariate logistic regression model (without total 
body FFSTM) and the backward stepwise removal of non-significant variables was repeated 
resulting in the final logistic regression model shown in Table 5.2. It can be seen that trunk 
FFSTM remained in the model alongside the same variables described above i.e. HOMA, 
adiponectin, subcutaneous fat thickness, age and smoking. Leg and arm FFSTM did not 
remain in this model. When a multivariable logistic regression model was built for metabolic 
syndrome diagnosed using the full criteria, the final model contained HOMA, adiponectin, 
age and trunk FFSTM but not subcutaneous fat thickness or smoking (see Table 5.2). 
 
The attenuation of metabolic syndrome risk by subcutaneous fat (see model 1 in Table 5.2) 
was further investigated by performing a univariate linear regression analysis of the 
relationship between subcutaneous fat and insulin resistance (HOMA, acting as dependent 
variable). This gave a significant, positive relationship (unstandardised β=0.04, p=0.003) that 
was severely attenuated (β=0.003, p=0.79) when waist circumference (β=0.009, p<0.0005) 
was included as an additional independent variable.  
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Table 5.2 Logistic regression models showing significant risk factors for metabolic syndrome 
diagnosed using criteria with or without inclusion of waist circumference 
Model 
number 
Categorical variable 
Independent 
variables 
Odds ratio (95 % CI’s); 
p-value 
1 
Presence of metabolic 
syndrome (criteria without 
waist) 
Trunk FFSTM: 1.34 (1.10, 1.61); 0.002 
Subcutaneous fat: 0.56 (0.39, 0.79); 0.001 
Adiponectin: 0.84 (0.77, 0.92); <0.0005 
HOMA: 1.31 (1.16, 1.48); <0.0005 
Age: 1.10 (1.04, 1.16); 0.001 
Smoking: 3.07 (1.28, 7.33); 0.01 
2 
Presence of metabolic 
syndrome (criteria with 
waist) 
Trunk FFSTM: 1.19 (1.11, 1.27); <0.0005 
Adiponectin: 0.94 (0.91, 0.98); 0.004 
HOMA: 1.31 (1.16, 1.47); <0.0005 
Age: 1.08 (1.04, 1.12); <0.0005 
 
HOMA: homeostasis model assessment; FFSTM: fat–free, soft–tissue mass 
 
5.4.3 Risk factors for each of the individual components of the metabolic syndrome  
 
Table 5.3 displays backward, stepwise multivariable logistic regression models for each of 
the 4 cardiometabolic components of the metabolic syndrome. Visceral fat, HOMA, age, and 
smoking are associated with an increased risk of high serum triglyceride levels, whilst 
adiponectin and leg fat are associated with reduced risk (model 1). In model 2, snuff use and 
adiponectin are associated with a reduced risk of low HDL levels, whereas trunk FFSTM is 
associated with a higher risk. Model 3 shows that adiponectin and subcutaneous fat reduce 
the risk of impaired fasting glucose, whereas age and HOMA increase the risk. It should be 
noted that in univariate analyses HOMA correlated very strongly with insulin (r=0.95) when 
compared to glucose (r=0.40) suggesting that HOMA is a much stronger marker of insulin 
than glucose levels.  Age and waist circumference are each associated with an increased risk 
of hypertension (model 4). 
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Table 5.3: Logistic regression model showing significant risk factors for the components of 
the metabolic syndrome 
Model 
number 
Categorical variable Independent 
variables 
Odds ratio (95% CI’s); p-value 
1 
Triglyceride  
≥ 1.70 mmol/L 
Visceral fat                       1.22 (1.04, 1.44); 0.02 
Leg fat                              0.85 (0.79, 0.92); <0.0005 
Adiponectin                      0.92 (0.86, 0.98); 0.006 
HOMA                             
 
1.11 (1.00, 1.24); 0.05 
Age                                   
 
1.07 (1.02, 1.12); 0.007 
Smoking                           2.53 (1.21, 5.30); 0.01   
2 
HDL  
< 1.30 mmol/L 
Trunk FFSTM              
 
1.14 (1.04, 1.24): 0.005 
Adiponectin                
 
0.93 (0.90, 0.97); <0.0005                
Snuff use                          0.63 (0.40, 0.99); 0.05 
3 
Glucose  
≥ 5.60 mmol/L 
Subcutaneous fat             
 
0.59 (0.42, 0.83); 0.002 
Adiponectin                   
 
0.93 (0.87, 1.00); 0.04 
HOMA                             
 
1.73 (1.49, 2.00); <0.0005 
Age                                   1.09 (1.03, 1.15); 0.002 
4 
Blood pressure  
≥ 130/85 mmHg 
Waist                                
 
1.05 (1.01, 1.08); 0.005 
Age                                   1.05 (1.00, 1.11); 0.04 
HOMA: homeostasis model assessment; FFSTM: fat–free, soft–tissue mass 
 
5.4.4 Risk for metabolic syndrome across hexiles of each risk factor 
 
Figure 5.1 shows the odds ratios (ORs) for metabolic syndrome risk across hexiles (quintiles 
for trunk FFSTM) of each of the continuous independent variables found in the final 
multivariable logistic regression model shown in Table 5.2. The ORs are shown both 
unadjusted and adjusted for all the other independent variables in the final model (Table 5.2). 
Trunk FFSTM was analysed as quintiles because with hexiles only 1 metabolic syndrome 
case was observed in the first hexile. The unadjusted ORs for metabolic syndrome risk are 
significant for each trunk FFSTM quintile, rising to a maximum in quintile 5 (see Fig 5.1A). 
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However, after adjustment for all the other variables, all ORs fell with only quintile 5 
demonstrated a significant OR (p<0.005). This attenuation of risk was analysed in more detail 
by adding each of the variables to the model one at a time. It was observed that only the 
addition of adiponectin to the model caused any of the trunk FFSTM quintiles i.e. quintiles 3 
and 4, to become non-significant, suggesting that adiponectin was largely responsible for the 
risk attenuation. Figure 5.1B shows a similar analysis of metabolic syndrome risk across 
hexiles of subcutaneous fat thickness. The unadjusted ORs for metabolic syndrome rise fom 
hexile 1 to a peak at hexile 3 and then fall progressively to a nadir at hexile 6. Only hexile 3 
shows a statistically significant OR (p<0.05). After adjustment for all the variables, the ORs 
were all lower, with hexile 3 becoming non-significant but hexile 6 now showing a 
significantly lower (p<0.05) OR relative to hexile 1. Adding each of the variables on their 
own to the model or in combination demonstrated that the addition of trunk FFSTM with 
adiponectin produced a model that mimicked that observed when all variables were added 
together. The analysis of HOMA hexiles (Fig 5.1C) shows that for the unadjusted ORs, risk 
for metabolic syndrome increased from hexile 1 to reach a maximum at hexile 6, with hexiles 
4 (p<0.05), 5 (p<0.05) and 6 (p<0.0005) all showing statistically significant ORs. Adjusting 
for all the variables reduced all the ORs, leaving only hexile 6 with a significant OR 
(p<0.005). Further analysis demonstrated that adiponectin in combination with trunk FFSTM 
were the main contributors to this effect. The data in Fig 5.1D shows that for adiponectin 
hexiles, the unadjusted ORs for metabolic syndrome drop from hexile 1 to 2, plateau till 
hexile 4 and then drop to hexile 5 with a nadir at hexile 6. All ORs are significantly different 
to that for hexile 1. After adjustment for all variables the ORs increase slightly but only the 
OR for hexile 4 becomes non-significant (p=0.054). When age is divided into hexiles, the 
unadjusted ORs for metabolic syndrome rise steadily from hexile 1 to hexile 6, with 
significant (p<0.05) ORs observed at hexiles 5 and 6 (Fig 5.1E). A very similar pattern is 
observed for the fully adjusted ORs, which show no attenuation. With regards smoking, the 
OR for metabolic syndrome remained significant with or without adjustment for all the other 
variables. 
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Figure 5.1 legends: Risk of metabolic syndrome across hexiles/quintiles of: A. trunk fat free 
mass, B. abdominal subcutaneous fat thickness, C. HOMA, D. adiponectin and E. age. 
Lighter bars represent unadjusted odds ratios whilst darker bars represent odds ratios with 
adjustment for trunk FFSTM, subcutaneous fat, HOMA, adiponectin, smoking and age; *p < 
0.05, **p < 0.005, ***p < 0.0005 vs hexile 1. 
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5.5 Discussion 
 
This study has shown that in a population of urban African females with a high prevalence of 
metabolic syndrome and obesity, trunk FFSTM and abdominal subcutaneous adipose tissue 
increases and reduces the risk, respectively of metabolic syndrome. Further analysis 
demonstrated that this was due to a positive association of trunk FFSTM with risk of low 
HDL levels and a negative association of subcutaneous adiposity with risk of impaired 
fasting glucose. Other risk factors for metabolic syndrome were insulin resistance, age and 
smoking whilst adiponectin, at all levels across its range, was associated with lower risk. The 
risk of metabolic syndrome associated with the other variables, specifically at low levels and 
with the exception of age, was attenuated after adjusting for adiponectin.  
 
Metabolic syndrome was defined in this study without the waist circumference criterium. 
This was done because the main aim of our study was to isolate risk factors for the metabolic 
syndrome that were modulators of the cardiometabolic rather than the anthropometric 
component of the syndrome. There are many CVD risk factors that correlate with waist 
circumference and therefore it is reasonable to suggest that a number of these factors may 
associate with metabolic syndrome simply through their relationship with waist 
circumference. It is also possible that the inclusion of waist circumference within the criteria 
for metabolic syndrome masks the true relationship of other factors with the cardiometabolic 
components of the syndrome, as exemplified in the current study for subcutaneous abdominal 
fat. The definition of metabolic syndrome in our study required the presence of 3 out of 4 of 
the cardiometabolic components. This ensured that all subjects with the syndrome as defined 
by our criteria would also have been included in the cohort of subjects defined using the 
normal harmonised criteria (16) and would have a severe cardiometabolic disease risk profile.        
 
The current study is the first to show that subcutaneous abdominal fat attenuates the risk for 
metabolic syndrome. The reason that no previous studies have observed this relationship may 
be due to the fact that it is masked by the inclusion of waist circumference within the criteria 
for diagnosing metabolic syndrome, as demonstrated in the present study. Thus, subcutaneous 
abdominal fat is only revealed as protective for metabolic syndrome when waist is removed 
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from the metabolic syndrome criteria. Furthermore, our data shows that high subcutaneous fat 
level is related to a lower risk of metabolic syndrome; via the effect of abdominal 
subcutaneous fat on glucose levels (see Table 5.3). This could possibly be explained by 
subcutaneous fat acting as a triglyceride reservoir, thus reducing its deposition in visceral fat 
or at ectopic sites such as muscle, liver, pancreas where lipid deposition leads to increased 
insulin resistance (382). Furthermore, a recent large, multinational, cross–sectional study has 
shown that abdominal subcutaneous fat is associated with a lower risk of type 2 diabetes in 
women (383), and in a study of 73 type 2 diabetic patients, increased superficial 
subcutaneous abdominal fat was associated with lower HbA1c and fasting glucose levels 
(384). The present study extends the findings of these earlier investigations, which did not 
measure subcutaneous fat outside of the abdominal area, and demonstrates that it is 
specifically the abdominal subcutaneous fat depot that is related to improved glycaemia.  It 
should however be noted that a number of other studies have shown that subcutaneous 
abdominal fat has a statistically significant positive association with insulin resistance (90, 
385, 386). In a univariate regression model this was also observed in the current study. 
However, addition of waist circumference to the model severely attenuated the relationship to 
non-significance. This suggests that data within the literature that conflicts with our 
observations regarding the relationship between subcutaneous abdominal fat and insulin 
resistance may partly be due to confounding from other variables.   
 
 
Data from the current study demonstrating that age, smoking, insulin resistance and 
adiponectin are associated with metabolic syndrome risk are expected, as other studies show 
similar associations (see Table 5.2) (20, 180, 255, 283). However, the finding that trunk 
FFSTM was positively associated with both metabolic syndrome and low HDL levels, was 
not expected. Interpretation of this data is complicated by the fact that the DXA–derived 
trunk FFSTM measure is a composite of all the soft tissue components of the trunk including 
muscle and organ mass. It is therefore difficult to determine which of these components is the 
true causative variable. We hypothesise that ectopic fat deposition within the trunk, which 
DXA is unable to measure, may be the principle element causing these associations. One of 
the major components of the trunk region is the liver, and it is known that steatohepatitis is 
characterised by low HDL levels (387). Future analyses involving a more discriminatory 
body scanning technique, such as magnetic resonance imaging (MRI), must be undertaken to 
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test this hypothesis. It is interesting to note that an increased risk of metabolic syndrome with 
higher whole body FFSTM was observed in a previous study (388), as was an inverse 
association between HDL levels and non–adipose body mass in both a cross–sectional (389) 
and a longitudinal study (390). Furthermore, a recent study has shown that ectopic fat 
deposition in the liver and skeletal muscle has a greater effect on insulin sensitivity in African 
than European females (391). 
 
Adiponectin appears in 3 of the 4 logistic regression models describing the risk factors for the 
4 cardiometabolic components of the metabolic syndrome (see Table 5.3). This demonstrates 
the wide effect of this adipokine on components of the metabolic syndrome. White South 
Africans seem to have higher levels of adiponectin compared with the other ethnic groups 
(33).  Little data are available on the role of adiponectin in the aetiology of metabolic 
syndrome in developing countries (178), but studies of African populations do suggest a 
protective role of adiponectin against metabolic syndrome (33, 179).  Our data also shows 
that leg fat protects against elevated triglyceride levels. Such an association has been 
observed in other studies (392, 393) and may be explained by the hypothesis that 
subcutaneous fat acts to buffer post–prandial triglyceride and free fatty acid levels (382). An 
interesting finding is the positive effect of smokeless tobacco use (snuff) on HDL levels. One 
other study performed on traditional smokeless tobacco (snus) use in Sweden, also showed a 
positive association with HDL levels (394). The mechanism of this association is unknown 
however, it must be noted that smokeless tobacco formulations differ widely and other 
studies demonstrate more atherogenic lipid profiles in smokeless tobacco users (395). 
 
Our data shows that for HOMA and trunk FFSTM there is a gradual increase in metabolic 
syndrome risk across their range (see Figure 5.1) and this trend is attenuated after adjustment 
for all the other independent variables present in the multivariable logistic regression model 
for metabolic syndome (see Table 5.2), leaving significant ORs only for the highest 
hexile/quintile.  However, it is adiponectin that is the main cause of the attenuation of risk 
associated with FFSTM, whilst adiponectin and FFSTM explain the attenuation of metabolic 
syndrome risk associated with HOMA. This suggests that at lower levels of HOMA and 
FFSTM adiponectin is a confounder and explains a large proportion of the risk for metabolic 
syndrome. Furthermore, risk of metabolic syndrome drops dramatically with increasing levels 
of adiponectin and this effect is margina-lly attenuated by adjustment for the other variables. 
These results demonstrate that adiponectin across its full concentration range has significant 
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effect on metabolic syndrome risk and acts independently of the other metabolic syndrome 
risk factors, whilst HOMA and trunk FFSTM only have independent effects at high levels. 
Age also has a significant effect on metabolic syndrome risk only at the top end of its range, 
and this effect is not attenuated by adjusting for the other variables. The risk of metabolic 
syndrome produced by smoking was also not affected by adjustment for the other variables. 
With increasing subcutaneous abdominal fat, the OR for metabolic syndrome rose to a peak 
by hexile 3 and then fell dramatically by hexile 6. This pattern may be due to confounding 
because adjustment for the other variables from the logistic regression model caused the peak 
OR at hexile 3 to fall and significance to disappear, whilst at hexile 6 a significant protective 
effect appeared. Adiponectin and trunk FFSTM were the main contributors to this effect. This 
emphasises the influence of adiponectin on metabolic syndrome risk at lower levels of 
abdominal subcutaneous fat but an independent protective effect of subcutaneous fat at high 
levels. These results also demonstrate the strong effect of trunk FFSTM on metabolic 
syndrome risk, which may be mediated by ectopic fat, as described previously.   
 
This study demonstrates that for most variables the risk they cause for metabolic syndrome is 
only observed at the high end of their range, with the risk induced at lower levels mostly due 
to confounding by other risk factors, most particularly adiponectin. Adiponectin is the only 
variable that produces significant disease risk across its full range with minimal confounding 
from other variables. Furthermore, adiponectin modifies metabolic syndrome risk by effects 
on multiple components of the syndrome i.e. HDL, triglycerides and glucose tolerance. 
Hypertension is the only metabolic syndrome component that is not modulated by 
adiponectin or HOMA. This suggests that the aetiology of metabolic syndrome is two–
pronged, with insulin resistance–adiponectin being primary aetiological factors for the lipid 
and glucose sections of the syndrome, whilst age and waist underpin the development of 
hypertension.       
 
Limitations of this study include its cross–sectional format. Also, abdominal fat levels were 
not assessed using the gold standard techniques of CT or MRI scanning but rather used 
ultrasound. However, this method has been favourably validated against MRI (396, 397). A 
further limitation of this study was the lack of assessment of ectopic fat deposition, 
particularly within the liver. We did not investigate hypotheses that focussed on one specific 
association e.g. visceral fat as a principle risk factor for metabolic syndrome. The aim of this 
study was to uncover possible novel risk factors rather than to focus on risk factors observed 
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in other studies, the majority of which have not been performed in sub-Saharan African 
populations. However, this study used a large sample size and measured a wide variety of 
appropriate variables in a population for whom little data exists on the aetiology of metabolic 
syndrome. This is the only study to determine how risk for metabolic syndrome varies across 
the range of each risk factor and how these factors modulate the effect of one another across 
their ranges. Defining metabolic syndrome without the use of the waist criteria also allowed 
us to uncover a novel association with subcutaneous abdominal fat that provides valuable 
new information on the effects of different body tissue compartments on metabolic syndrome 
risk. This study also highlights the effect of trunk FFSTM on the aetiology of 
cardiometabolic disease. Finally, alcohol consumption was not captured at this time point, 
thus we could not control for it in the analyses. 
 
5.6 Conclusions 
 
In conclusion, this study demonstrates that the cardiometabolic components of the metabolic 
syndrome are favourably modulated by various subcutaneous body fat depots and that trunk 
FFSTM may have detrimental effects on HDL levels via an unknown mechanism that 
warrants further investigation. Falling adiponectin levels independently affect multiple 
components of the metabolic syndrome (HDL, triglycerides and glucose tolerance), 
significantly reducing metabolic syndrome risk even at the lower end of its range (hexiles 5 
and 6). Other risk factors (trunk FFSTM, abdominal subcutaneous fat, HOMA, and age) have 
prominent effects on metabolic syndrome risk only at the upper end of their range and the 
effects observed at lower levels are largely due to confounding from adiponectin. The 
mechanisms by which adiponectin and abdominal subcutaneous fat attenuate metabolic 
syndrome risk, whilst trunk FFSTM increases risk need to be further investigated and may 
provide information on novel targets for therapeutic interventions. 
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CHAPTER 6: DISCUSSION AND CONCLUSIONS  
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6.1 Consolidated findings of the thesis 
 
This thesis set out to investigate the factors associated with cardiometabolic diseases in 
ageing black South African women living in an urban–setting.  The objectives of this thesis 
and related findings are highlighted in Table 6.1. 
 
Table 6.1: Summary table of objectives and findings 
Number Objectives Chapter Key findings 
1.  To describe patterns of physical 
activity in a middle–aged cohort of 
urban black South African women 
living in Soweto, Johannesburg  
3  Most women in the study were 
physically active. 
 All domains of physical activity 
were higher in the physically active 
group compared with the inactive 
participants (all p < 0.001). 
 Overall sitting time was 180 minutes 
per day, but did not differ between 
the activity groups. 
 
2.  To examine the association 
between socio–economic status and 
physical activity patterns  
3  Household SES score was inversely 
associated with time spent walking 
for travel (r = −0.10; p < 0.01), but 
was not associated with any other 
activity variable.  
 Participants in the lowest tertile for 
walking for travel had a significantly 
higher household SES score 
compared with women in the middle 
(p < 0.05) and highest (p < 0.001) 
tertiles. 
 
3.  To determine if physical activity is 
associated with anthropometry and 
metabolic variables 
3  Total moderate–vigorous physical 
activity was negatively associated 
with fasting insulin, and walking for 
travel was inversely associated with 
total cholesterol.  
 Work moderate–vigorous physical 
activity was positively associated 
with fat–free, soft–tissue mass. 
 Sitting time was positively 
associated with serum triglycerides 
and diastolic blood pressure.  
4.  To describe the change in body 
composition over a10–year study 
period in a cohort of urban black 
South African women. 
4  There was a significant increase in 
all body composition measures (all p 
< 0.001), with a mean weight gain 
for the whole sample of 5.17 ± 8.86 
kg.  
 The prevalence of high waist 
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circumference (≥ 80cm) and obesity 
increased (both p < 0.001).    
5.  To determine whether baseline 
measurements of body–size 
dissatisfaction and body–size 
discrepancy are associated with 
baseline body composition 
measures, and correlate with 
changes in body composition over 
10–years of follow–up. 
4  At baseline, women who wanted to 
be leaner had significantly higher 
body composition outcomes 
compared with those with a negative 
or zero FID score (p < 0.0005 for all 
comparisons).  
 There were no differences between 
the FID groups for absolute change 
in the any of the body composition 
measures even when this data was 
expressed as percentage change from 
the baseline, and when FID negative 
and zero groups were combined and 
compared with the FID positive 
group 
 With regard to body–size 
discrepancy at baseline, 74% of the 
subjects underestimated their actual 
body–size (negative PAD score), 2% 
overestimated actual body weight 
(positive PAD score), and 24% 
correctly perceived their actual body 
weight (zero PAD score).   
 At follow up, the proportion of 
women in each of the PAD groups 
were similar to baseline, i.e. 73.5%, 
0.70%, and 25.8% respectively.  
 Women who underestimated actual 
body weight status had a 
significantly higher body 
composition compared with those 
who overestimated or correctly 
perceived their actual body weight 
(p<0.0005 for all comparisons).   
 Women who correctly perceived 
actual body weight had a 
significantly greater increase in fat 
mass than the women who 
underestimated body weight. 
 Absolute change in total body fat 
was lower in those who 
underestimated body–size when 
compared with those who accurately 
assessed body–size. 
 An underestimation of body–size 
was negatively associated with 
absolute change in peripheral 
adiposity 
6.  To determine whether baseline 
lifestyle factors including diet and 
physical activity are associated 
with changes in body composition 
4  Baseline diet was not associated with 
change in body composition; 
however, total vigorous physical 
activity was inversely associated 
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with change in BMI, waist, total 
body fat, and central and peripheral 
adiposity. 
 Smoking was associated with a 
smaller increase in lean tissue over 
time, while alcohol was inversely 
associated with change in waist.  
7.  To identify the main contributing 
factors to the cardiometabolic 
features of the metabolic syndrome 
in a cohort of urban African 
women known to have a high 
prevalence of obesity and 
metabolic syndrome 
 
5  In a multivariable logistic regression 
model, trunk FFSTM, HOMA, 
adiponectin, subcutaneous fat 
thickness, age and smoking were 
associated with the cardiometabolic 
features of the metabolic syndrome. 
8.  To determine how disease risk 
varied across the range of levels of 
each risk factor 
 
5  For each trunk FFSTM quintile, the 
unadjusted ORs for metabolic 
syndrome are significant.  
 The unadjusted ORs for metabolic 
syndrome in the subcutaneous fat 
model are only significant in hexile 
3. 
 The analysis of HOMA hexiles 
showed that metabolic syndrome risk 
increases progressively from hexile 1 
to 6, with hexiles 4–6 showing 
statistically significant ORs.  
 The unadjusted ORs for metabolic 
syndrome in the adiponectin model 
decrease from hexile 1 to 2, plateau 
until hexile 4 and then drop in hexile 
5 with the lowest point at hexile 6. 
All ORs are significantly different 
compared with hexile 1.  
 Age hexiles increase steadily from 
hexile 1 to 6, with significant ORs at 
hexile 5 and 6.  
9.  To examine whether each risk 
factor modulated the contribution 
of the other factors to disease risk 
across their range 
5  After adjustment for all the other 
variables, only quintile 5 in the trunk 
FFSTM model remained significant. 
Adiponectin was responsible for 
attenuating the risk. 
 After adjustment for the other 
variables, hexile 3 became non–
significant in the subcutaneous fat 
model, while hexile 6 showed a 
significantly lower OR compared 
with hexile 1. These changes in the 
ORs were mainly due to trunk 
FFSTM and adiponectin. 
 In the analysis of adjusted HOMA 
hexiles, only hexile 6 remains 
significant. The main contributor to 
this effect was the combination of 
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trunk FFSTM and adiponectin. 
 After adjustment the ORs for the 
adiponectin model increase slightly 
but only hexile 4 becomes non–
significant. 
 After adjustment, age hexile ORs are 
similar to unadjusted ORs. 
10.  To determine which individual 
components of the metabolic 
syndrome were influenced by each 
of the risk factors 
5  Visceral fat, HOMA, age, and 
smoking are associated with an 
increased risk of high serum 
triglyceride levels, whilst 
adiponectin and leg fat are associated 
with reduced risk.  
 Snuff use and adiponectin are 
associated with a reduced risk of low 
HDL levels, whereas trunk FFSTM 
is associated with a higher risk.  
 Adiponectin and subcutaneous 
adipose fat reduce the risk of 
impaired fasting glucose, whereas 
age and HOMA increase the risk.   
 Age and waist circumference are 
each associated with an increased 
risk of hypertension. 
 
6.2 Emerging scientific areas from the results:   
6.2.1 The increasing prevalence of obesity and cardiometabolic diseases in urban–
dwelling, black South African women with age 
 
Our data has shown that obesity and related cardiometabolic diseases are common in this 
cohort of black South African women, and these diseases increase with age. Obesity in this 
study population was also related to non–classical risk factors.  For example, the psycho–
social processes surrounding body–size perception in African women seems to be changing. 
This thesis highlights the existence of one obese group of women content with body–size, 
while another group of obese women had a desire to be thinner.  In the diverse South African 
society, this finding might be important for obesity interventions in black South African 
women.  Moreover, the fact that the traditional acceptance of large body size is being 
challenged from within this ethnic group, indicates that plans to address weight gain might be 
welcomed by ageing obese Africans.  Our data suggests that focussing on walking as a means 
of addressing the obesity pandemic might be beneficial, particularly as most participants 
walked for travel.  However, some studies have documented that walking is seen as a chore 
and not leisure, suggesting that the acceptability of walking as recreational physical activity 
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needs to be explored further in African society. The actual intensity of the walking was not 
captured. Therefore, once the intensity of the walking is known, public health interventions 
toward obesity could encourage walking to work at a moderate–vigorous pace in a greater 
number of this population. However, it should be noted that the unemployment rate in this 
cohort is high (42.4%) and therefore alternative mechanisms would be required in those 
without jobs e.g. encourage walking in other spheres of their daily routine.  
 
6.2.2 Understanding the physiological and contextual mechanisms behind the high 
prevalence of obesity and cardiometabolic diseases 
6.2.2.1 The physiological mechanisms relating to metabolic syndrome in African females 
 
Previous studies of women have speculated what the contributing factors of metabolic 
syndrome were; and until now very little data has been available on the proposed aetiology of 
this disease, particularly in a cohort of African females with a very high level of obesity.  
This multi–faceted syndrome and the fact its individual components can each have unique 
risk factors may be the reason for the lack of understanding regarding its underlying causes.  
We have attempted to determine some of the body composition and metabolic causes of the 
syndrome in this thesis. 
 
We have shown that low abdominal subcutaneous fat is associated with higher risk of 
metabolic syndrome, because of its interaction with blood glucose.  A more robust 
investigation of the data shows that even at low levels of abdominal subcutaneous fat, an 
association with metabolic syndrome is still evident.  A possible explanation could be that the 
subcutaneous fat compartment acts a metabolic reservoir protecting the abdominal region 
from primary deposition of fat around the central organs. However, once this site has reached 
its capacity for fat deposition, then visceral and ectopic fat deposition increases. However, 
within our study we found that visceral fat was not a risk factor for metabolic syndrome and 
correlated with only one of the components of the syndrome i.e. triglycerides. The reasons for 
these findings are not known, however studies have shown that visceral fat levels in back 
African subjects are lower than in subjects of European ancestry (92) and visceral fat does 
not correlate with insulin sensitivity in the former population but does in the latter (90). These 
data therefore suggest that visceral adiposity is not as important a cardiometabolic disease 
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risk factor in Africans as in other population groups. Another interesting finding is the 
inverse association of leg fat with high triglycerides.  Thus, subcutaneous fat in the 
abdominal and gluteofemoral regions are associated with glycaemic control and optimal 
metabolism of triglycerides, respectively. 
 
Our data has shown that the risk factors for metabolic syndrome are attenuated when adjusted 
for each other. Thus, adiponectin explains most of the weakening of the relationship between 
the risk factors in metabolic syndrome. So at every level of those risk factors, the risk 
produced by that risk factor is actually due to adiponectin and most of these risk factors only 
increase the risk of metabolic syndrome in their highest level, but at the lower level of those 
risk factors it is adiponectin that is the main contributor. Visceral adipose tissue and insulin 
resistance are the main determinants of adiponectin in African Americans (398). Insulin resistance is 
also a key predictor of adiponectin in Cameroonian women (399). However, body fat was observed 
to be a determinant of adiponectin in African women and not the African American women. The 
reason for the discrepancy could be explained by the use of waist circumference as a crude measure 
of intra-abdominal adiposity rather than visceral adiposity in the Cameroon study.  However, black 
South Africans have comparable visceral adipose tissue to African Americans (90-92), suggesting that 
the determinants of serum adiponectin are similar. Finally, our data shows that adiponectin is an 
important contributing factor and this adipokine explains risk of metabolic syndrome in 
African women, independent of insulin resistance.  
 
6.2.2.2 African females in an urban, obesogenic context 
 
South Africa has transitioned out of a system of government sanctioned inequality fairly 
recently. While the new regime promises to elevate the socio–economic status of the black 
majority, inequality is still evident today and most black Africans live in poverty stricken, 
obesogenic environments (400).   Consumer demand for cheap, calorie dense foods are 
common amongst this population group (237) and most African women are classified as 
sedentary despite attaining the recommended weekly amount of physical activity (41).   
Most women in this study have access to sedentary promoting products e.g. ownership of 
motor vehicles, and monthly subscription to satellite television; despite their high cost.  This 
phenomenon exists in the presence of high unemployment and low high school completion.  
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Thus, South Africa is experiencing a dual transition, one of global urbanisation and its 
accompanying negative impact on the well–being of ageing women, and one of socio–
political change which aims to reduce poverty in black South Africans (401).  Both of these 
transitions seem to have an influence on the health status of black South African women.  
The primary reason for urbanisation is access to employment and higher perceived economic 
status compared with the rural lifestyle.  However, settlement in urban areas is usually 
accompanied by the adoption of westernised behaviours. We have shown that the prevalence 
of obesity and its related metabolic disorders is very high in this urban population.  The 
emergence of these diseases has developed despite most women in the cohort achieving more 
than the WHO recommended amount of daily physical activity.  The consumption of high–fat 
foods did not have an influence on the body composition outcomes in this study population.  
Our data suggest that higher intensity physical activity protects against fat accumulation and 
the risk of cardiometabolic diseases.  We have also shown that walking as a means of 
transport is the most prominent method of physical activity in black South African women.  
This form of physical activity is cost–effective and thus important to include in an obesity 
intervention in African populations.   
 
 
 
The prevalence of tobacco smoking in this study population is low, which is comparable to 
the national and international incidence of smoking in women (23, 202).  We have 
nevertheless shown that smoking is associated with decreased lean tissue and increased risk 
of metabolic syndrome.  The low prevalence of tobacco consumption is partially due to the 
stringent regulations surrounding the sale and marketing of tobacco products in South Africa.  
On the other hand, cigarette smoking is also expensive and thus not affordable to most 
people. The presence of smokeless tobacco (snuff) was significantly higher compared with 
tobacco smokers. The potential protective effect of smokeless tobacco against low HDL 
levels was shown in this study.  South African smokeless tobacco products are however not 
regulated, and are addictive because of the high nicotine content (304).  The consumption of 
these products is therefore of public health concern and the positive effect of snuff use on 
HDL levels requires further investigation. 
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Alcohol use in this study population is similar to that of smoking.  Central adiposity 
decreases over time in those women who consume a higher frequency of alcohol. However, 
the chronic use of alcohol is associated with progressive physiological damage of essential 
organs, and increases the risk of future organ transplantation and heavy reliance on lifelong 
chronic medication (402).  Therefore despite the positive effects of modifiable lifestyle 
behaviour risk factors shown in this study, adherence to poor health choices may result in 
increased metabolic syndrome risk and early morbidity. 
 
6.3 Theoretical relevance 
 
South Africa is in the midst of epidemiological transition with most of the inhabitants living 
in urban settings.  City life is economically appealing, however most South Africans living in 
urban areas are poor and have a high prevalence of cardiometabolic diseases (76, 223).  We 
have shown that the prevalence of obesity, metabolic syndrome and their accompanying 
components in black South African women is high.   Our findings add to the few data 
available on the contributing factors associated with cardiometabolic diseases in African 
women. 
 
The initial conceptual framework discussed in Chapter 1 (Fig.1.2) highlighted the possible 
associations of risk factors of obesity and metabolic syndrome.  The findings of this thesis 
require that the original conceptual framework be modified (Fig. 6.1).   No studies have 
shown the impact of body–size discrepancy on long–term body composition changes in 
African populations.  Psycho–social factors were significantly associated with lower changes 
in adiposity, thus have been added into the modified framework.  Likewise, data are 
conflicting regarding the association of socio–economic factors with body composition in 
developing countries; however we have confirmed a significant direct association between 
socio–economic status and body fat in this study population. 
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Figure 6.1: Modified conceptual framework. Evidence to strengthen the hypothesised 
associations proposed in the beginning of the thesis have been confirmed, and are therefore 
represented with solid red lines. 
 
The addition of smokeless tobacco/snuff to the model is novel. We have shown that the 
consumption of snuff in black South African women is high, and the inverse association of 
snuff with low HDL suggests a protective role against dyslipidaemia.  Another interesting 
finding was the protective effect of adiponectin with the cardiometabolic components of 
metabolic syndrome, suggesting that higher concentrations of this hormone reduce the risk 
and future onset of metabolic syndrome. 
 
Insulin resistance was associated with metabolic syndrome as anticipated; however, the 
inverse association of subcutaneous adipose tissue with impaired fasting glucose was 
unexpected.  Similarly, the significant association of trunk FFSTM with metabolic syndrome 
via its association with low HDL was also not foreseen.   
 
Age was significantly associated with a number of cardiometabolic disease risk factors. We 
have observed that age is also associated with a lower change in fat–free, soft–tissue mass, 
suggesting a link between chronological age and sarcopenia in African women.  Importantly, 
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active smoking seems to exacerbate this relationship.  This fact could be crucial for future 
public health interventions targeting tobacco consumption in ageing black South African 
women.  Finally, the association of waist circumference with components of metabolic 
syndrome emphasise the importance of including regular moderate–vigorous physical activity 
as part of a lifelong plan to decrease cardiovascular disease risk as depicted in Figure 6.1.  
The modified conceptual framework also highlights the interrelatedness of various risk 
factors, demonstrating the complexity surrounding the pathogenesis of metabolic syndrome 
in African women. 
 
6.4 Contextual relevance, local and national 
 
Our longitudinal findings have confirmed that the prevalence of obesity and related diseases 
has increased in black South African women living in Soweto.  Lifestyle behaviours were 
confirmed to have an influence on these diseases.  This thesis could therefore assist policy 
makers involved in addressing obesity in African populations, particularly emphasising the 
influence of physical activity and the domain of walking as means of transport as a protective 
mechanism against the onset of cardiometabolic diseases.   However, the intensity of the 
walking physical activity domain was not determined in this study, and most of the study 
participants had a high proportion of sitting time, which could partly explain the high 
prevalence of obesity.  Thus, as most participants already walked, it would probably be more 
beneficial to focus on targeting sitting time. It was also observed that the underlying factors 
associated with obesity and metabolic syndrome in African women are multi–faceted and 
complex, suggesting that a holistic, integrated approach is necessary to dealing with these 
disorders. 
 
Our findings also demonstrate that the traditional African belief system around body–size 
preference is changing. There seems to be a co–existence of belief patterns within black 
South Africans with our data showing the presence of various groups, i.e. preference for the 
traditional obese body–shape, thinness, or contentment with present body–size. These data 
suggest that future obesity interventions undertaken by policy makers in South Africa should 
recognise the cultural beliefs around body shape.  
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6.5 Limitations and advantages 
 
Specific limitations are mentioned in the papers, but a significant limitation for the thesis was 
that dietary patterns of the study population were not included in the analyses.  Therefore, we 
are potentially missing another important piece of the puzzle around modifiable lifestyle 
factors.  However, this data has been collected and will be part of subsequent analyses post–
PhD. 
 
There are a number of advantages of this thesis which will be listed: 
 I was fortunate to be able to draw on 10 years of secondary and prospective data from 
the Bt20 study. 
 The sample was large enough to be representative of black South African women 
living in Soweto, Johannesburg, which is an urban–setting undergoing rapid 
urbanisation.  
 Access to an established network of research entities allowed the researcher to collect 
body composition and biochemical data using advanced equipment and standardised 
laboratory methods.  This allowed for the comprehensive analysis of a multitude of 
risk factors and covariates associated with metabolic syndrome. 
 The process of data collection was made manageable with the help of a professional 
team of multi–lingual research assistants.  The translation of information into the 
participants’ home language where necessary ensured that all participants understood 
all aspects of the study, allowing them to share information and complete the 
questionnaires correctly. 
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6.6 Recommendations for further research 
6.6.1 Further research regarding body–size dissatisfaction and body–size discrepancy in 
African women 
 
The findings of this thesis could lead to questions around obesity interventions in African 
women experiencing acculturation.  Therefore in an experimental study design, baseline 
anthropometric, psycho–social and metabolic measurements should be determined. An 
intervention of supervised moderate–vigorous exercise should be performed to determine 
whether baseline anthropometric, metabolic and psycho–social variables change over time as 
a result of regular physical activity.  It would also be advantageous to measure compensation 
and sedentary time. These data will be compared to a closely matched, non–physically active 
control population.  This information may assist future attempts at reducing obesity in black 
South African women. 
 
We also assumed that participants in this study would prefer a larger body size because of 
traditional African ideals which associate obesity with prosperity and other beneficial aspects 
(5, 67, 70).  However, comparison with women from other South African ethnic groups is 
important to determine whether preference for higher body size is limited to black Africans or 
wider acculturation is taking place. 
 
6.6.2 The role of diet in obesity  
 
Research indicates that the consumption of sugar sweetened beverages has increased globally 
and is associated with weight gain, type 2 diabetes and metabolic syndrome (403, 404). Soft 
‘carbonated’ drinks and canned fruit juices can have up to 45 g of added refined sugars (330 
ml serving), essentially increasing the daily average calorie intake, which may translate into 
further cardiometabolic risk.  There are a number of potential research studies involving 
dietary behaviour that should be performed in African women:   
 Firstly, the research into the dietary behaviour patterns of African women are limited, 
implying that baseline and follow–up data are needed.   
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 Secondly, studies conducted in the South African context can attempt to determine if 
interventions such as cognitive behavioural therapy, increased physical activity, 
reduced caloric intake or a combination of these alter the cardiometabolic risk 
associated with obesity in African women. 
 Thirdly, analysis of these interventions is needed to determine whether they influence 
the body–size dissatisfaction and body–size discrepancy patterns of black South 
African women living in urban settings. 
 Fourthly, an investigation of the impact of socio-economic status on dietary intake 
and food security. 
 
6.6.3 To determine cut–points of cardiometabolic diseases in an ethnically diverse 
society 
 
Waist circumference is used as a proxy measure of central adiposity in the identification of 
metabolic syndrome, and recent data suggests there is a need to use a more appropriate waist 
cut–point for black African women (4).  A continuation of this valuable study would be to 
explore whether the current cut–points used to diagnose the cardiometabolic components are 
appropriate for an African population.  Receiver operator curve analysis can be used to 
determine ethnic–specific cut–points. Moreover, further longitudinal studies are required to 
fully understand the factors associated with metabolic outcomes in ageing African women. 
 
6.6.4 Trunk fat–free, soft–tissue mass 
 
From the findings of the thesis, we speculated an association of trunk FFSTM with metabolic 
syndrome, however, given the limitation of the use of DXA to determine body composition in 
the truncal region, we would like to confirm this relationship using MRI to determine which 
component of trunk FFSTM is the true modulator of HDL levels. 
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6.6.5 Objective measurements of physical activity and sedentary behaviour 
 
The objective measurement of physical activity and sedentary behaviour would provide more 
robust information of physical activity patterns and sedentary time in African populations, 
particularly as Western cultures seem to underestimate sedentary behaviour (405) and 
overestimate physical activity time (406). 
 
6.7 Conclusions  
 
This thesis highlighted some of the elements associated with obesity and associated 
cardiometabolic diseases in a population of African females with a high prevalence of 
metabolic syndrome.  Our findings suggest that obesity interventions focus on lifestyle 
behaviour change to address the obesity pandemic in female African populations, particularly 
physical activity, sitting time, and snuff use.  The prevalence of snuff consumption was high, 
however further studies are required to determine whether the association with HDL is true, 
and if it has any negative health consequences in this population. 
 
A positive association of trunk FFSTM with the risk of high HDL levels was observed and 
requires further investigation, as does the negative association of subcutaneous abdominal fat 
with the risk of elevated glucose levels. Finally, our findings display the protective influence 
of adiponectin against metabolic syndrome and its components, suggesting that this adipokine 
has a key role in the aetiology of metabolic syndrome in African women. 
 
The findings of this thesis show that the majority of urban black South African women have a 
high prevalence of obesity and cardiometabolic disease risk factors despite being classified as 
‘physically active’.  However, the intensity of the respective domains of physical activity is 
unknown.  As walking as a means of travel/transport is a major contributor to physical 
activity, future research should attempt to determine whether the intensity of this activity 
plays a role in the prevention of cardiometabolic diseases.  It was also demonstrated that an 
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underestimation of body–size is common and is associated with a lower gain in total body 
adiposity and a desire to lose weight in most of the participants.    
 
Finally, this thesis observed that adiponectin has a significant protective role against 
metabolic syndrome that is independent of other risk factors. The protective and augmentive 
effects of abdominal subcutaneous fat and lean trunk mass, respectively, on metabolic 
syndrome risk demonstrate the existence of novel interactions between body composition and 
cardiometabolic disease. 
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APPENDIX 2: CAREGIVER INFORMATION SHEET 
 
Developmental Pathways to Health Research Unit (DPHRU) 
Department of Paediatrics, School of Clinical Medicine, Faculty of Health Sciences, Wits 
 
Study title: Factors associated with obesity and metabolic syndrome in an ageing cohort of 
black women living in Soweto, Johannesburg (Study of Women in and Entering Endocrine 
Transition [SWEET]) 
Greeting: Hi, my name is Philippe Gradidge and I’m studying a PhD at the University of the 
Witwatersrand (Wits). 
Introduction:  I am doing research on obesity and metabolic syndrome. The purpose of the 
study is learn more about what causes obesity and metabolic syndrome in ageing black 
women.  
Invitation to participate: I am requesting your permission to volunteer as a participant in 
this study. 
What is involved in this research study:  We will ask you to give us some information 
about your general health and lifestyle, and we will do a questionnaire with you regarding 
your menstrual cycle, your physical activity, recreation activity, food frequency, and attitude 
towards obesity.  We will be taking some routine measurements (such as your weight, blood 
pressure, height etc.). We will conduct a bone X-ray (DXA scan) to look at your body 
composition. We would like to take a blood sample to test for different hormones and to see 
whether you have any health risks. You should only feel a slight prick but if you want EMLA 
cream can be applied on request.  EMLA cream is a topical anaesthetic cream that numbs the 
area where blood will be pulled so as to minimise discomfort.  The results of these tests will 
be confidential, but we will notify you if we see any health problems. If you would like know 
your results any way please notify a member of the team.  
Risks: There are no risks involved in this research because the processes are non-evasive. 
Benefits: There are no direct benefits to the participants involved in the study. 
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Participation is voluntary: Participation in this study is voluntary and you may withdraw at 
any time without any penalty or loss of benefits. 
Reimbursements: You will be provided with R50 for transport as well as a sandwich and 
fruit juice. 
Time commitment required:  There data collection process will take approximately 6 to 7 
hours to complete. 
Confidentiality:  All data collected for this study will be kept strictly confidential. No 
personal information will be made publicly known. Data collected will be analysed as a 
group and not individually.  
Contact details of researchers: Please contact, Philippe Gradidge (011 717 3363) for any 
queries and/or further information regarding the study. 
Contact details of REC administrator and chair - Rene Wills can also be contacted for any 
questions regarding the study ethics at 011 274 9278. 
Your participation in this study is greatly appreciated. If you are happy to participate in this 
study, kindly read and sign the attached consent form. 
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APPENDIX 3: CAREGIVER INFORMED CONSENT 
 
Caregiver informed consent 
I agree to myself being a participant in the SWEET study, a sub-study of Birth to Twenty 
The goals and methods of SWEET study are clear to me. 
I understand that the study will involve interviews. All the details and purposes of this study 
have been explained to me. I understand that I have the right to refuse to participate in the 
study. 
I agree to participation in the study on the condition that: 
I can withdraw from the study at any time voluntarily and that no adverse consequences will 
follow on withdrawal from the study. 
I have the right not to answer any or all questions posed in the interviews and not to 
participate in any or all of the procedures / assessment. 
The University of the Witwatersrand Human Ethics committee has approved the study 
protocol and procedures. 
All results will be treated with the strictest confidentiality. 
Only group results, and not my individual results, will be published in scientific journals and 
in the media. 
The SWEET study scientific team are committed to treating participants with respect and 
privacy through interviews conducted in private and follow-up counselling available on 
request.   
I will receive a referral note to a health service if any result is out of the normal range or a 
problem is detected in the course of the study. 
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PARTICIPANT (Caregiver) 
Printed Name  Signature / Mark or Thumbprint  Date and Time 
 
RESEARCH ASSISTANT: 
Printed Name   Signature    Date and Time 
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APPENDIX 4: ANTHROPOMETRIC MEASUREMENTS 
 
Anthropometry/Measurements 
 
DATE: Day  Month  Year  
Birth to Twenty ID NUMBER:  
 
Measurements 
 Standing height (mm):  
 Weight (kg):  
 Waist circumference (mm):  
 Hip circumference (mm):  
 
Blood pressure 
 (1) (2) (3) 
Systolic BP:    
Diastolic BP:    
Pulse:    
 
Research assistant 
name: 
 Date:  
 
 
 
 
 
 
 
 
 
168 
 
APPENDIX 5: GLOBAL PHYSICAL ACTIVITY QUESTIONNAIRE  
 
PHYSICAL ACTIVITY (Modified STEPs Core data set) 
The next questions are about the time you spend doing different types of physical activities.  This includes activities 
you do at home, at work, travelling from place to place and during your spare time.  You are requested to answer 
the questions even if you don’t consider yourself to be an active person. 
Occupation-related Physical Activity (paid or unpaid work):   
When answering the following questions, think back over the past 12 months and consider (think of) a usual week:  
1 Does your work involve mostly sitting or standing still, OR 
walking for very short periods (less than 10 minutes)? 
YES .......................................................... 1 
NO ............................................................ 2 
(If Yes, go to 4) 
2a Does your work involve vigorous activities, (like heavy lifting, 
digging, or heavy construction) for at least 10 minutes at a 
time? 
YES .......................................................... 1 
NO ............................................................ 2 
(If No, go to 3a) 
2b In a usual week, how many days do you do vigorous activities 
as part of your work? 
  
DAYS_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _  ─┴──┘ 
2c On a usual day on which you do vigorous activities, how much 
time do you spend doing such work? 
___________ HOURS ________ 
MINUTES 
3a Does your work involve moderate-intensity activities (like 
brisk walking or carrying light loads) for at least 10 minutes 
at a time? 
YES .......................................................... 1 
NO ............................................................ 2 
(If No, go to 4) 
3b 
In a usual week, how many days do you do moderate-intensity 
activities as part of your work? 
 
DAYS_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ 
3c 
On a usual day on which you do moderate-intensity activities, 
how much time do you spend doing such work? 
___________ HOURS ________ 
MINUTES 
4 How long is your usual workday? 
___________ HOURS ________ 
MINUTES 
Travel-related Physical Activity: Other than activities that you’ve already mentioned; I would like to ask you 
about the way you travel to and from places (to work, to shopping, to market, to church, etc). 
5a 
Do you walk or use a bicycle (pedal cycle) for at least 10 
minutes at a time to get to and from places? 
YES .......................................................... 1 
NO ............................................................ 2 
(If No, go to 6) 
5b 
In a usual week, how many days do you walk or cycle for at 
least 10 minutes to get to and from places? 
 
DAYS_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ 
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5c 
On a usual day, how much time do you spend walking and 
cycling for travel 
___________ HOURS ________ 
MINUTES 
Non-work related and leisure time Physical Activity:  The next questions ask about activities you do in your 
leisure or spare time, for recreation or fitness.  Do not include the physical activities you do at work or for travel 
already mentioned 
6 
In your leisure or spare time do you do any vigorous or 
moderate-intensity physical activity lasting more than 10 
minutes at a time? 
YES .......................................................... 1 
NO ............................................................ 2 
(If No, go to 9) 
7a 
In your leisure or spare time, do you do any vigorous activities 
(like running or strenuous sports, weightlifting) for at least 10 
minutes at a time? 
YES .......................................................... 1 
NO ............................................................ 2 
(If No, go to 8a) 
7b 
IF YES, in a usual week, how many days do you do vigorous 
activities as part of your leisure or spare time? 
 
DAYS_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ 
7c How much time do you spend doing this on a usual day? 
___________ HOURS ________ 
MINUTES 
8a 
In your leisure or spare time, do you do any moderate-intensity 
activities (like brisk walking, cycling or swimming) for at 
least 10 minutes at a time? 
 
YES .......................................................... 1 
NO ............................................................ 2 
(If No, go to 9) 
8b 
IF YES, in a usual week, how many days do you do moderate-
intensity activities as part of your leisure or spare time? 
 
DAYS_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ 
8c How much time do you spend doing this on a usual day? 
___________ HOURS ________ 
MINUTES 
Sitting / Resting Activity:  Now I would like to ask you about the time spent sitting or resting, not including 
sleeping, in the past 7 days.  This may include time sitting at a desk, visiting friends, reading, or sitting down to 
watch television during working hours and leisure or spare time. 
9. 
Over the past 7 days, how much time did you spend sitting or 
reclining (lying) on a usual day (exclude sleeping)? 
___________ HOURS ________ 
MINUTES 
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APPENDIX 6: BODY–SIZE DISCREPANCY 
 
 
1. Which one of the body image silhouettes looks the most like your body? 
2. Which one of the body image silhouettes would you like your body to look like? 
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APPENDIX 7: CONSUMPTION OF HIGH–FAT FOODS, SMOKING, ALCOHOL 
AND WEIGHT MANAGEMENT 
 
1. Which of the following do you usually eat most of the time? 
 None Yes 
Chicken (with skin)   
Red meat (fatty cuts)   
Fried eggs   
Fried fish   
French fries   
Full cream milk   
Processed meats   
Crisps   
Margarine spread on bread   
Butter on bread   
 
2. Have you ever smoked? 
No Yes 
 
If yes, do you currently smoke? 
No Yes 
 
3. Do you use snuff? 
No Yes 
 
4. How would describe your alcohol intake? 
None Less than 1 drink per day 1–3 drinks per day >3 drinks per day 
 
5. How often during the past 2 years have you tried to lose weight (mark one only) 
0 
time 
1 
time 
2 
times 
3 or more 
times 
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APPENDIX 8: SOCIO–ECONOMIC INFORMATION 
 
1. Which one of the following do you have in your household at the present time? 
 
 Yes No 
Electricity   
Television   
Radio   
Motor vehicle   
Fridge   
Washing machine   
Telephone   
Video machine   
Electronic media network (MNET)   
Satellite television (DSTV)   
Cellular telephone   
 
2. What is your current level of formal education (mark one)? 
 
None  
Grade 1  
Grade 2  
Grade 3  
Grade 4  
Grade 5  
Grade 6  
Grade 7  
Grade 8  
Grade 9  
Grade 10  
Grade 11  
Grade 12  
Tertiary education  
 
3. Are you currently employed? 
No Yes 
 
3.1. If yes, what type of employment? 
----------------------------------------------------------------------------------- 
4. What is your current level of formal education (mark one)? 
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APPENDIX 9: PUBLICATION–Patterns, levels and correlates of self–reported physical 
activity in urban Soweto women 
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APPENDIX 10: PUBLICATION–The role of lifestyle and psycho–social factors in 
predicting changes in body composition in black South African women 
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APPENDIX 11: SUPPLEMENTARY TABLE 3.1 
 
Supplementary Table 3.1: Multiple regression models for anthropometric and metabolic 
variables using observed data 
 
Dependent 
variable 
N Independent 
variables 
Coefficients ( 95% 
Confidence 
Interval)‡ 
Beta 
Coefficients† (p-
value) 
Adjusted 
 R
2
 (p-
value) 
Fasting blood 
glucose  
530 Age 
Waist 
circumference 
0.0013 (0.0002, 
0.0025) 
0.0008 (0.00001, 
0.0015) 
 
0.09 (0.03) 
0.10 (0.03) 
0.02 
(0.002) 
Fasting insulin  310 Age 
Waist 
circumference 
-0.003 (-0.006, 
0.0009) 
0.007 (0.004, 0.009) 
 
-0.08 (0.15) 
0.31 (<0.001) 
0.09 
(<0.001) 
High density 
lipoprotein 
cholesterol 
455 Age 
Waist 
circumference 
-0.002 (-0.006, 
0.0011) 
-0.003(-0.005, -
0.0004) 
 
-0.06 (0.18) 
-0.12 (0.02) 
0.02 
(0.006) 
Low density 
lipoprotein 
cholesterol  
455 Age 
Waist 
circumference 
0.007 (0.004, 0.009) 
0.002 (0.0008, 
0.004) 
 
0.26 (<0.001) 
0.14 (0.002) 
0.11 
(<0.001) 
Total cholesterol 456 Age 
Waist 
circumference  
Walking for 
travel 
0.05 (0.03, 0.07) 
0.008 (-0.005, 0.02) 
-0.0004(-0.0009, 
0.00008) 
 
0.23 (<0.001) 
0.06 (0.23) 
-0.09 (0.05) 
0.07 
(<0.001) 
Systolic blood 
pressure 
602 Age 
Waist 
circumference 
0.002 (0.0015, 
0.003) 
0.0009 (0.0006, 
0.001) 
 
0.23 (<0.001) 
0.17 (<0.001) 
0.10 
(<0.001) 
Diastolic blood 
pressure 
599 Age 
Waist 
circumference  
Sitting time 
0.21 (0.11, 0.32) 
0.20 (0.13, 0.26) 
0.001 (0.0002, 
0.002) 
 
0.13 (<0.001) 
0.20 (<0.001) 
0.08 (0.01) 
0.07 
(<0.001) 
Fat mass 636 Age 
SES score 
238 (139, 337) 
66.8 (25.5, 108) 
 
0.18 (0.001) 
0.12 (0.002) 
0.05 
(<0.001) 
Fat free soft tissue 
mass 
636 Age 
SES score 
Work MVPA 
13.2 (-43.4, 69.8) 
27.6 (3.93, 51.2) 
0.69 (0.12, 1.26) 
 
0.02 (0.65) 
0.09 (0.02) 
0.09 (0.02) 
0.02 
(<0.001) 
Waist 925 Age 0.35 (0.25, 0.45) 0.21 (<0.001) 0.04 
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APPENDIX 12: SUPPLEMENTARY TABLE 3.2 
 
Supplementary Table 3.2: Pearson’s correlations for body composition and metabolic 
outcomes 
 
Variabl
e 
Fasti
ng 
gluc
ose 
Fasti
ng 
insul
in 
HO
MA 
HDL LDL Triglyc
erides 
Total 
chole
sterol 
Syst
olic 
bloo
d 
pres
sure 
Dias
tolic 
bloo
d 
pres
sure 
Tota
l 
body 
fat 
Fat-
free, 
soft-
tissu
e 
mass 
Waist 
circumf
erence 
Age 0.12 
(<0.0
001) 
0.01 
(0.84
) 
-0.08 
(0.02
) 
-0.09 
(0.01
) 
0.31 
(<0.0
001) 
0.08 
(0.02) 
0.27 
(<0.0
001) 
0.28 
(<0.0
001) 
0.18 
(<0.0
001) 
0.15 
(<0.0
001) 
0.01 
(<0.8
2) 
0.21 
(<0.000
1) 
SES 
score 
-0.01 
(0.88
) 
0.07 
(0.04
5) 
0.74 
(0.04
) 
0.01 
(0.84
) 
-0.04 
(0.70
) 
-0.03 
(0.38) 
0.04 
(0.22) 
-0.08 -0.05 0.15 0.08 0.21 
Sitting 
time 
0.03 
(0.45
) 
0.00
4 
(0.90
) 
-0.02 
(0.51
) 
0.09 
(0.01
) 
-0.07 
(0.04
) 
0.12 
(<0.00
01) 
-0.11 
(0.00
1) 
0.04 
(0.22
) 
0.07 
(0.03
) 
-0.06 
(0.05
) 
-0.04 
(0.17
) 
-0.04 
(0.07) 
Total 
MVPA 
0.08 
(0.01
) 
-0.10 
(0.00
2) 
-0.14 
(<0.0
001) 
0.09 
(0.01
) 
-0.05 
(0.14
) 
0.06 
(0.06) 
-0.06 
(0.08) 
0.04 
(0.26
) 
0.05 
(0.16
) 
0.01 
(0.69
) 
0.05 
(0.14
) 
0.05 
0.13) 
Total 
work 
MVPA 
0.03 
(0.31
) 
-0.09 
(0.01
) 
-0.12 
(<0.0
001) 
0.10 
(0.00
3) 
-0.01 
(0.71
) 
0.06 
(0.09) 
-0.04 
(0.19) 
0.03 
(0.36
) 
0.02 
(0.55
) 
0.02 
(0.57
) 
0.71 
(0.03
) 
0.05 
(0.14) 
Total 
walkin
g for 
travel 
0.11 
(0.00
1) 
0.01 
(0.75
) 
-0.02 
(0.42
) 
0.78 
(0.02
) 
-0.07 
(0.03
) 
0.03 
(0.33) 
-0.10 
(0.00
4) 
-
0.00
3 
(0.93
) 
0.04 
(0.18
) 
-0.01 
(0.72
) 
-0.04 
(0.27
) 
0.002 
(0.94) 
Total 
leisure 
MVPA 
0.03 
(0.41
) 
-0.02 
(0.50
) 
-0.04 
(0.27
) 
0.02 
(0.55
) 
-0.09 
(0.01
) 
0.02 
(0.53) 
-0.10 
(0.00
4) 
0.02 
(0.53
) 
0.03 
(0.32
) 
-
0.00
2 
(0.95
) 
0.03 
(0.32
) 
0.02 
(0.50) 
Total 
fat 
mass 
0.09 
(0.02
) 
0.30 
(<0.0
001) 
0.21 
(<0.0
001) 
-0.11 
(0.01
) 
0.15 
(<0.0
001) 
0.05 
(0.19) 
0.08 
(0.06) 
0.18 
(<0.0
001) 
0.25 
(<0.0
001) 
- 0.74 
(<0.0
001) 
0.85 
(<0.000
1) 
Fat-
free, 
soft-
tissue 
mass 
0.09 
(0.00
4) 
0.23 
(<0.0
001) 
0.15 
(<0.0
001) 
-0.09 
(0.01
) 
0.14 
(<0.0
001) 
0.02 
(0.54) 
0.06 
(0.07) 
0.12 
(<0.0
001) 
0.15 
(<0.0
001) 
0.79 
(<0.0
001) 
- 0.75 
(<0.000
1) 
Waist 
circumf
erence 
0.13 
(<0.0
001) 
0.32 
(<0.0
001) 
0.21 
(<0.0
001) 
-0.17 
(<0.0
001) 
0.24 
(<0.0
001) 
0.04 
(0.23) 
0.14 
(<0.0
001) 
0.24 
(<0.0
001) 
0.25 
(<0.0
001) 
0.83 
(<0.0
001) 
0.75 
(<0.0
001) 
- 
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APPENDIX 13: SUPPLEMENTARY TABLE 4.1 
 
Supplementary Table 4.1:  Comparison between body composition, lifestyle and psychosocial 
characteristics of black African women with and without DXA data at both time points  
 
Variable 
Women with DXA at 
both time points 
(n=264) 
Women without DXA 
at both time points 
(n=164) 
Age (years) 42.0 ± 5.50 39.4 ± 4.62* 
Body mass index (kg.m
-2
) 30.5 ± 6.32 31.3 ± 7.33 
Waist circumference (cm) 88.3 ± 12.9 86.2 ± 13.6 
Hip circumference (cm) 113 ± 12.9 115 ± 15.0 
Sitting time (mins.wk
-1
) 1260 (840-1680) 1260 (840-2100) 
Physical activity (mins.wk
-1
) 300 (140-840) 480 (180-1440) 
Current smokers 9 (3.53%) 4 (2.86%) 
Alcohol use 47 (18.4%) 25 (17.6%) 
Feel minus ideal index (FID) 0.92 ± 1.53 1.24 ± 1.62 
Perceived minus actual weight status 
discrepancy score (PAD) 
-0.95 ± 0.75 -0.84 ± 0.68 
 
*P<0.005; data given as mean ± SD, median (interquartile range) or n (%) 
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APPENDIX 14: SUPPLEMENTARY TABLE 4.2 
 
Supplementary Table 4.2: Comparison between baseline FID groups at baseline for follow-up 
body composition measures 
Variable 
Subjects who wanted 
to be fatter 
Subjects who were 
content with their 
body shape 
Subjects who wanted 
to be leaner 
BMI (kg.m
-2
) 26.5 ± 4.90 (44) 31.0 ± 5.65(137)
†
   35.5 ± 7.50 (247)
††† ***
   
Waist circumference 
(cm) 
87.7 ± 12.3 (43) 94.7 ± 11.5 (134) 103 ± 15.1 (238)
††† ***
   
Hip circumference 
(cm) 
105 ± 10.9 (43) 114 ± 11.5 (133) 123 ± 15.6 (237)
††† ***
   
Fat mass (kg) 24.2 ± 9.0 (32) 31.4 ± 9.53 (84) 35.4 ± 10.1 (148)
††† *
   
Fat free soft tissue 
mass (kg) 
41.6 ± 7.08 (32) 43.5 ± 6.24 (84) 46.7 ± 7.48 (264)
††† ***
   
Central adiposity 
(kg) 
10.1 ± 4.34 (30) 13.5 ± 4.69 (84) 15.8 ± 5.32 (147)
††† *
  
Peripheral adiposity 
(kg) 
13.2 ± 4.75 (30) 17.1 ± 5.51 (84) 19.1 ± 5.71 (147)
††† *
  
 
Data presented as mean ± SD (n); 
†
P<0.05, 
†††
P<0.0005 versus subjects who wanted to be 
fatter; 
*
P<0.05, 
***
P<0.0005 versus subjects who were content with body shape; abbreviation, 
body mass index (BMI)
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APPENDIX 15: SUPPLEMENTARY TABLE 4.3 
 
Supplementary Table 4.3: Comparison between PAD groups at baseline for follow-up body 
composition measures 
Variable 
Subjects who 
underestimated 
actual body weight 
Subjects who 
accurately perceived 
actual body weight 
Subjects who 
overestimated actual 
body weight 
BMI (kg.m
-2
) 34.7 ± 6.57 (316) 29.0 ± 7.62 (103) 23.3 ± 4.37 (9)
††† ***
   
Waist circumference 
(cm) 
102 ± 13.5 (307) 90.8 ± 14.7 (97) 82.7 ± 11.1 (9)
††† *
  
Hip circumference 
(cm) 
121 ± 13.9 (306) 111 ± 15.5 (96) 99.1 ± 11.2 (9)
††† *
  
Fat mass (kg) 35.2 ± 9.65 (198) 26.3 ± 9.82 (59) 18.3 ± 9.06 (6)
††† ***
   
Fat free soft tissue 
mass (kg) 
46.8 ± 6.69 (198) 40.6 ± 6.20 (59) 32.5 ± 3.85 (6)
††† ***
   
Central adiposity 
(kg) 
15.8 ± 4.71 (196) 10.6 ± 4.83 (58) 7.28 ± 4.23 (6)
††† ***
   
Peripheral adiposity 
(kg) 
18.9 ± 5.49 (196) 14.9 ± 5.41 (58) 10.2 ± 5.16 (6) 
 
Data presented as mean ± SD (n); 
†
P<0.05, 
†††
P<0.0005 versus subjects who underestimated 
actual body weight; 
*
P<0.05, 
***
P<0.0005 versus subjects who accurately perceived actual 
body weight; abbreviation, body mass index (BMI) 
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APPENDIX 16: SUPPLEMENTARY TABLE 5.1 
 
Supplementary Table 5.1: Anthropometric and metabolic variables in women with and 
without metabolic syndrome
†
  
Variables Women with 
metabolic syndrome
†
 
(n=320) 
Women without 
metabolic syndrome 
(n=325) 
Age (years) 50.1 ± 5.33 48.5 ± 5.13
**
 
BMI (kg.m
-2
) 35.4 ± 6.6 30.9 ± 6.98
***
 
Waist (cm) 104 ± 11.6 93.4 ± 14.4
***
 
Hip (cm) 122 ± 13.5 114 ± 14.6
***
 
Arm fat (kg) 4.08 ± 1.14 3.36 ± 1.25
***
 
Arm FFSTM (kg) 4.70 ± 0.86 4.20 ± 0.75
***
 
Leg fat (kg) 14.8 ± 4.31 13.5 ± 4.72
***
 
Leg FFSTM (kg) 16.3 ± 2.77 14.9 ± 2.78
***
 
Trunk fat (kg) 16.1 ± 4.37 12.7 ± 5.15
***
 
Trunk FFSTM (kg) 23.0 ± 3.18 20.6 ± 3.08
***
 
Total body fat (kg) 35.0 ± 8.76 29.5 ± 10.3
***
 
Total FFSTM (kg) 44.0 ± 6.43 39.7 ± 6.26
***
 
Subcutaneous fat thickness (cm) 3.49 ± 1.01 3.35 ± 1.03 
Visceral fat thickness (cm) 4.89 ± 1.54 3.94 ± 1.76
***
 
Systolic blood pressure (mmHg) 138 [128, 150] 121 [113, 136]
***
 
Diastolic blood pressure (mmHg) 91.5 [86.5, 99.5] 81.2 [75.0, 90.5]
***
 
HbA1c (%) 5.90 [5.60, 6.50] 5.70 [5.40, 6.10]
***
 
Fasting glucose (mmol.L
-1
) 5.00 [4.60, 5.70] 4.60 [4.30, 4.90]
***
 
Insulin (pmol.L
-1
) 12.0 [7.80, 17.3] 8.32  [5.65, 12.8]
***
 
HOMA 2.65 [1.75, 4.45] 1.76 [1.19, 2.69]
***
 
Adiponectin (μg.mL-1) 5.91 [3.78, 8.62] 8.47 [5.51, 12.6]*** 
Leptin (ng.mL
-1
) 31.1 [18.6, 45.9] 22.7 [13.1, 40.5]
***
 
Total cholesterol (mmol.L
-1
) 4.38 ± 1.04 4.61 ± 1.05 
LDL (mmol.L
-1
) 2.71 ± 0.88 2.75 ± 0.90 
HDL (mmol.L
-1
) 1.10 [0.90, 1.20] 1.40 [1.10, 1.60]
***
 
Triglycerides (mmol.L
-1
) 1.30 [0.90, 1.70] 1.00 [0.70, 1.30]
***
 
Employed (%) 57.5 (52.1, 62.9) 57.7 (52.3, 63.1) 
Completed high school education (%) 26.6 (21.7, 31.5) 33.6 (28.4, 38.9) 
Smokers (%) 9.37 (6.16, 12.6) 7.38 (4.53, 10.2) 
Consume snuff (%) 19.1 (14.8, 23.5) 21.4 (16.9, 25.9) 
†
Metabolic syndrome diagnosis was made in subjects in whom 3 or more of the following 5 
variables exceeded the cut points set out by the harmonised guidelines (2): waist 
circumference, blood pressure, glucose, triglyceride and HDL levels; data expressed as mean 
± SD or median [interquartile range] or % (95% CIs); BMI: body mass index; FFSTM: fat–
free, soft– tissue mass; HOMA: homeostasis model assessment; *p < 0.05, **p < 0.005, ***p < 
0.0005 vs women with metabolic syndrome 
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